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ABSTRACT 
Maternal obesity and excessive gestational weight gain cause a perpetuating “vicious 
cycle” of obesity, where obese women or women who gain excess gestational weight have a 
higher risk of giving birth to large for gestational age  infants, who then, years later, can 
become obese adults entering into their own pregnancies. Many observational studies have 
supported the role of physical activity (PA) in helping pregnant women to minimize, if not 
prevent, excessive gestational weight gain (GWG). Since maternal PA has potential to 
prevent excessive GWG and decrease the risk for delivering large-for-gestational-age (LGA) 
infants, identifying strategies to help pregnant women increase their PA participation during 
gestation becomes critical in light of the increasing obesity prevalence for both adults and 
children.  
The Blossom Project team of Iowa State University conducted a pilot randomized 
controlled trial entitled ‘Moms to Move’ (M2M). The objectives of M2M study were 1) to 
promote moderate PA participation among previously non-exercising, overweight and obese 
pregnant women, via walking,; 2) and to evaluate the impact of increased moderate PA on 
GWG and birth outcomes The intervention in this study was a walking program, which 
participants in the intervention group were informed the current physical activity guidelines, 
150 minutes of moderate PA spread through the week, and were given a treadmill for home 
use. The results of the study showed that there were significantly more moderately intense 
cadence (cadence ≥80 steps/min) among the women in the intervention group compared to 
control group at V2 (overweight p < 0.0001; obese p < 0.025), V3 (overweight p < 0.0001; 
obese p = 0.0722), and V4 (overweight p < 0.0001; obese p < 0.025). Women in the 
intervention group also significantly increased their meaningful walks at V2 (diff = 32.6 
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min, p = 0.054), V3 (diff = 37.1 min, p = 0.01) and V4 (diff = 35.4 min, p = 0.014). Even 
though it was not statistically significant, there was a trend for women in the intervention 
group to have more favorable pregnancy and birth outcomes compared to the control group.  
Besides evaluating PA participation of the overweight and obese women during 
pregnancy, the study was also set forth to compare exercise self-efficacy (barrier self-
efficacy and task self-efficacy) of participants in the walking intervention versus non-
intervention control group toward the end of the trial, and to examine the relative 
contribution of pre-pregnancy body mass index (BMI), barrier self-efficacy and task self-
efficacy in predicting physical activity amount (step count) at the end of second and late 
third trimesters of pregnancy using an objective measurement tool. The findings of this 
study demonstrated that pregnant women in the walking intervention, which started at the 
beginning of the second trimester (weeks 12-15 of gestation) had a higher barrier and task 
self-efficacy at the end of second (weeks 27-29) and late third trimester.  At V3, task self-
efficacy (r2 = 0.254, p < 0.003) and barrier self-efficacy (r2 = 0.123, p < 0.049) 
independently predicted step count; however task self-efficacy together with pre-pregnancy 
BMI explained 30.0% (p < 0.006) of the variance, which was selected as the best model to 
predict step count.  At V4, task self-efficacy (r2 = 0.234, p < 0.003) and pre-pregnancy BMI 
(r2 = 0.167, p < 0.015) independently predicted step count, and both variables combined 
explained 35.9% of the variance (p < 0.001), which was selected as the best model to predict 
step count. In summary, task self-efficacy and pre-pregnancy BMI emerged as the major 
contributors to the prediction at both time points. In other words, task self-efficacy together 
with pre-pregnancy BMI were the most proximal determinants of PA participation for 
overweight and obese pregnant women during pregnancy.  
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Lastly, a follow-up study was conducted at one and six months post-partum to obtain 
the maternal post-partum weight and child outcomes. The purposes of this follow-up study 
were 1) to compare maternal weight retention of participants enrolled in the walking 
intervention during pregnancy versus the control group, as well as their child outcomes 
(weight-for-length z-score, fat mass and % fat mass); 2) to examine the relationship between 
pre-pregnancy BMI and rates of GWG at different time points during pregnancy with 
maternal weight retention and weight-for-length z-scores of infants. At six months post-
partum, obese women in the intervention group retained less than 1% of their maternal 
weight compared to 7% weight retention among obese women in the control group. Obese 
women in the control group experienced a 3.54% weight gain from one month to six months 
post-delivery. In contrast, obese women in the intervention group reduced their weight by 
1.22% from one month to six months post-delivery. Although not statistically significant, 
there was a tendency for the offspring of obese women in the intervention group to have 
lower WLZ scores at one month and six months old. In fact, this trend starts at birth; as 
obese women who participated in the walking intervention had lower infant birth weight z-
scores and decreased odds of fetal macrosomia. In addition, percentage of weight retention 
and WLZ scores were significantly correlated with rate of GWG especially at the early time 
points during pregnancy. 
Taken together, the findings reported in this dissertation, suggest that targeting PA 
interventions for overweight and obese women during pregnancy could be a promising 
starting point for obesity prevention.  
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CHAPTER 1: GENERAL INTRODUCTION 
Introduction 
The rate of obesity is rapidly increasing worldwide, and the prevalence of obesity in 
the United States continues to remain one of the highest (World Health Organization, 2012). 
In the past two decades, the incidence of obesity among children has also rapidly increased. 
Within the United States, the National Health and Nutrition Examination Survey 
(NHANES) 2009 – 2010 showed that 9.7% of infants and toddlers had a high weight-for-
recumbent length and 16.9% of children and adolescents from 2 through 19 years of age 
were obese (Ogden, Carroll, Kit, & Flegal, 2012). These values are concerning, as obese 
children and adolescents are more likely to become obese adults and possess obesity-
associated morbidities (Daniels, 2006). 
The development of chronic disease, such as obesity, has largely been attributed to 
unhealthy lifestyle choices or uncontrollable genetic predispositions. However, emerging 
evidence reveals that one’s exposure within the intrauterine environment may play a pivotal 
role in the development and progression of chronic disease  (D. J. P. Barker, 2007; Matthew 
W Gillman, 2005; Oken & Gillman, 2003; Wadhwa, Buss, Entringer, & Swanson, 2009). 
This theory, the “Developmental Origins of Health and Disease (DOHaD)”, or better known 
as “Barker’s hypothesis”, proposes intrauterine stress from nutrient deficiency in utero can 
permanently alter fetal organ systems, a process called fetal programming (D. J. P Barker, 
Winter, Osmond, Margetts, & Simmonds, 1989; D. J. P. Barker, 2007; Osmond, Barker, 
Winter, Fall, & Simmonds, 1993). While initially proposed to account for health 
consequences of small for gestational age infants, the DOHaD hypothesis has been recently 
used to gain a better understanding of the obesity epidemic (Adamo, Ferraro, & Brett, 2012; 
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Dabelea & Crume, 2011; Oken & Gillman, 2003). The DOHaD hypothesis elucidates how 
an unfavorable intrauterine environment due to maternal obesity and excessive gestational 
weight gain (GWG) increases the risk of obesity in the offspring. These two factors cause a 
perpetuating “vicious cycle” of obesity, where obese women or women who gain excess 
gestational weight have a higher risk of giving birth to large for gestational age (LGA) 
infants, who then, years later, can become obese adults entering their own pregnancies 
(Oken, 2009a). Higher birth weight is associated with higher attained BMI later in life 
(Curhan et al., 1996; Dempsey et al., 2004; M W Gillman, Rifas-Shiman, Berkey, Field, & 
Colditz, 2003; Parsons, Power, Logan, & Summerbell, 1999; F. Rasmussen & Johansson, 
1998). In Western and developed countries such as the United States, reproductive-age 
women are more likely to give birth to LGA infants due to an obesogenic environment 
(Dabelea & Crume, 2011). 
Maternal obesity and excessive GWG are two of the main causes of giving birth to a 
LGA infant (Adamo et al., 2012; Dabelea & Crume, 2011; Nelson, Matthews, & Poston, 
2010; Oken, 2009b). The association of maternal obesity and offspring obesity continues 
into childhood, as demonstrated by Whitaker and colleagues who found children ages 2 to 4 
(n = 8494) born to obese mothers had more than twice the likelihood of being obese. By 4 
years of age, one in four children of obese mothers were obese, compared to less than one in 
ten for normal weight mothers (R C Whitaker, 2004). 
Excess GWG also leads to giving birth to LGA infants. Recent reviews (Adamo et 
al., 2012; Nelson et al., 2010; Poston, 2012) have used epidemiological and observational 
data to support the relationship between excessive GWG and offspring obesity. Project 
Viva, a landmark study in the United States, also showed that GWG is directly associated 
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with a child being overweight at age 3 (OR 1.30; 95% CI: 1.04 – 1.62 for each 5 kg of 
GWG) even after adjusting for sociodemographic factors, breastfeeding duration, glucose 
tolerance, and gestation length (Oken, Taveras, Kleinman, Rich-Edwards, & Gillman, 2007). 
These findings support the conclusion that women should avoid excessive weight gain in 
early pregnancy and that overweight or obese women should avoid excessive GWG at all 
costs.  
Weight gain and obesity occur when energy intake exceeds energy expenditure, 
resulting in an energy imbalance. It is well established that healthy eating habits and regular 
physical activity (PA) are two modifiable targets in preventing excessive weight gain and 
should be encouraged among pregnant women. Physical activity during pregnancy has been 
viewed as an important part of reproductive health. According to the American College of 
Obstetrics and Gynecology (ACOG) 2002 guidelines, in the absence of medical or obstetric 
complications, pregnant women can accumulate 30 minutes or more of moderate-intensity 
exercise on most, if not all, days of the week (ACOG Committee Obstetric Practice, 2002). 
The risks of moderate-intensity activity performed by healthy women during pregnancy are 
very low, and it does not increase the risk of low birth weight, preterm delivery, or early 
miscarriage (Downs, Chasan-Taber, Evenson, Leiferman, & Yeo, 2012). However, 
pregnancy itself is a life event which leads to decreases in exercise among many women 
(Brown & Trost, 2003; Godin, Vezina, & Leclerc, 1986; Mottola, 2002). The main 
exception to this finding is walking, a common and popular choice of PA during pregnancy. 
When Mottola and Campbell evaluated activity patterns during pregnancy, they found that 
all categories of activity decreased except walking, which actually increased significantly by 
the 3rd trimester among the 529 women they surveyed (Mottola & Campbell, 2003). Many 
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observational studies have supported the role of PA in helping pregnant women to minimize, 
if not prevent, excessive GWG (J. Clapp & Little, 1995; Haakstad, Voldner, Henriksen, & 
Bø, 2007; Olson & Strawderman, 2003; Stuebe, Oken, & Gillman, 2009). Since maternal 
PA has potential to prevent excessive GWG, decreasing the risk for delivering LGA infants, 
identifying strategies to help pregnant women increase their PA participation during 
gestation becomes critical in light of the increasing obesity prevalence.  
Dissertation Organization 
This dissertation contains a general introduction, a literature review, and three 
manuscripts, followed by a general conclusion. Three manuscripts represent each chapter of 
the dissertation. The second chapter, “A randomized-controlled walking intervention to 
improve pregnancy and birth outcomes by promoting moderate physical activity among 
overweight and obese pregnant women: Moms to Move (M2M) study”, will be submitted to 
the journal Medicine and Science in Sports and Exercise. The third chapter, “Objectively 
measured step count can be predicted by self-efficacy and pre-pregnancy BMI among 
overweight and obese pregnant women in a randomized-controlled trial”, has been 
submitted to the International Journal of Behavioral Nutrition and Physical Activity. The 
fourth chapter, “Impact of a walking intervention during pregnancy on post-partum weight 
retention and infant outcomes”, will be submitted to journal Obesity. Lastly, the appendices 
contain all of the approved documents for the study by the Institutional Review Board of 
Iowa State University, and the blood profiles of the participants, which are not included in 
any of the aforementioned, but will be included in an additional manuscript that is still in the 
developmental stages. 
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CHAPTER 2: LITERATURE REVIEW 
Obesity Overview 
Overweight and obesity are defined as abnormal or excessive fat accumulation that 
may cause adverse health outcomes (World Health Organization, 2012). In adults, Body 
Mass Index (BMI: weight in kilograms divided by the square of the height in meters, kg/m2) 
is used to classify an individual as underweight (BMI < 18.5 kg/m2), normal weight (BMI 
18.5-24.9 kg/m2), overweight (BMI 25.0-29.9 kg/m2) or obese (BMI ≥30.0 kg/m2). Obesity 
is further classified into three levels: Class I obesity (BMI 30.0-34.9 kg/m2), Class II obesity 
(BMI 35.0-39.9, kg/m2) and Class III (BMI ≥ 40.0 kg/m2). In children and adolescents (aged 
2 – 19 years), weight status is determined using an age- and sex-specific percentile for BMI 
as children’s body composition varies at different ages and between the genders (Centers for 
Disease Control and Prevention, 2012a). Body mass index between 85th to 95th percentiles is 
classified as overweight, and BMI above 95th percentile is classified as obese among 
children. 
According to the World Health Organization (WHO), in 2008 more than 1.5 billion 
adults ages 20 and older were classified as overweight and 500 million were identified as 
obese (World Health Organization, 2012). Obesity is considered a major public health 
problem in developed, industrialized countries, primarily the United States and Europe. 
More recently, developing countries like Mexico, China, and Thailand have seen the most 
dramatic increases in obesity rates (Popkin & Gordon-Larsen, 2004). A phenomenon known 
as the nutrition paradox is observed in many developing countries (Caballero, 2005). In 
these countries, the issues of hunger and obesity co-exist not only in different regions of the 
country, but within the same family. Despite the increasing rate of obesity worldwide, the 
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prevalence of obesity in the United States continues to be one of the highest (World Health 
Organization, 2011). According to the latest data from U.S. Centers for Disease Control and 
Prevention (CDC), more than one-third of the U.S. adults are obese (Centers for Disease 
Control and Prevention, 2012b). Obesity rates in the United States range from 34.9% in 
Mississippi (highest) to 20.7% in Colorado (lowest) and clinically severe (>100 lbs. [45 kg] 
overweight) obesity rates continue to increase rapidly. In 2000, 3.9% of U.S. adults had a 
BMI 40 kg/m2or greater, this percentage grew to 6.55% by 2010 (Sturm & Hattori, 2012). A 
report released by Trust for America’s Health (TFAH) and the Robert Wood Johnson 
Foundation (RWJF) in 2012 indicated that if obesity rates continue to follow current trends, 
39 states could have obesity rates above 50%, with the highest at 66.7% (Mississippi) and 
lowest at 44.8% (Colorado) (F as in fat: how obesity threatens America’s future 2012, 
2012).  
In the past two decades, the incidence of obesity among children has started to 
increase. In 2010, more than 43 million children under the age of five were overweight 
worldwide (World Health Organization, 2012). In the United States, the National Health and 
Nutrition Examination Survey (NHANES) 2009-2010 showed that 9.7% of infants and 
toddlers had a high weight-for-recumbent length and 16.9% of children and adolescents 
from 2 through 19 year old were obese (Ogden et al., 2012). Interestingly, this data had not 
changed compared to 2007-2008 NHANES data despite the vigorous effort put forth by the 
government and different institutes. Childhood and adolescent obesity continues to be a 
major concern as research has indicated obese children and adolescents are more likely to 
become obese adults and possess obesity-associated morbidities (Daniels, 2006). 
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Obesity markedly impairs overall quality of life (Fontaine & Barofsky, 2001). It is 
associated with increased risk of type 2 diabetes (Eckel et al., 2011), cardiovascular disease 
(Krauss, Winston, Fletcher, & Grundy, 1998), mental disease (Scott, McGee, Wells, & 
Oakley Browne, 2008), certain types of cancer (Vucenik & Stains, 2012), as well as overall 
mortality (Allison, Fontaine, Manson, Stevens, & VanItallie, 1999). The health care costs of 
obesity-related diseases has become a severe burden to the government and society 
(Voelker, 2012). It is estimated that, by 2030, the price tag of treating obesity related 
diseases will add up to $66 billion if current trends are not halted. The medical costs for an 
obese person are estimated to be $1429 higher than a normal weight individual (Centers for 
Disease Control and Prevention, 2012b).  
Maternal Obesity  
A) Overview of the prevalence 
The rate of obesity in women is alarming. Among the 1.5 billion overweight 
individuals worldwide, 300 million of them were obese women in 2008 (World Health 
Organization, 2012). As a result, the population of obese childbearing women is also 
increasing (Zera, McGirr, & Oken, 2011). In the United States, approximately two-thirds of 
childbearing age women were either overweight or obese in 1999-2004. For women, Class I 
and II obesity doubled and class III obesity tripled between 1979 and 2004 (K. Rasmussen 
& Yaktine, 2009). Flegal and colleagues reported that 14.7% of women aged 20 to 39 years 
had a BMI 30-34.9 kg/m2 (Class I obesity); 9.7% had a BMI 35-39.9 kg/m2  (Class II 
obesity), and 7.5% had a BMI ≥ 40 kg/m2 (Class III obesity) (Flegal, Carroll, Kit, & Ogden, 
2012). By the age of 44, 85% of women have had at least one pregnancy (Johnson et al., 
2006) and unfortunately statistics show that 53.4% of them were overweight or obese when 
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becoming pregnant (Centers for Disease Control and Prevention, 2010). High maternal BMI 
is associated with many adverse health outcomes for the mother and fetus, which will be 
discussed further below. Therefore, women are encouraged to conceive at a normal BMI. 
One of the goals of the Healthy People 2020, which is put forth by the US Department of 
Health and Human Services (HHS) once every decade, is that 53.4% of women should have 
a healthy weight (BMI 18.5-24.9 kg/m2) before pregnancy by 2020 (MICH- 16.5) (Healthy 
People 2020, 2012). This goal is a 10% improvement from the level observed in 2007.  
B) Adverse health outcomes in obese pregnancies 
Obesity, independent of gestational weight gain (GWG), is linked to many adverse 
pregnancy outcomes including the health of the pregnant woman and her baby. Evidence 
from a substantial body of literature is sufficient to consider an obese pregnancy an “at risk” 
pregnancy (Baeten, Bukusi, & Lambe, 2001; Cnattingius, Bergström, Lipworth, & Kramer, 
1998; Nelson et al., 2010; Sebire et al., 2001). In this literature review, selected adverse 
obstetric outcomes are highlighted (gestational diabetes, gestational hypertension, 
labor/delivery complications, and maternal and fetal deaths). The outcomes noted are seen 
more frequently and/or more severe pertaining to the issue of obesity during pregnancy; 
however, a more comprehensive overview of maternal and fetal risks of maternal obesity 
can be found in Figure 1. 
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Figure 1: Risks associated with pregnancies complicated by overweight or obesity. The x-
axis shows the time course and the y-axis illustrates the degree of elevated risk (OR) for 
each outcome based on published literature. Adapted from (Adamo et al., 2012). 
a) Gestational diabetes mellitus (GDM) 
 During pregnancy, fasting glucose decreases and hepatic glucose production 
increases progressively with gestation. The increase of insulin secretion does not suppress 
the hepatic glucose production, which leads to a phenomenon called maternal hepatic insulin 
resistance (Lain & Catalano, 2007). In other words, insulin sensitivity decreases during 
pregnancy. The reasons for the changes in insulin sensitivity during pregnancy are uncertain, 
but it is believed that several hormones (i.e.: human placental lactogen (HPL), progesterone 
and prolactin) and cytokine (i.e.: tumor necrosis factor- (TNF-)) that are elevated during 
pregnancy could play a role (Lain & Catalano, 2007). The decrease in insulin sensitivity is 
further exacerbated with obesity (S. Chu, Callaghan, et al., 2007; Sebire et al., 2001; Torloni 
et al., 2009). A meta-analysis conducted by Chu et al., which included twenty studies on 
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GDM revealed that the unadjusted odds ratio (OR) of overweight, obese, and severely obese 
pregnant women in developing GDM were 2.14 (95% confidence interval (CI): 1.82 – 2.53), 
3.56 (3.05 – 4.21), and 8.56 (5.07 – 16.04) respectively compared to normal weight pregnant 
women (S. Chu, Callaghan, et al., 2007). On the other hand, each year approximately 3 – 
15% of pregnant women develop GDM, depending on the population and diagnostic test 
used (Yogev & Catalano, 2009). Multiple risk factors are associated with the development 
of GDM. These include ethnicity, previous history of GDM, age, parity, and family history 
of diabetes; however, obesity is an independent risk factor and plays a significant 
contribution. According to the findings of Kim et al., the percentage of GDM attributed to 
overweight, obesity, and extreme obesity was 46.2% (95% CI: 36.1 – 56.3) using 2003 birth 
certificate information from the Pregnancy Risk Assessment Monitoring System (PRAMS) 
(Kim et al., 2010). Gestational diabetes mellitus not only causes a “high risk” pregnancy due 
to the potential delivery complications, but women with GDM have an increased risk of 
developing type 2 diabetes mellitus later in life (Bellamy, Casas, Hingorani, & Williams, 
2009), and  their children are at greater risk of developing obesity later in life (Poston, 
Harthoorn, & Van Der Beek, 2011).  
b) Gestational hypertension and pre-eclampsia 
 Hypertensive disorder during pregnancy is defined as new onset of hypertension 
after 20 weeks of gestation. If it is associated with proteinuria, this condition is called pre-
eclampsia. Pre-eclampsia is diagnosed when proteinuria is shown by one or more on 
proteinuria test results of  ≥300 mg per 24-hour urine collection (Oteng-Ntim & Doyle, 
2012). The risk of developing gestational hypertension or pre-eclampsia increases greatly 
with increasing pre-pregnancy BMI (Bhattacharya, Campbell, Liston, & Bhattacharya, 2007; 
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O’Brien, Ray, & Chan, 2003; Sebire et al., 2001). According to Bhattacharya et al.’s study, 
among 24,241 nulliparous women with singleton pregnancies delivering in Aberdeen, UK, 
morbidly obese women had the highest risk of pre-eclampsia (OR 7.2; 95% CI: 4.0 – 11.2), 
followed by moderate obese women (OR 3.1; 95% CI: 2.8 – 3.5), and overweight women 
(OR 1.6; 95% CI: 1.2 – 1.8) compared to women with normal BMI (Bhattacharya et al., 
2007). When using waist circumference (measured between 10 to 12 weeks of gestation) as 
a risk marker, Sattar and colleagues also showed that among 1142 participants, those with a 
waist circumference greater than 80 cm, a conventional, non-pregnant waist circumference 
action level (Lean, Han, & Morrison, 1995), had a twofold greater risk (OR 1.8; 95% CI: 1.1 
– 2.9) of developing gestational hypertension and a threefold greater risk (OR 2.7; 95% CI: 
1.1 – 6.8) of developing pre-eclampsia (Sattar et al., 2001). The risk of pre-eclampsia 
doubled with each 5-7 kg/m2 increase in pre-pregnancy BMI (O’Brien et al., 2003). Besides 
the immediate, adverse maternal, and neonatal outcomes, pre-eclampsia can lead to a higher 
risk of developing cardiovascular disease among women in later life (Bellamy, Casas, 
Hingorani, & Williams, 2007; Craici, Wagner, Hayman, & Garovic, 2008; O’Brien et al., 
2003).  
c) Labor/delivery complications 
 Maternal obesity is associated with increased risk of labor induction (Sebire et al., 
2001; Usha Kiran, Hemmadi, Bethel, & Evans, 2005; J. Zhang, Bricker, Wray, & Quenby, 
2007). For example, Usha and colleagues’ population-based observational study (n = 
60,167) showed that women with BMI ≥ 30 kg/m2 had an OR of 1.6 (95% CI: 1.3 – 1.9) for 
labor induction compared to women with BMI 20 – 30 kg/m2. However, in terms of labor 
duration, the evidence is inconsistent. Some researchers demonstrated higher incidences of 
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prolonged labor and delay in the first stage of labor among the obese population, but others 
did not (Nuthalapaty, Rouse, & Owen, 2004; Sheiner et al., 2004; J. Zhang et al., 2007). 
Interestingly, Zhang and colleagues elucidated that the high risk of delay in the first stage of 
labor among obese women was due to poor uterine contractility, which then leads to the 
increased incidence of emergency Cesarean section (C-section) (J. Zhang et al., 2007). The 
study demonstrated that the myometrium contracted with less force, frequency, and [Ca2+] 
flux among the obese women compared to the normal weight women. The increased risk of 
C-section among the obese women in this study was consistently observed despite the 
adjustment for maternal age, smoking, parity and birth weight of the infants. The result of an 
increased incidence of C-section among obese pregnant women of Zhang et al.’s study is 
supported by other investigators (S Y Chu et al., 2007; Dietz, Callaghan, Morrow, & 
Cogswell, 2005; Sebire et al., 2001; Sheiner et al., 2004). Using data from the Pregnancy 
Risk Assessment Monitoring System (PRAMS), Dietz and colleagues examined the risk of 
C-section with excess pre-pregnancy BMI in the US population-based sample (n = 24,423 
nulliparous women) (Dietz et al., 2005). The results of the study revealed that the incidence 
of C-section among very obese (BMI ≥ 35 kg/m2) women was as high as 42.6%. Compared 
to normal weight women, the estimated adjusted OR was 1.4 (95% CI: 1.0 – 1.8) for 
overweight women, 1.5 (95% CI: 1.1 – 2.1) for obese women, and 3.1 (95% CI: 2.3 – 4.8) 
for very obese women when the women delivered without any complications. The result of 
the US population-based sample is comparable to the increased risks found in other 
countries (Sheiner et al., 2004). For example, Israeli obese women who delivered between 
1988 and 2002 had a 27.5% rate of undergoing C-section delivery compared to 10.8% of the 
normal weight women even after the exclusion of hypertensive disorders and GDM patients 
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(OR = 3.2; 95% CI: 2.9 – 3.5). Currently, there is no conclusive mechanism to explain the 
observed independent risk factor between C-section delivery and maternal obesity. Besides 
poor uterine contractility among obese women, Usha and colleagues also suggested that 
obese women have an increased rate of large-for-gestational-age infants, which may have 
led to more C-section deliveries during labor. In addition, obese women also have increased 
fat deposition in the soft tissues of the pelvis (Usha Kiran et al., 2005). More studies are 
needed to investigate the causal link between obesity with C-section.  
d) Maternal and fetal deaths 
In a more severe case, high prepregnancy BMI has been shown to cause maternal 
and fetal deaths. According to the Confidential Enquiry into Maternal Deaths in the UK, 
27% of the 261 deaths happening between 2006 and 2008 were related to maternal obesity 
(Cantwell et al., 2011). The prevalence of direct and indirect causes of mortality such as 
thromboembolism, pre-eclampsia, and cardiovascular disease was higher in the obese 
maternal population. In the United States, maternal death rates reported from California 
were similar compared to those reported in the UK. Thirty percent of 386 women who died 
in pregnancy during 2002 and 2003 were obese pregnant women (California Department of 
Public Health, 2011). In terms of fetal death, a meta-analysis published by Chu and 
colleagues reported a higher risk of stillbirths among overweight  (OR 1.47; 95% CI: 1.08 – 
1.94) and obese women (OR 2.07; 95% CI: 1.59 – 2.74) compared to normal weight 
pregnant women (Chu, Kim, et al., 2007). In a cohort study from Denmark, obese women 
had more than doubled risk of experiencing a stillbirth (OR 2.8; 95% CI: 1.5 – 5.3) and 
neonatal death (OR 2.6; 95% CI: 1.2 – 5.8) even after adjusting for maternal cigarette 
smoking, alcohol and caffeine intake, maternal age, height, parity, gender of the child, years 
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of schooling, working status, cohabitation with partners as well as hypertensive disorders 
and GDM  (Kristensen, Vestergaard, Wisborg, Kesmodel, & Secher, 2005). The authors 
further elucidated that many of the stillbirth incidences in the study were caused by 
unexplained intrauterine death and fetoplacental dysfunction among obese women compared 
with normal weight women. Moreover, in a large cohort (n = 134,527) of Missouri births 
from 1978 to 1997, Salihu and colleagues observed a dose-dependent linear trend between 
BMI and the risk of stillbirth: class I obesity (adjusted hazard ratio 1.3; 95% CI: 1.2 – 1.4); 
class II obesity (adjusted hazard ratio 1.4; 95% CI: 1.3 – 1.6) and extreme obesity (adjusted 
hazard ratio 1.9; 95% CI: 1.6 – 2.1) (Salihu et al.). They further discovered that obese black 
mothers experienced more stillbirths than their white counterparts (adjusted hazard ratio 1.9; 
95% CI: 1.7 – 2.1) compared with adjusted hazard ratio 1.4; 95% CI: 1.3 – 1.5). 
Excessive Gestational Weight Gain 
A) Overview of weight gain during pregnancy and recommendations 
It is essential for women to gain weight in a normal pregnancy due to the biological 
processes that promote the development of new fetoplacental tissue, and maternal protein 
and fat tissue to support gestation and postnatal lactation. The most commonly described 
pattern of GWG is sigmoidal, when the majority of the weight gain during pregnancy 
happens in the second and early third trimesters (K. Rasmussen & Yaktine, 2009). Table 1 
below shows the current 2009 GWG recommendations by the Institute of Medicine (IOM) 
based on a woman’s pre-pregnancy BMI (K. Rasmussen & Yaktine, 2009). These guidelines 
were developed after an intensive review of the available evidence. The main goals of these 
guidelines were to improve neonatal outcome and optimize maternal health. Different from 
the first published GWG recommendations in 1990, these new guidelines are based on the 
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WHO BMI categories (underweight: BMI < 18.5 kg/m2; normal weight: BMI 18.5 – 24.9 
kg/m2; overweight: BMI 25.0 – 29.9 kg/m2; obese: BMI ≥ 30.0 kg/m2) instead of the 
Metropolitan Life Insurance tables (low: BMI < 19.8 kg/m2; normal: BMI 19.8 – 26.0 
kg/m2; high: BMI > 26.0 – 29.0 kg/m2). Additionally, these new guidelines include a weight 
gain recommendation range for obese (all classes) women.  
An optimum GWG happens when a woman gives birth to a healthy newborn and 
provides sufficient postpartum maternal fat stores to support lactation without increasing the 
risk of obesity (K. Rasmussen & Yaktine, 2009). The 2009 IOM GWG guidelines take into 
account the risk of giving birth to a small-for-gestational-age (SGA) (birth weight ≤ 10th 
percentile) or large-for-gestational-age (LGA) (birth weight ≥ 90th percentile) baby; 
therefore, birth weight played a pivotal role in developing the guidelines. In general, obese 
women are advised to gain less weight than non-obese women. The weight gain 
recommendation of 5 to 9 kg (11 to 20 lbs.) for obese women allows the growth of the fetus 
without much gain in maternal tissue, especially maternal fat. However, the 2009 IOM 
GWG guidelines do not further stratify the obese population to class I, II or III due to the 
limited studies to guide the recommendations.  
Some studies provided evidence of no harm to the mother and fetus when very obese 
women actually lost weight during pregnancy (Kiel, Dodson, Artal, Boehmer, & Leet, 2007; 
Nohr et al., 2008; Oken, Kleinman, Belfort, Hammitt, & Gillman, 2009). For example, a 
cohort study using birth certificate data from 120,251 obese women in Missouri argued that 
the optimal GWG for class I and II obese women should be 4.6 to 11.4 kg, and 0 to 4.1 kg 
respectively; while, class III obese women should be advised to lose 0 to 4.1 kg instead of 
gaining weight during pregnancy. These recommendations were developed by taking into 
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account the risk for pre-eclampsia, C-section, LGA babies, and SGA babies among women 
in the study (Kiel et al., 2007). Another study conducted by Hinkle and colleagues supported 
the above findings. Compared to those who gained according to the recommendation 
guidelines of 5 to 9 kg among the obese class II and III women, a GWG of -4.9 to 4.9 kg did 
not significantly increase the risk of giving birth to SGA infants, but rather decreased the 
risk of LGA infants (Hinkle, Sharma, & Dietz, 2010). 
Gestational weight gain is influenced by changes in maternal physiology, maternal 
metabolism and placental metabolism. The components of GWG and the proximal percent 
of each of these components include 27% of fetus, 20% of placenta, amniotic fluid and 
uterus, 3% of breast weight, 23% blood volume and extravascular fluid, and 27% maternal 
fat stores (Herring, Rose, Skouteris, & Oken, 2012). Weight gain at the beginning of 
pregnancy closely reflects maternal fat gain, while weight gain later on in pregnancy reflects 
fetal components (Kleinman et al., 2007; Muscati, Gray-Donald, & Koski, 1996). Therefore, 
in alignment with the IOM guidelines, underweight and normal weight women are advised 
to deposit fat in early- and mid-pregnancy stages as a caloric reserve for late pregnancy and 
lactation; however, women entering pregnancy overweight or obese are not required to have 
this extra caloric reserve (Herring et al., 2012). Lederman and colleagues reported that fat 
accumulation is positively correlated with GWG (r = 0.81, p < 0.0001). In this study, the 
authors showed that fat mass gain among underweight women who gained according to the 
recommendation was the highest (4.8 ± 3.8 kg), followed by normal weight (3.9 ± 3.7 kg), 
overweight (2.8 ± 5.4 kg) and obese (0.2 ± 5.0 kg) women (Lederman et al., 1997). Some 
studies even demonstrated that maternal fat gain had no benefits for fetal growth among 
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normal or overweight women (Langhoff-Roos, Lindmark, & Gebre-Medhin, 1987; 
Lawrence, McKillop, & Durnin, 1991).  
Additionally, since infant birth weight is associated with gestational weight gain 
during the second and third trimester (Lawton, Mason, Kelly, Ramsay, & Morewood, 1988; 
Lertbunnaphong, Talungjit, & Titapant, 2012), Muscati and colleagues argued that timing of 
GWG was as important as the total amount of weight gain during pregnancy (Muscati et al., 
1996). They provided evidence that early GWG (≤ 20 weeks) was a strong predictor of six-
week post-partum weight retention. The rate of weight gain for the first half of pregnancy 
should be carefully monitored among overweight women to avoid excessive fat deposition. 
As a result, they concluded that in order to promote fetal growth and reduce the risk of 
substantial post-partum weight retention, it was more advantageous for women, especially 
overweight women, to delay their weight gain until late pregnancy. Lederman and 
colleagues also showed that women who gained more than recommended amounts also 
gained significantly more fat mass. The results of Lederman and colleagues are supported by 
more recent data, which demonstrated that weight gain in early pregnancy reflects maternal 
fat deposition and could potentially lead to offspring obesity (Fraser et al., 2010; Huda, 
Brodie, & Sattar, 2010). In summary, excessive GWG should be avoided throughout 
pregnancy for the health of the mother and fetus.  
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Table 1: Institute of Medicine (2009) Recommendations for Total and Rate of Weight 
Gain during Pregnancy, by Pre-pregnancy BMI.  
 
 Total Weight Gain  
Rates of Weight Gain 2nd and 3rd 
Trimester* 
Pre-pregnancy BMI 
Range in 
kg 
Range 
in lbs  
Mean (range) 
kg/week 
Mean (range) 
lbs/week 
Underweight (< 18.5 kg/m²) 12.5 - 18 28 - 40  0.51 (0.44 - 0.58) 1 (1 - 1.3) 
Normal weight (18.5 - 24.9 
kg/m²) 11.5 - 16 25 - 35  0.42 (0.35 - 0.50) 1 (0.8 - 1) 
Overweight (25.0 - 29.9 kg/m²) 7 - 11.5 15 - 25  0.28 (0.23 - 0.33) 0.6 (0.5 - 0.7) 
Obese (≥ 30.0 kg/m²) 5 - 9 11 - 20  0.22 (0.17 - 0.27) 0.5 (0.4 - 0.6) 
* Calculations assume a 0.5 - 2 kg (1.1 - 4.4 lbs) weight gain in the first trimester  
  Adapted from  (K. Rasmussen & Yaktine, 2009). 
 
B) Adverse health outcomes of excessive GWG 
Excessive GWG is another concern in the field of maternal and child health. The 
latest data shows that 48% of pregnant women gained more weight than recommended. The 
majority of the women who gained excessively during gestation were women who were 
overweight or obese before entering to pregnancy (Centers for Disease Control and 
Prevention, 2010). Excessive GWG can be particularly concerning for overweight and obese 
women due to their already increased risk for adverse pregnancy outcomes. Evidence shows 
that women who gain an appropriate amount of weight during pregnancy are likely to have 
good obstetric and neonatal outcomes. They also have less concern with the amount of 
weight that they need to lose in the postpartum period  (Siega-Riz et al., 2009). In the 
following section, a selection of the main adverse pregnancy outcomes pertaining to 
excessive GWG will be discussed. Adverse outcomes for the child such as macrosomia 
(LGA infant), and increased risk for later child obesity will be addressed under the topic of 
“Fetal Origin of Obesity”. 
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a) Gestational diabetes mellitus (GDM) 
In general, the evidence of a positive relationship between excessive GWG and 
GDM is inconclusive. For example, when Hedderson and colleagues sought to determine the 
relationship between rate of GWG and risk of GDM (n = 1134), they found that women with 
a rate of weight gain between 0.27 – 0.40 kg/week and > 0.40 kg/ week had an odds ratio of 
1.43 (95% CI: 0.96 – 2.14) and 1.74 (95% CI: 1.16 – 2.60) to develop GDM compared to 
women in the rate of weight gain  < 0.27 kg/week (Hedderson, Gunderson, & Ferrara, 
2010). In contrast, data from the Danish National Birth Cohort (n = 60,892) revealed that 
GDM was significantly associated with low weight gain (<10 kg compared to 10 – 15 kg) 
instead of high weight gain during pregnancy (adjusted OR 2.3; 95% CI: 1.9, 2.8) (Nohr et 
al., 2008). Additionally, when Herring and colleagues examined women (n = 1960) in 
Project Viva, a pre-birth cohort in eastern Massachusetts, they found that women in the 
highest quartile of weight gain had increased odds of impaired glucose tolerance (adjusted 
OR 2.54; 95% CI: 1.25 – 5.15), but not GDM (adjusted OR 0.93; 95% CI: 0.50 – 1.70) 
compared with women who gained at the lowest quartile (Herring et al., 2009).  
b) Gestational hypertension and pre-eclampsia 
There appears to be a strong link between excessive GWG and the development of 
pre-eclampsia. In the Danish National Birth Cohort (n = 60,892), women who gained 16 – 
19 kg and ≥ 20 kg had an adjusted OR of 1.6 (95% CI: 1.3 – 1.8) and 2.8 (95% CI: 2.4 – 3.2) 
respectively to develop pre-eclampsia during pregnancy compared to women who only 
gained 10 – 15 kg (Nohr et al., 2008). When examining the effects of low and high GWG in 
different maternal BMI classes, Cedergen found that obese women with low GWG had only 
half of the risk to develop pre-eclampsia compared to those with high GWG (adjusted OR 
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0.52; 95% CI: 0.42 – 0.62). The study also showed that normal and overweight women had 
twice the risk of developing pre-eclampsia with excessive GWG (Cedergren, 2006). 
Cedergen’s work was supported by Brennand et al., who found that obese women with low, 
acceptable and high weight gain had a prevalence of 3.7%, 6.3% and 14.9% respectively to 
develop pre-eclampsia during pregnancy (Brennand, Dannenbaum, & Willows, 2005). This 
positive relationship between excessive GWG and risk of pre-eclampsia and hypertension 
disorder holds true for other ethnicities, such as the Latino population. Among a group of 
obese (BMI > 29 kg/m2) Latino women (n = 1231), Fortner et al. found that women in the 
study who gained excessively had a 3-fold risk of hypertension disorder (95% CI: 1.1 – 7.2) 
and a 4-fold risk of pre-eclampsia (95% CI: 1.2 – 14.5) compared to women who gained 
according to the 1990 IOM guidelines (Fortner, Pekow, Solomon, Markenson, & Chasan-
Taber, 2009).  
c) Post-partum weight retention 
Excessive GWG is positively associated with postpartum weight retention 
(Gunderson, 2009; Nelson et al., 2010; Yogev & Catalano, 2009), and is a strong predictor 
of long-term overweight and obesity beyond pregnancy (Susan Y Chu, Callaghan, Bish, & 
D’Angelo, 2009; Davis, Zyzanski, Olson, Stange, & Horwitz, 2009). It also leads to higher 
weight status for future pregnancies (Gunderson, 2009). Nohr and colleagues reported that 
around 12% of normal-weight, overweight and obese class I women moved up one BMI 
category with a GWG of 16 – 19 kg, but this percentage increased to approximately 25% 
when these women gained ≥ 20 kg (Nohr et al., 2008). In Gunderson and colleagues’ study 
of 1300 women who delivered at the University of California, San Francisco (UCSF) 
hospital between 1980 and 1990 showed that normal weight (BMI ≤ 26 kg/m2) women who 
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gained above the 1990 IOM recommendations had a 2.5 to 3-fold higher risk of becoming 
overweight at their following pregnancy (Gunderson, Abrams, & Selvin, 2000).  
In terms of the risk of long-term obesity, Rooney and Schauberger demonstrated that 
women who gained less than the 1990 IOM guidelines were 4.1 kg heavier between 5 to 10 
years later (at follow-up visit), while those who gained according to the guidelines and 
exceeded the guidelines were 6.5 kg and 8.4 kg heavier respectively (p = 0.01). This study 
also showed that women who lost all gestational weight by 6-months postpartum were 
lighter (only 2.4 kg heavier at follow-up) than women who retained some gestational weight 
at 6-months post-partum (8.3 kg heavier) (Rooney & Schauberger, 2002). In summary, 
excessive GWG contributes to obesity in women, which may increase the overall health care 
burden. Therefore, interventions are needed to help pregnant women reach their targeted 
weight range, especially women who are overweight and obese before they conceive.  
Fetal Origins of Obesity 
A) The concept of Developmental Origins of Health and Disease (DOHaD) hypothesis 
In the past, it was thought that chronic diseases such as coronary heart disease, 
diabetes, cancer, asthma, and obesity were the results of genetic inheritance and/or 
unhealthy lifestyles; however, a new paradigm to better understand these diseases has 
emerged in recent years. Mounting evidence reveals that one’s exposure to the intrauterine 
environment, and environmental exposure during infancy may play a pivotal role in the 
development and progression of chronic diseases (Barker, 2007; Gillman, 2005; Oken & 
Gillman, 2003; Wadhwa, Buss, Entringer, & Swanson, 2009). This new paradigm is referred 
to as the “Developmental Origins of Health and Disease (DOHaD)” or also known as 
“Barker’s hypothesis”. This hypothesis emerged almost 25 years ago, which evolved from a 
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series of epidemiological studies of infant and adult mortality by Barker and colleagues 
(Barker et al., 1993; Barker, Winter, Osmond, Margetts, & Simmonds, 1989; Barker & 
Osmond, 1986). Their studies provided the foundation of the relationship between restricted 
fetal growth and small size at birth due to nutrient deficiency in utero (Barker, 2007). This 
“intrauterine stress” became an agent to permanently alter the structure and function of fetal 
organ systems, which in turn leads to coronary heart disease and stroke in adult life. This 
process is also called fetal programming, which means the gene expression of a certain 
organ is altered when it gets exposed to a variety of environmental stimuli, such as stress, 
poor nutrition and/or drugs. This alteration is permanent and usually it leads to disease 
development (Wadhwa et al., 2009). Barker et al. showed that for every one kilogram 
decrease in birth weight there was a 14% increased risk of mortality by 75 years of age 
(Barker et al., 1989). Low birth weight is also associated with  other risk factors, for 
example hypertension, insulin resistance and stroke (Cota & Allen, 2010).  
Another aspect of the DOHaD hypothesis is the concept of compensatory growth. 
Compensatory growth is also called “catch-up” growth, which describes the phenomenon of 
a period of under-nutrition in the utero environment followed by a rapid weight gain during 
early development. This catch-up period may lead to disproportionally high fat mass to fat-
free mass, which has been associated with adverse health outcomes. Barker and colleagues’ 
study of coronary events among the 8760 people born in Helsinki from 1934 – 1944 showed 
that those who had below average birth weight and BMI at 2 years of age, but rapidly 
increased their BMI from 2 to 11 years of age, had significantly higher coronary risk factors. 
Therefore, they concluded that catch-up growth further exacerbated the risk of developing 
cardiovascular disease in later life (Barker, Osmond, Forsén, Kajantie, & Eriksson, 2005). 
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B) DOHaD hypothesis in obesity 
 Many investigators have recently turned to the DOHaD hypothesis to gain a better 
understanding of the obesity epidemic (Adamo et al., 2012; Dabelea & Crume, 2011; Oken 
& Gillman, 2003). When the relationship between birth weight and obesity later in life was 
studied, the researchers found “trouble on both ends of the birth weight spectrum,” as 
mentioned by Oken and Gillman (Oken & Gillman, 2003). Fetal origins of obesity is related 
to both low and high birth weight, which suggests the presence of two pathogenesis of 
obesity.  
a) Association of birth weight and obesity risk factors 
At one end of the spectrum, low birth weight (≤ 2500 g) is associated with central or 
truncal obesity (M. Barker, Robinson, Osmond, & Barker, 1997; Law, Barker, Osmond, 
Fall, & Simmonds, 1992), insulin resistance (Bavdekar et al., 1999; McKeigue, Lithell, & 
Leon, 1998; Mi et al., 2000), and metabolic syndrome (D J P Barker, Hales, et al., 1993; 
Valdez, Athens, Thompson, Bradshaw, & Stern, 1994; Yarbrough, Barrett-Connor, Kritz-
Silverstein, & Wingard, 1998). In a study examining the ratio of waist to hip circumference, 
the authors found that the waist to hip ratio of men (n = 845) who were born during 1920 – 
30 at Hertfordshire (UK) and men (n = 239) who were born during 1935 – 43 at Preston 
(UK) was inversely related to birth weight after controlling for gestational length. 
Additionally, they also observed a similar trend when weight at one year of age was 
examined after controlling for adult height, alcohol consumption, smoking, social class, and 
age. Therefore, the authors concluded that adverse conditions or growth failure in uterine 
and during infancy may be the main culprit of the detrimental abdominal fat storage detected 
in this study (Law et al., 1992).  
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There is no exception when it comes to the relationship of birth weight to adolescent 
female abdominal fat storage. Again, in one of Barker and colleagues’ studies they found 
girls who had the smallest birth weight (≤ 3000 g) were the fattest at the time of 
measurement (mean age = 15.6 year old, total n = 216). For every kilogram decrease in birth 
weight, the subscapular to triceps skinfold ratio increased by 9% in girls whose BMI was 
above the median (21 kg/m2) and 27% in those whose BMI was over 25 kg/m2. As a result, 
there appeared to be a tendency to store fat centrally that seemed to be programmed during 
fetal growth, especially for those who were overweight (M. Barker et al., 1997). It is well 
documented that central fat deposition is an independent risk factor of insulin resistance, 
non-insulin dependent diabetes and metabolic syndrome (Lévy-Marchal & Czernichow, 
2006). Therefore, birth weight has an inverse relationship with the diseases aforementioned 
(Philips, 1998). McKeigue and colleagues reported a positive monotonic relation of insulin 
sensitivity with birth weight in males at full term. This relationship was the strongest in 
those who were overweight at age 70 (McKeigue et al., 1998). In a population-based sample 
of older women, both the prevalence (12 vs. 4.3%) and the risk of developing metabolic 
syndrome (OR 2.41; 95% CI: 1.06 – 5.51) increased in women who had the lowest birth 
weight tertile (2.5 – 6.8 lb, mean 5.5 lb) compared to the women who had the highest birth 
weight tertile (8.1 – 13.0 lb, mean 9.4) (Yarbrough et al., 1998).  
Besides low birth weight, catch-up growth could potentially play a part in the 
development of metabolic syndrome, too. Fagerberg and colleagues have studied the 
combination of low birth weight and catch-up growth in predicting the occurrence of 
metabolic syndrome in late middle aged men  (Fagerberg, Bondjers, & Nilsson, 2004). They 
found that among all of the participants (n = 396), those who gained the most weight from 
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birth to 18 years of age also had the highest incidence of metabolic syndrome at 58 years (p 
= 0.008). The correlations between weight ratio from birth to age 18 and metabolic 
syndrome at 58 were: BMI (r = 0.24, p < 0.001), WHR (waist-to-hip ratio) (r = 0.24, p < 
0.001), diastolic blood pressure (r = 0.13, p < 0.05), insulin (r = 0.14, p < 0.01), triglycerides 
(r = 0.10, p < 0.05), HDL cholesterol (r = -0.13, p < 0.01) and LDL particle size (r = -0.17, p 
< 0.05) (Fagerberg et al., 2004). The relationship of low birth weight and insulin resistance 
syndrome was also observed in some other developing countries such as India (Bavdekar et 
al., 1999) and China (Mi et al., 2000) where low birth weight was particularly common.  
On the other end of the spectrum, studies have demonstrated that higher birth weight 
is associated with higher attained BMI later in life (Curhan et al., 1996; Gillman, Rifas-
Shiman, Berkey, Field, & Colditz, 2003; Parsons, Power, Logan, & Summerbell, 1999; 
Rasmussen & Johansson, 1998; Sørensen et al., 1997). This relationship is relatively robust 
even after controlling for potential confounders. For example, in the Nurses’ Health Study I 
(n = 71,100 women) and II (n = 92,940) women who weighed more than 10 lbs at birth 
compared to those who weighed between 7.1 and 8.5 lbs had an OR of 1.62 (95% CI: 1.38 – 
1.90) of being obese in midlife after controlling for maternal weight (Curhan et al., 1996). In 
the U.S. Growing Up Today Study, a cohort study of diet, activity, and growth of girls (n = 
7981) and boys (n = 6900), the investigators found that  each 1-kg increment increase in 
birth weight among full term infants was associated with an approximate 50% increased risk 
of being overweight at ages 9-14 years. The risk reduced to approximately 30% after 
adjusting for physical activity, television watching, energy intake, breastfeeding duration, 
and maternal BMI (Gillman, Rifas-Shiman, Berkey, Field, & Colditz, 2003).  
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Therefore, there is a direct relationship between birth weight and BMI in childhood 
and adulthood, but an inverse relationship between low birth weight and central adiposity, 
insulin resistance, and metabolic syndrome. These relationships can be described as  U- or J-
shaped relationships where the extremes of both ends of the birth weight spectrum possess 
obesity risk factors later in life (Oken & Gillman, 2003). Because a large number of  
reproductive-age women in Western societies or developed countries (i.e.: America) 
struggle with the risk of giving birth to LGA infants rather than the risk of giving birth to 
SGA infants due to the plentiful food supply and obesogenic environment (Dabelea & 
Crume, 2011), the focus of my dissertation will be mainly to discuss the potential causes and 
mechanisms that lead to giving birth to LGA infants and how it could cause obesity later in 
life in developed countries.   
b) Evidences of the causes: maternal obesity and excessive GWG 
Maternal obesity and GWG are two of the main causes of giving birth to a LGA 
infants in most Western countries (Adamo et al., 2012; Dabelea & Crume, 2011; Nelson et 
al., 2010; Oken, 2009b). When Hull and colleagues studied the impact of maternal BMI on 
neonatal body composition, they found that the newborns (n = 77) of overweight and obese 
women (BMI ≥ 25 kg/m2) had higher percent fat (12.5 ± 4.2% vs. 13.6 ± 4.3%; p ≤ 0.0001), 
fat mass (414.1 ± 264.2 vs. 448.3 ± 262.2; p ≤ 0.05), and fat-free mass (3310.5 ± 344.6 vs. 
3162.2 ± 343.4; p ≤ 0.05) compared to normal-weight women when the neonatal body 
compositions were measured using the PEA POD system (Hull, Dinger, Knehans, 
Thompson, & Fields, 2008). The findings of Hull et al. have been supported by other studies 
(Harvey et al., 2007; Neggers, Goldenberg, Cliver, Hoffman, & Cutter, 1995; Sewell, 
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Huston-Presley, Super, & Catalano, 2006; Shields, Knight, Powell, Hattersley, & Wright, 
2006).  
There is also much evidence suggests that the association of maternal obesity and 
offspring obesity will persist through childhood, adolescence and adulthood (C. Li, Goran, 
Kaur, Nollen, & Ahluwalia, 2007; L. Li, Law, Conte, & Power, 2009; Salsberry & Reagan, 
2005; Robert C Whitaker, Wright, Pepe, Seidel, & Dietz, 1997). For example, when 
Whitaker and colleagues studied the role of maternal obesity in predicting obesity among 
preschool-aged children, they found that children ages 2 to 4 (n = 8494) who were born to 
obese mothers had more than twice the likelihood of being obese.  By 4 years of age, one in 
four children of obese mothers were obese, compared to less than one in ten for normal 
weight mothers (R C Whitaker, 2004). Li and colleagues’ study of 2626 children in the 
National Longitudinal Study of Youth (NLSY) between ages 2 to 14 provided a consistent 
result. In this study, the authors noted that children of obese women were at a greater risk of 
becoming overweight (OR 4.1; 95% CI: 2.6 – 6.4) even after the adjustment of potential 
confounders (i.e.: parity, gestational age, breastfeeding) (C. Li et al., 2005). Data from other 
developed countries, such as Finland (Laitinen, Power, & Järvelin, 2001), England (Reilly et 
al., 2005), Sweden (Koupil & Toivanen, 2008), and Australia (O’Callaghan, Williams, 
Andersen, Bor, & Najman, 1997) also demonstrated a similar association. 
When discussing the relationship between GWG and offspring obesity, according to 
some of the most recent reviews (Adamo et al., 2012; Nelson et al., 2010; Poston, 2012), 
many epidemiological and observational data  support  an association between the two. One 
particular landmark study in the United States is Project Viva, which showed that excessive 
GWG is directly associated with a child being overweight at age 3 (OR 1.30; 95% CI: 1.04 – 
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1.62 for each 5 kg of GWG) after adjusting for sociodemographic factors, breastfeeding 
duration, glucose tolerance, and gestation length (Oken et al., 2007). Another big cohort 
study, the US Collaborative Perinatal Project (n = 10,226), supported the findings of Oken et 
al (Wrotniak, Shults, Butts, & Stettler, 2008). In this study, there was a 3% increase in the 
rate of being overweight among offspring at age 7 for every 1 kg of GWG (OR 1.03; 95% 
CI: 1.02 – 1.05). When looking at the pattern of weight gain across the gestational period by 
using the Avon Longitudinal Study of Parents and Children (ALSPAC), a UK-based 
prospective pregnancy cohort (n =  12,500), Fraser and colleagues reported a positive 
relationship between GWG in early pregnancy (0 to 14 weeks) and offspring adiposity at 
age 9 years in all data; while GWG was only related with offspring adiposity in women who 
gained > 500 g/wk between 14 and 36 weeks (Fraser et al., 2010). Through these findings, 
the authors concluded that women should avoid excessive weight gain in early pregnancy, as 
this early weight gain may cause the GWG and offspring adiposity relationship.  
Generally speaking, women who are overweight or obese prior to conceiving should 
avoid excessive GWG at all costs. Studies have demonstrated the significantly increased 
association between excessive GWG and offspring obesity among overweight and obese 
women compared to normal weight women (Z. M. Ferraro et al., 2012; Guihard-Costa, 
Papiernik, & Kolb, 2004; Hull et al., 2011). For example, when GWG was classified as 
appropriate or excessive according to the 2009 IOM guidelines within each of the pre-
pregnancy BMI categories, Hull and colleagues found that newborns of women in the 
overweight pre-pregnancy BMI category had a significantly higher percent fat mass (p = 
0.001) when the mothers gained excessively (infant fat mass = 484.4 ± 28.8 g) compared to 
those who gained appropriately (infant fat mass = 303.6 ± 46.1 g). The differences were not 
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significant among the obese group due to the already relatively high fat mass of the 
newborns (infant fat mass of appropriate group = 472.9 ± 56.0 g vs. infant fat mass of 
excessive group = 486.4 ± 33.5 g) (Hull et al., 2011). The combination of maternal obesity 
and excessive GWG appear to cause adverse health outcomes both to the mother and fetus.    
c) Mechanisms   
Evidence supporting the association between maternal obesity, excessive gestational 
weight gain and offspring obesity has been primarily attributed to genetics, and familial 
socioeconomic and lifestyle factors. However, in recent years, investigators have considered 
whether the intrauterine environment of obese women and of those with excessive 
gestational weight gain, could potentially program long-term offspring obesity. BMI or 
weight of children correlated more strongly with maternal BMI or weight than paternal BMI 
or weight, as shown by epidemiological and observational studies, which further supports 
the role of the intrauterine environment on downstream obesity development (Danielzik, 
Langnase, Mast, Spethmann, & Müller, 2002; Lawlor et al., 2007; C. Li et al., 2007; 
Moschonis, Grammatikaki, & Manios, 2008; Reilly et al., 2005; Q. Wu & Suzuki, 2006). In 
the words of Barker, ‘The womb may be more important than the home’(Barker, 1990).    
In order to evaluate the contribution of the intrauterine environment to the risk of 
developing obesity in childhood and beyond, animal and human studies have been 
conducted to provide supporting evidence for this potential etiology of obesity. For example, 
by using an enteral nutrition-based over-feeding obese rat model, Shankar and colleagues 
were able to show that the offspring of rats who were exposed to maternal obesity in utero 
were programmed to be obese later in life when they were fed a high-fat diet (Shankar et al., 
2008). Compared to the offspring of lean dams, offspring of obese dams had significantly 
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higher weight gain, as well as higher total, visceral, and subcutaneous percent fat mass when 
they were given the same high-fat diet (p < 0.005). Additionally, offspring of obese dams 
had 1.6-fold greater percent fat ratio compared to offspring of lean dams when they 
consumed the same control diet (normal diet) (p < 0.05).  
 In terms of human studies, some of the best models to examine the role of the 
intrauterine environment on offspring obesity are those studies on pre- and post-bariatric 
surgery patients. Thus far, both Kral et al. and Smith et al. have done elegant work 
comparing siblings who were born before and after the mother’s surgery, since siblings 
carry similar genes and share a similar postnatal environment (Kral et al., 2006; Smith et al., 
2009). In Kral and colleagues’ study, the siblings (aged 2 to 18 years old) who were born 
after substantial maternal weight loss due to biliopancreatic bypass surgery, had a 52% and 
45.1% reduction in the prevalence of obesity and severe obesity, respectively (Kral et al., 
2006). The results of Kral et al.’s study were later supported by Smith and colleagues, who 
also examined cardiometabolic risk factors of their participants (n = 54 before surgical 
weight loss; n = 57 after surgical weight loss) (Smith et al., 2009). Besides the lower 
prevalence of macrosomia (LGA infant) and severe obesity among the post-surgery siblings, 
the Smith et al., also reported that children who were born after maternal surgical weight 
loss had greater insulin sensitivity, improved lipid profiles, lower C-reactive protein 
(indication of inflammation), decreased leptin (adipose-derived hormone), and increased 
ghrelin (circulating hunger hormone), compared with their siblings who were born before 
the surgery.  
In an innovative way, Lawlor et al. also conducted a sibling study to examine the 
role of the intrauterine environment on offspring obesity without using data from bariatric 
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patients (Lawlor, Lichtenstein, Fraser, & Langstrom, 2011). Lawlor et al. compared within-
sibling associations to non-sibling associations to examine the relative strength of a shared 
intrauterine environment and/or of shared familial (genetic and lifestyle) risk factors on 
offspring BMI at age 18 years (n = 146,894 individuals from 136,050 families). The results 
showed that in women with normal pre-pregnancy BMI, there was no association between 
maternal GWG and greater offspring BMI, within-siblings; however, a positive association 
was found between maternal GWG and offspring BMI within-siblings in overweight/obese 
mothers. Therefore, the authors concluded that among normal weight women, the positive 
association between GWG and offspring BMI is mainly due to shared familial risk factors, 
while in overweight/obese women this association could be caused by both intrauterine 
environment and shared familial risk factors. By and large, evidence to support the role of 
the intrauterine environment on intergenerational transmission of obesity has slowly 
emerged in the past decade. However, the question yet to be answered is what are the 
potential underlying mechanisms in the intrauterine environment of obese women and/or 
women who gain excessive weight during gestation and ultimately causing the persistent 
influence on offspring obesity? The mechanisms responsible for these effects remain 
unknown, but potential pathways have been areas of intense research, and these include the 
developmental over-nutrition hypothesis and epigenetics.        
i) The developmental over-nutrition hypothesis 
Through studying the Dutch famine (1944 – 45), researchers started to realize the 
important role of prenatal and early post-natal nutrition in offspring obesity (Ravelli, Stein, 
& Susser, 1976). In this study, the investigators observed that males exposed to nutritional 
deprivation in utero during the first half of pregnancy experienced higher adult obesity rates 
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(p < 0.0005). The proposed mechanism was that under-nutrition during the critical early 
period of development in the womb affected the differentiation of hypothalamic centers 
(function to regulate food intake and growth); therefore, when food availability increased 
later in life, this then caused an accumulation of excess fat in a predetermined maximum 
size of an individual body.  
On the contrary, fetal over-nutrition is equally detrimental to offspring development. 
The fetal over-nutrition hypothesis, or fetal teratogenesis, was first proposed by Pederson in 
the 1950s (Pedersen, 1954). In his study, Pederson observed a greater delivery of glucose 
from diabetic mothers to their fetuses, which directly (fetal glucose consumption) or 
indirectly (fetal hyperinsulinemia) caused excessive growth in the developing fetuses. 
Maternal glucose can freely transfer to the fetus, but maternal insulin does not cross the 
placenta, which leads to fetal pancreatic release of insulin in response to the glucose load. 
Excessive production of insulin acts as fetal growth hormone, which causes growth and 
adiposity. Therefore, women who have GDM are at higher risk of giving birth to LGA 
infants (Dabelea & Crume, 2011). Besides the risk at birth, these infants are also at a higher 
risk of being overweight and obese during childhood and adolescence (Chandler-Laney, 
Bush, Rouse, Mancuso, & Gower, 2011; M W Gillman et al., 2003; Hillier et al., 2007), 
having higher blood pressure (Wright et al., 2009), and becoming diabetic later in life 
(Fetita, Sobngwi, Serradas, Calvo, & Gautier, 2006).   
Even without being diagnosed with GDM, many studies have demonstrated a 
continuous, linear relationship between maternal hyperglycemia with macrosomia and other 
adverse health outcomes (Hill, Krishnaveni, Annamma, Leary, & Fall, 2005; The HAPO 
Study Cooperative Research Group, 2008; Yogev, Langer, Xenakis, & Rosenn, 2005). For 
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example, in the multicenter, multinational, Hyperglycemia and Adverse Pregnancy 
Outcomes (HAPO) study, the investigators observed a strong relationship between maternal 
glucose levels and birth weight, cord-blood serum C-peptide (indication of insulin levels), 
and neonatal adiposity among the 23,316 non-diabetic participants (The HAPO Study 
Cooperative Research Group, 2008). This study has provided some of the most 
comprehensive evidence for the Pedersen Hypothesis.  
In more recent decades, the developmental over-nutrition hypothesis has been 
broadened to include other fuels, such as free fatty acids, ketone bodies, and amino acids, 
which could contribute to fetal hyperinsulinemia, and therefore fetal over-growth (Freinkel, 
1980). In 1985, it was reported that placental lipoprotein lipase could hydrolyze maternal 
triglycerides to free fatty acids. These free fatty acids were able to cross the placenta and 
incorporate into fetal lipids (Knopp, Bergelin, Wahl, & Walden, 1985). As a result, several 
human studies have provided evidence for the relationship between maternal lipids and fetal 
adiposity (Di Cianni et al., 2005; Kitajima et al., 2001; Knopp et al., 1985). 
Overweight/obese women and/or women with excessive GWG may possess the same 
physiological condition, which is comparable to women with GDM or hyperglycemia, 
where plasma levels of glucose and other nutrients are elevated. Consequently, in a review 
on the role of the prenatal environment in the development of obesity, Whitaker and Dietz 
claimed that diabetes, obesity and excess GWG can independently influence the transfer of 
metabolic substrates to the fetus due to the high circulating concentration of substrates 
(Robert C Whitaker & Dietz, 1998). The substrates, after crossing the placenta, could then 
directly or indirectly affect the fetus’ development by increasing insulin secretion.        
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Similar to maternal under-nutrition, maternal over-nutrition could affect 
hypothalamic cell proliferation. Hypothalamic maturation occurs during the intrauterine 
period of human development, with the majority taking place during early gestation 
(Koutcherov, Mai, Ashwell, & Paxinos, 2002). Maternal obesity or over-nutrition could 
influence the hypothalamic expression of appetite regulators (Bouret, 2012). The two most 
commonly studied appetite regulators are the neuropeptide Y (NPY), which is an appetite 
stimulator, and the pro-opiomelanocortin (POMC), which is an appetite suppressor. A study 
by Chen and colleagues showed that offspring from obese rats had greater levels of 
hyperphagia, adiposity, hyperlipidemia, and glucose intolerance (Chen, Simar, & Morris, 
2009). When hypothalamic appetite regulators were measured, there was increased 
hypothalamic NPY signaling in adult offspring, which explained the increased drive to eat in 
perinatally malprogrammed rats. In short, disruption of the hypothalamic maturation during 
gestation could lead to long-term dysfunction of energy homeostasis. 
ii) Epigenetics 
    Epigenetics is the study of heritable changes in gene expression caused by other 
processes, such as DNA methylation and histone modifications, without altering the DNA 
sequence. The rapid increase in obesity rates worldwide cannot be explained by changes in 
the genome over a short period of time; therefore, researchers are examining the influences 
of environmental factors on gene expression. Gestation is a vulnerable and critical period for 
epigenetic modifications to occur, due to the high rates of DNA synthesis and methylation 
(Wadhwa et al., 2009). As a result, more recently, studies have suggested that epigenetic 
modifications that may happen in utero could be the explanation for  the relationship 
between maternal obesity and excessive GWG and long-term offspring obesity (Fall, 2012; 
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Godfrey et al., 2011; Wadhwa et al., 2009). Thus far, animal models have been used 
extensively to understand this relationship, especially in the area of maternal over-nutrition 
relating to genes involved in the regulation of energy homeostasis (Q. Wu & Suzuki, 2006). 
However, human studies focused on the influence of the intrauterine environment on 
epigenetic modifications are limited. One study has demonstrated the correlation between 
maternal hyperglycemia to placental leptin DNA methylation levels (Bouchard et al., 2010). 
Another human study conducted by Godfrey et al. found that higher methylation of retinoid 
X receptor- (RXR) chr9 was associated with higher neonatal adiposity, which has an 
inverse relationship with maternal carbohydrate intake in early pregnancy (Godfrey et al., 
2011). Therefore, they concluded that diet in early pregnancy could influence a child’s 
adiposity through the methylation of RXR gene. The field of epigenetics on DOHaD 
hypothesis is an emerging research area. More human studies are yet to be conducted to 
support this mechanism on the development of offspring obesity.  
Preventing Pediatric Obesity during Pregnancy 
The DOHaD hypothesis elucidates how an unfavorable intrauterine environment due 
to maternal obesity and excessive GWG increases the risk of obesity in the offspring. These 
two factors cause a perpetuating “vicious cycle” of obesity, where obese women or women 
who gain excess gestational weight have a higher risk of giving birth to LGA infants, who 
then, years later, can become obese adults entering into their own pregnancies (Oken, 
2009b). Therefore, obesity prevention by targeting pregnancy could be a promising starting 
point. Pregnancy is a naturally occurring life transition that often makes women concerned 
about the well-being of their babies and many women desire to become role models for their 
new children (Phelan, 2010). This can make pregnancy a “teachable moment”.  As a result, 
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pregnancy may be an ideal time to introduce lifestyle intervention as women are motivated 
to adopt healthy behaviors for the sake of their children. Weight gain and obesity occur 
when energy intake exceeds energy expenditure, which results in energy imbalance. It is 
well-established that healthy eating habits and regular physical activity are two modifiable 
targets in preventing weight gain at all ages and among all populations. Thus, these two 
behaviors should be encouraged among pregnant women, too. Due to the nature of the 
proposed project, the following dissertation will be focused on maternal physical activity; 
however, an overview of diet during pregnancy will be discussed.  
A) Maternal physical activity (PA)  
a) Maternal PA recommendations, trends and types 
     A positive relationship between PA and health and wellness across an individual’s 
lifespan as well as its significant impact on the public health is widely known. Regular PA is 
shown to reduce the risk of cardiovascular disease, stroke, type 2 diabetes, cancer, obesity, 
depression and anxiety (“Physical activity guidelines advisory committee report, 2008. To 
the Secretary of Health and Human Services. Part A: executive summary,” 2009). In more 
recent years, PA during pregnancy has been viewed as an important part of reproductive 
health. Pregnant women are encouraged to have an active lifestyle, which has replaced the 
traditional view that pregnant women should engage in limited exercise (Downs et al., 
2012). Maternal PA is considered safe when performed by healthy pregnant women without 
any prenatal complications. There is little, if any, evidence for harmful effects of prenatal 
PA on maternal and child health outcomes as examined in many published reviews (Morris 
& Johnson, 2005; Mudd, Owe, Mottola, & Pivarnik, 2013; Pivarnik et al., 2006).  
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According to the American College of Obstetrics and Gynecology (ACOG) 2002 
guidelines, in the absence of either medical or obstetric complications, pregnant women can 
accumulate 30 minutes or more of moderate-intensity exercise on most, if not, all days of the 
week (ACOG Committee Obstetric Practice, 2002).  Later, when the U.S. Department of 
Health and Human Services (DHHS) issued the first-ever physical activity guidelines for 
Americans in 2008, they included the recommendations for the pregnant population who are 
healthy and without medical complications (“Physical activity guidelines advisory 
committee report, 2008. To the Secretary of Health and Human Services. Part A: executive 
summary,” 2009). Two key guidelines from the U.S. DHHS are 1. Pregnant women who are 
not already active should get at least 150 minutes of moderate-intensity aerobic activity per 
week, preferably spread throughout the week; 2. Pregnant women who are highly active 
prior to conception can continue their activities, but they need to consult with their health 
care provider and adjust their activities as the pregnancy progresses.  
When examining the prevalence of PA participation during pregnancy, studies 
concurred that pregnancy itself is a life event which leads to a drastic decrease in exercise 
among many women (Brown & Trost, 2003; Godin et al., 1986; Mottola, 2002). For 
example, when Pereira et al. examined the longitudinal changes in PA from pre-pregnancy 
to the post-partum period, they reported  2.7 hours per week of decline in self-reported total 
PA from pre-pregnancy (9.6 hr/wk) to the 2nd trimester of pregnancy (6.9 hr/wk) (n = 1442) 
(Pereira et al., 2007). When Cramp and Bray examined the patterns of pre- and postnatal 
women’s leisure time PA (LTPA), using a multilevel longitudinal analysis (n = 309), the 
average growth curve showed a gradual decline in LTPA (MET-hr/month) during pregnancy 
compared to pre-pregnancy levels (A. Cramp & Bray, 2009). In this example, LTPA did not 
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include occupational, household, and caregiving activities. The prevalence of pregnant 
women who met PA guidelines was generally low.  
Using the NHANES 1999 – 2006 self-reported cross-sectional PA data, Evenson and 
Wen noted that only 22.9% of pregnant women met the 2008 recommendations for physical 
activity when vigorous activities were included (Evenson & Wen, 2010).  When PA was  
objectively measured using an ActiGraph accelerometer in the NHANES 2003 – 2006 cross-
sectional data (n = 359)  (Evenson & Wen, 2011), it showed that pregnant women only 
participated in an average of 12.0 ± 0.86 minutes/day of moderate activity and 0.3 ± 0.08 
minutes/day of vigorous activity using the threshold cutpoints of Troiano et al (Troiano et 
al., 2008). When sedentary behavior was measured, the authors reported that pregnant 
women spent 57.1% of their monitored time in this category of activities.  
There are also differences in prenatal PA behaviors across pregnancy. After 
evaluating 31 pregnancy and exercise studies, Poudevigne and O’ Connor concluded that as 
pregnancy progresses, PA participation decreases especially in leisure and work-related PA 
categories (Poudevigne & Connor, 2006). In a cross-sectional survey (n = 467), Haakstad et 
al. demonstrated that 30% of the women were defined as non-exercisers in the first 
trimester, 36% in the second trimester and 53% in the third trimester. The definition of 
regular exercise used in this study was vigorous recreational PA at least 20 min once a week 
(Haakstad et al., 2007). As for  epidemiological evidence, NHANES 1999 – 2006 self-
reported PA data showed significantly lower moderate to vigorous LTPA among women in 
the third trimester compared to women in the first trimester (Evenson & Wen, 2010); 
whereas, according to the objectively measured PA, U.S. pregnant women spent 11.5 
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minutes/day at the first trimester, 14.3 minutes/day at the second trimester, and 7.6 
minutes/day at the third trimester in moderate to vigorous PA (Evenson & Wen, 2011).  
When examining the type of activities performed by pregnant women, Clissold et al. 
found that women who remained active during pregnancy changed their activity from sports, 
fitness classes and jogging to walking, swimming and gardening (Clissold, Hopkins, & 
Seddon, 1991).  One study from Sweden demonstrated that a water aerobics program was 
more effective than a land-based PA program in decreasing pregnancy-related low back pain 
due to the weightlessness in water (Granath, Hellgren, & Gunnarsson, 2006). More recently, 
Field suggested that other low-intensity exercise, such as water aerobics, yoga and tai chi 
could be safer and more desirable for pregnant women (Field, 2012). Evenson and Wen 
reported the most common type of leisure activities among the 1280 pregnant women in the 
NHANES 1999 – 2006 data was walking (40%), followed by recreational activities (18.6%), 
and indoor aerobic conditioning activities (11.8%) (Evenson & Wen, 2010). 
i) Walking during pregnancy 
Walking is a common and popular choice of PA during pregnancy. It could be due to 
its lower intensity and higher accessibility compared with some other LTPA. When Mottola 
and Campbell evaluated  activity patterns during pregnancy, they found that all categories of 
activity decreased except walking, which actually increased significantly by the 3rd trimester 
among the 529 women they surveyed (Mottola & Campbell, 2003). When the Project Viva 
team assessed change in LTPA from pre-pregnancy to mid-pregnancy (26 – 28 weeks of 
gestation) and six months postpartum, they found that total activity decreased significantly 
from pre-pregnancy to mid- pregnancy, and it remained low at six months postpartum. 
However, when the total amount of time spent walking was assessed, it only decreased 
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slightly from pre-pregnancy to mid-pregnancy, but it rebounded at six months postpartum, 
and exceeded the pre-pregnancy level (Pereira et al., 2007). In observational studies, 
walking at a brisk pace has been shown to reduce the risk of gestational diabetes (C. Zhang, 
Solomon, Manson, & Hu, 2006), pre-eclampsia (Saftlas, Logsden-Sackett, Wang, Woolson, 
& Bracken, 2004), excessive GWG (Stuebe et al., 2009), and macrosomia (Owe, Nystad, & 
Bo, 2009).  
Due to the growth of fetal tissue, the elevated basal metabolic rate and increased 
energy cost of moving a heavier body, overall energy requirements are higher during 
pregnancy (Prentice et al., 1996). In fact, according to Hytten’s estimate, in a well-nourished 
woman, the energy cost of pregnancy is approximately 335 MJ (80,000 kcal), but women 
may compensate this energy cost by selecting less demanding activities and reducing the 
pace of activities (Prentice et al., 1996). In terms of walking during pregnancy, thus far, 
three studies demonstrated that pregnant women walked at a slower pace as their pregnancy 
progressed or when walking pace among pregnant women was compared with a non-
pregnant population (DiNallo, Le Masurier, Williams, & Downs, 2008; Löf, 2011; van 
Raaij, Schonk, Vermaat-Miedema, Peek, & Hutvast, 1990). Under the laboratory condition, 
DiNallo et al. noted that self-selected walking pace at 32 weeks (mean = 2.8 m/h; SD = 0.5) 
was significantly lower than the self-selected walking pace at 20 weeks (3.1 m/h, SD = 0.6) 
when women walked on a treadmill. The estimated mean activity counts from the ActiGraph 
accelerometer also showed significantly lower estimated mean activity counts at 32 weeks 
(mean = 1,662.6 counts, SD = 513.3) compared to 20 weeks (mean = 2,291.9 counts, SD = 
659.9) (DiNallo et al., 2008). While, under free living conditions, Löf  compared the activity 
energy expenditure between pregnant (n =18) and non-pregnant (n = 21) populations using 
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the Intelligent Device for Energy Expenditure and Physical Activity (IDEEA) and doubly-
labeled water (Löf, 2011). The study showed that, on average, pregnant women (1.1 ± 0.1 
m/s) walked at a significantly slower pace than non-pregnant women (1.2 ± 0.1 m/s).  
It is stated in the 2008 Physical Activity Guidelines for Americans that some activity 
is better than none (“Physical activity guidelines advisory committee report, 2008. To the 
Secretary of Health and Human Services. Part A: executive summary,” 2009). Even though 
pregnant women might not be as efficient as non-pregnant women when it comes to PA 
participation, it is still necessary to encourage pregnant women to engage in PA as it is safe 
for them and the health benefits appear to outweigh the risks. 
b) Impact of PA on maternal and child health 
     As mentioned above, prenatal PA is generally safe for healthy pregnant women. 
Strong scientific evidence shows that the risks of moderate-intensity activity performed by 
healthy women during pregnancy are very low, and do not increase the risk of low birth 
weight, preterm delivery, or early miscarriage (Downs et al., 2012). In general, the fetus is 
not deprived of substrate (i.e.: glucose) during periods of maternal PA among well-
nourished women and women who have an adequate ingestion of nutrients throughout the 
day. In fact, many human and animals studies have shown that glucose and oxygen delivery 
to the fetus is not compromised due to maternal exercise in uncomplicated singleton 
pregnancies (J F Clapp, Little, Appleby-Wineberg, & Widness, 1995; James F. Clapp, 2003; 
Lotgering, Gilbert, & Longo, 1983, 1985). An acute period of fetal hypoglycemia may occur 
at the onset of maternal PA; however, a greater placental surface area available for glucose 
uptake in active women might help compensate for this shortage (James F. Clapp, 2003). 
Even among pregnant women who did not exercise regularly, previous work showed that 
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maternal PA did not impact uteroplacental blood flow as measured by ultrasound scans 
immediately after a graded exercise test in a laboratory condition (Kennelly et al., 2002).  
In terms of the fetal responses to maternal PA, ACOG 2002 guidelines stated that 
most of the potential fetal risks are hypothetical, and fetal injuries are highly unlikely (Artal 
& O’Toole, 2003). Instead of harming the fetus, regular aerobic exercise during pregnancy 
has shown to help with fetal cardiovascular development. Infants of pregnant women who 
performed routine workouts during gestation have improved heart rate and heart rate 
variability (May, Glaros, Yeh, Clapp, & Gustafson, 2010). In addition, maternal PA does not 
increase the risk of delivering SGA newborns (Hegaard, Pedersen, Nielsen, & Damm, 
2007).  Moderate PA during pregnancy seems to be protective against birth weight extremes 
with a high probability to deliver appropriate-for-gestational-age infants (AGA) (Z. Ferraro, 
Gaudet, & Adamo, 2012; Mudd et al., 2013). ACOG guidelines indicated that the risk of 
giving birth to an extremely low birth weight infant is rare in exercising pregnant women 
who consume an adequate energy intake throughout the day (Artal & O’Toole, 2003). As a 
result, in summary, research over the past 20 years in the field of maternal PA suggests that 
any effects of PA on maternal and child health are unlikely to be negative, and it actually 
brings benefits to both mothers and offspring when it is performed according to 
recommendations and consent is given from health care providers.  
Some of the positive health outcomes of PA during pregnancy include, but are not 
limited to a reduced risk of excessive GWG (Stuebe et al., 2009), pre-eclampsia (Kasawara, 
Nascimento, Costa, Surita, & Silva, 2012), gestational diabetes (Dempsey et al., 2004), 
incidence of operative delivery (J F Clapp, 1990), and low back pain (Pivarnik et al., 2006). 
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The benefits of maternal PA on excessive GWG and offspring health and development are 
discussed further, below.  
i) Maternal PA and excessive GWG 
Thus far, many observational studies have supported the role of PA in helping 
pregnant women to minimize, if not prevent excessive GWG (J. Clapp & Little, 1995; 
Haakstad et al., 2007; Olson & Strawderman, 2003; Stuebe et al., 2009). For example, when 
Olson and Strawderman used a population-based study (healthy pregnant women from 
Upstate New York, n = 622) to examine some of the modifiable behavioral and psychosocial 
factors in relation to GWG, they found that women who decreased compared to those who 
maintained or increased their PA participation during pregnancy had a significantly greater 
GWG (2.74 lbs, p < 0.01) (Olson & Strawderman, 2003). Unfortunately, in this study the 
details of the frequency and duration of PA participation of the women prior to and during 
pregnancy were not discussed. However, when Clapp and Little evaluated the effects of 
recreational exercise on pregnancy weight gain among previously active women (routinely 
exercised three or more times a week for 30+ min a session), their results supported the 
findings of Olson and Strawderman (J. Clapp & Little, 1995). In this study, they found that 
women who continued their workout regimen throughout pregnancy compared to those who 
stopped their workout either before conception or in early pregnancy had a significantly (p < 
0.05) lower rate of weight gain from week 15 to 30 (0.47 kg/wk vs. 0.57 kg/wk), and 30 to 
37 (0.31 kg/wk vs. 0.47 kg/wk). Additionally, they also demonstrated that women who 
continued an active lifestyle during pregnancy had a lower subcutaneous fat deposit 
compared to those who were inactive during gestation by measuring the skinfold thickness 
at five different sites (11 ± 1 mm vs. 24 ± 2 mm; p < 0.001). When PA participation was 
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assessed among 1388 women from the Project Viva cohort study, Stuebe and colleagues 
reported an inverse relationship between excessive GWG with mid-pregnancy walking (OR 
0.91; 95% CI: 0.82 – 1.00, per half-hour/day) and vigorous PA participation (OR 0.76; 95% 
CI: 0.60 – 0.97, per half-hour/day) (Stuebe et al., 2009). Moreover, this positive impact of 
maternal PA participation on excessive GWG has been observed in other countries, such as 
Canada (Cohen, Plourde, & Koski, 2010), Norway (Haakstad et al., 2007) and China (Jiang 
et al., 2012).  
Aside from observational studies, many interventions have been conducted in the 
past decade to examine the effectiveness of healthy lifestyle with the incorporation of 
prenatal PA to limit GWG. The findings of these studies are generally inconsistent. Some 
interventions successfully (Claesson et al., 2008; Hui et al., 2012; Mottola et al., 2010; 
Shirazian, Monteith, Friedman, & Rebarber, 2010), partially successfully (Asbee et al., 
2009; Barakat, Lucia, & Ruiz, 2009; Haakstad & Bø, 2011; Phelan et al., 2011; Polley, 
Wing, & Sims, 2002) or non-successfully (Guelinckx, Devlieger, Mullie, & Vansant, 2010; 
Kinnunen et al., 2007; Phelan et al., 2011; Polley et al., 2002) helped women to minimize 
GWG. The inconsistent results of these studies could be due to the differences in the type, 
intensity, duration and frequency of the activities included. Besides that, the various 
population and demographic characteristics of study participants could play a role in the 
varying outcomes.  
Mottola et al. conducted a case-controlled trial to assess the impact of combined 
nutrition restriction and a walking program on prevention of excessive weight gain in 
overweight Canadian pregnant women (NELIP) (Mottola et al., 2010). Seventy-five 
overweight women (BMI 25.0 – 29.9) were recruited between 16 – 20 weeks gestation to 
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participate in the intervention until they delivered. The walking program was individualized 
to reach 30% peak HR reserve of the participant and it was performed three to four times a 
week (40 min per session) under supervision. The results of this intervention showed that 
80% of the participants did not exceed IOM recommendations on NELIP and their average 
total weight gain on NELIP was only 6.8 ± 4.1 kg. Unfortunately, many women had gained 
excessive weight before they joined the program, which lead to an average of 12.0 ± 5.7 kg 
total weight gain by the end of the intervention. Mottola and colleagues also observed a 
significant increase in average daily step counts from the baseline value of 5677.6 ± 1738.0 
steps to more than 10,000 steps per day.  
On the other hand, when Phelan et al. conducted the Fit for Delivery Study, largest 
randomized controlled trial (n = 401) to date, to evaluate the effectiveness of behavioral 
lifestyle intervention on minimizing excessive weight gain they only found success in 
normal weight pregnant women (Phelan et al., 2011). This intervention is considered one of 
the most comprehensive programs, as education and advice on GWG, prenatal PA and 
healthy eating during pregnancy were included. This multi-component program included: i) 
one individual counseling with an interventionist at treatment onset to discuss appropriate 
GWG, PA (30 min of walking most days of the week), and calorie goals (20 kcal/kg) with 
the emphasis on fat intake reduction; ii) daily self-monitoring was encouraged by providing 
body-weight scales, food records, and pedometers for home-use; iii) automated postcards 
were mailed weekly to prompt healthy eating and exercise habits; iv) personalized graphs 
for weight gain were mailed after each prenatal visit to provide feedback; v) three brief (10 – 
15 min) supportive phone calls were provided by dietitians during the intervention; vi) 
supplementary supportive phone calls (2 calls/month) were provided for women, who were 
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over or under, weight gain guidelines to help with meal planning and goal setting. Intent-to-
treat analyses showed that normal-weight women in the intervention group were less likely 
than women in the usual care group to gain above the IOM recommendations (40.2% vs. 
52.1%, p = 0.003), but there were no differences between the groups of overweight or obese 
women (66.7% vs. 61.1%, p = 0.33). However, both normal weight and overweight/obese 
women in the intervention were more likely to achieve their pre-conception weight or below 
at 6-months post-partum (OR: 2.1, 95% CI: 1.3 – 3.5, p = 0.005). As previously mentioned, 
this RCT was a multi-component intervention, in which prenatal PA was not the sole 
recommendation given to the pregnant women to limit excessive GWG.  
In summary, maternal PA has the potential to prevent excessive GWG; therefore, the 
need to identify strategies to help pregnant women to increase their PA participation during 
pregnancy becomes critical in light of the increasing obesity prevalence.  
ii) Maternal PA and offspring birth weight and body composition 
Maternal PA has been associated with delivering SGA infants; however, the 
limitations of these studies include little or no information on nutritional status and caloric 
intake of women during pregnancy, and there is no control for other confounding factors that 
could affect birth weight, such as gestational age at birth, socioeconomic status or 
environmental factors. Besides that, many of these studies involved a small number of 
participants who were lean and physically active pregnant women (i.e.: athletes), which is 
likely not generalizable to other populations (Z. Ferraro et al., 2012; Hopkins & Cutfield, 
2011). On the contrary, in some large population-based observational studies, data showed 
that maternal PA participation increased the likelihood of giving birth to AGA infant. Most 
importantly, maternal PA helped to reduce the risk of giving birth to a LGA infant by not 
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increasing the odds for a SGA infant (Juhl, Olsen, Andersen, Nøhr, & Andersen, 2010; 
Mudd et al., 2012; Owe et al., 2009). For example, data from the Norwegian Mother and 
Child Cohort Study (MoBa) of 16,064 nulliparous women with singleton pregnancies 
showed that there was a decreased risk of macrosomia in women who regularly exercised at 
least three times per week during week 17 (OR 0.72; 95% CI: 0.56 – 0.93) and week 30 (OR 
0.77; 95% CI: 0.61 – 0.96) of gestation compared to those who did less than three times per 
week (Owe et al., 2009). However, in this study the duration and intensity of each bout of 
exercise was not characterized.  
In another large cohort observational study (n = 79,692), Juhl et al. supported the 
findings of Owe by examining the dose-response of workout (duration) with risk of 
macrosomia (Juhl et al., 2010). They found that the higher the amounts of time (h/wk) the 
women spent in PA participation during pregnancy, the lower the risk of delivering LGA 
infants; however, again, the intensity of the workout regimen was not mentioned. In two 
smaller cohorts of observational studies, women who participated for at least 120 min/wk of 
at least moderate PA during pregnancy had a significantly lower risk of delivering a LGA 
infant without increasing the risk for a SGA infant  (Alderman, Zhao, Holt, Watts, & 
Beresford, 1998; Mudd et al., 2012).  
In terms of the association between maternal PA participation and body composition 
of the infant, there are only three studies, all from Clapp and colleagues. Two studies were 
observational studies where recruited women were recreational athletes (i.e.: runners, cross-
country skiers) (J F Clapp, Simonian, Lopez, Appleby-Wineberg, & Harcar-Sevcik, 1998; J 
F Clapp, 1996) and one of the studies was a randomized controlled trial with no information 
about pre-pregnancy PA participation (J F Clapp, Kim, Burciu, & Lopez, 2000). In the first 
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observational study conducted in 1996, Clapp and colleagues compared women who 
continued their exercise regimens (aerobic activities three or more times per week, for more 
than 30 min a session with intensity greater than 55% of maximal capacity) during 
pregnancy with women who voluntarily stopped all sustained exercise besides walking (no 
information on intensity, duration and frequency were given by author) during pregnancy 
and found that the offspring of women who continued their exercise regimens during 
pregnancy were smaller (3.40 ± 0.80 vs. 3.64 ± 0.70 kg) and had less fat (10.5% ± 0.9% vs. 
15.1% ± 0.6%) (J F Clapp, 1996). Two years later, Clapp conducted another study, which 
confirmed his previous findings (J F Clapp et al., 1998). However, in this study the women 
in the control group did not engage in anything more than occasional (less than once a 
month) recreational PA, and less than once a week, they would go on an after-dinner walk. 
Based on the findings of these two observational studies, Clapp and colleagues decided to 
conduct a randomized controlled trial (J F Clapp et al., 2000). They assigned groups of 
women at 8 weeks of gestation to either the control (no exercise, n = 24) or intervention 
(weight-bearing exercise for 3 to 5 times per week, n = 22) groups. Unlike what was found 
in the previous observational studies, the offspring of the exercising group were significantly 
heavier (3.75 ± 0.08 vs. 3.49 ± 0.07 kg) and longer (51.8 ± 0.3 vs. 50.3 ± 0.3 cm) and there 
was no significant difference in neonatal percent body fat.  The heavier offspring of the 
exercising women was the result of an increase in both lean and fat body mass. Therefore, 
the authors concluded that beginning a moderate PA program in early pregnancy and 
continuing throughout pregnancy improved the fetoplacental growth.    
Infants who were born LGA were more likely to be overweight or obese later in life; 
therefore, it is possible that offspring born AGA by women who participated in PA during 
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pregnancy could reverse this adverse long-term health outcome. Unfortunately, to date, there 
is limited research in examining the long-term longitudinal data on post-natal growth in the 
offspring of women who engaged in maternal PA during pregnancy. Again, there are 
currently three such studies in the literature, and two of them are the follow-up studies of 
Clapp and colleagues from the previously mentioned observational studies. Offspring of the 
exercising women continued to weigh less (18.0 ± 0.5 vs. 19.5 ± 0.6 kg) and were leaner (37 
± 1 vs. 44 ± 2 mm) at age 5 compared to the control group (J F Clapp, 1996). Surprisingly, 
the second observational study conducted did not have the same results, but the 
measurements in children were taken at age 1 instead of age 5 (J F Clapp et al., 1998).  A 
more recent women/toddler pairs study (n = 23) conducted by Mattran et al. showed that 
recall of LTPA at 3rd trimester (MET-min/wk) was marginally associated with lower toddler 
weight (rs = -0.39, p = 0.06) and weight-for-height z score (rs = -0.40; p = 0.06) between 18 
to 24 months of age in the offspring (Mattran, Mudd, Rudey, & Kelly, 2011). 
Overall, maternal PA is beneficial in reducing the odds of delivering a LGA infant. 
Strong scientific evidence shows that maternal obesity and excessive GWG are two of the 
major risk factors for delivering LGA infants. With the increasing prevalence of high birth 
weight (> 4.5 kg) and LGA babies (Ananth & Wen, 2002; Hadfield et al., 2009; Surkan, 
Hsieh, Johansson, Dickman, & Cnattingius, 2005), maternal PA may be advantageous for 
overweight or obese pregnant women. Moreover, the impact of maternal PA participation on 
postnatal growth in the offspring of overweight and obese pregnant women has not been 
studied. Therefore, with a robust positive relationship between birth weight and BMI in 
childhood and adulthood, reduction in birth weight of children of overweight and obese 
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women and prevention of excessive GWG through PA participation during pregnancy may 
bring valuable benefits to public health.  
c) Barriers and predictors of PA participation during pregnancy 
    Despite the demonstrated benefits of engaging in regular PA, and the 
recommendations set forth by public health agencies, many pregnant women still do not 
meet the PA recommendations. As a result, there is a need to understand what barriers 
prevent women from engaging in prenatal PA and what factors predict women’s PA 
participation.  
After reviewing approximately 300 studies on adult PA correlates, Sallis and 
colleagues concluded that perceived barriers are among the most cited psychosocial PA 
correlates (Sallis, Owen, & Fisher, 2008). When examining someone’s barriers to PA, a 
multilevel ecological approach seems to provide the best understanding of this very 
complex, interwoven relationship (Downs et al., 2012; Evenson, Moos, Carrier, & Siega-
Riz, 2009). The components of socioecological framework include intrapersonal, 
interpersonal, environmental, and policy-related factors. Pregnancy is a period of complex 
social, psychological, behavioral and biological change in a woman’s life (Devine, Bove, & 
Olson, 2000). Consequently, there are many barriers that can prevent pregnant women from 
engaging in PA.  
At the intrapersonal level, studies have reported that physical discomfort (i.e.: 
nausea, fatigue, back pain, swollen feet) (A. G. Cramp & Bray, 2009; Evenson et al., 2009; 
Leiferman, Swibas, Koiness, Marshall, & Dunn, 2011), embarrassment about appearance 
(Kieffer, Willis, Arellano, & Guzman, 2002), concern about safety and injury (Evenson et 
al., 2009; Leiferman et al., 2011), incorrect or lack of information from physicians 
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(Leiferman et al., 2011), lack of motivation (A. G. Cramp & Bray, 2009; Evenson et al., 
2009; Leiferman et al., 2011), and lack of time (A. G. Cramp & Bray, 2009; Evenson et al., 
2009; Leiferman et al., 2011) are some of the collective barriers described by pregnant 
women pertaining to prenatal PA. Two common interpersonal barriers most mentioned by 
women are the lack of social support (Evenson et al., 2009; Kieffer et al., 2002; Leiferman 
et al., 2011), and social norms (Evenson et al., 2009; Kieffer et al., 2002; Leiferman et al., 
2011). Environmental barriers include lack of access to available resources (i.e.: safe parks, 
trails, gyms) (Evenson et al., 2009; Kieffer et al., 2002; Leiferman et al., 2011), no childcare 
support (A. G. Cramp & Bray, 2009; Evenson et al., 2009; Kieffer et al., 2002), and 
weather-related concerns (A. G. Cramp & Bray, 2009; Evenson et al., 2009; Leiferman et 
al., 2011). Lastly, some pregnant women faced policy-related barriers. There were 5% of 
women in the Pregnancy, Infection, and Nutrition (PIN) Study that reported barriers in this 
category, which were mainly conflicts with work or school, and the cost of workout 
facilities (Evenson et al., 2009).  
Numerous studies have examined the association of theory-based psychosocial 
factors in predicting PA participation during pregnancy (Gaston & Cramp, 2011). These 
factors have been mainly investigated from the perspectives of the Theory of Planned 
Behavior (Downs & Hausenblas, 2007; H. Hausenblas & Symons Downs, 2004; H. 
Hausenblas, Downs, Giacobbi, Tuccitto, & Cook, 2008; Symons Downs & Hausenblas, 
2003; Weir et al., 2010), the socioecologic framework (Evenson et al., 2009; Leiferman et 
al., 2011), and the social cognitive theory (A. G. Cramp & Bray, 2009). Among these 
psychosocial factors, self-efficacy (a component the social cognitive theory) has yielded the 
most consistent positive relationship with PA participation during pregnancy. Self-efficacy 
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is the belief in one’s capabilities to put forth the necessary effort to overcome various 
challenges (Bandura, 1997). It influences the adoption, initiation, and maintenance of health 
behaviors such as leisure time PA participation (Sallis et al., 1986; Sallis, Hovell, & 
Hofstetter, 1992). Studies have shown that self-efficacy strongly correlates to PA 
participation among diverse populations including children, men, and non-pregnant women 
(McAuley & Blissmer, 2000; Motl, Snook, McAuley, Scott, & Douglass, 2006; Sharpe et 
al., 2008; Strauss, Rodzilsky, Burack, & Colin, 2001; T.-Y. Wu, Pender, & Noureddine, 
2003). 
Self-efficacy is likely an important factor that needs  to be targeted in behavioral 
interventions among the pregnant population (Oken & Gillman, 2012).  Hinton and Olson 
(Hinton & Olson, 2001) examined the psychosocial predictors of pregnancy-related changes 
in PA participation, and they concluded that exercise self-efficacy was a key predictor of PA 
participation during the perinatal period after controlling for age, prepregnancy BMI, and 
frequency of prepregnancy exercise. Further, Cramp and Bray (A. G. Cramp & Bray, 2009) 
completed an observational study that supported the findings of Hinton and Olson. In this 
cross-sectional study, they demonstrated that exercise self-efficacy (barrier and task self-
efficacy) independently predicted LTPA across pregnancy (at week 18, 24, 30 and 35 of 
gestation). In this study, barrier self-efficacy was defined as “anything that may stop you 
from doing physical activity”; while task self-efficacy was defined as confidence in their 
ability to participate in LTPA during pregnancy. 
In summary, identifying barriers to PA during pregnancy and predictors that 
motivate women from engaging in prenatal PA are crucial. Unlike the sociodemographic 
53 
 
 
correlates, psychosocial correlates like barriers and self-efficacy are modifiable 
characteristics, which could be targets for interventions.  
B) Maternal diet 
There is an increased maternal nutritional requirement during pregnancy. The energy 
need during the first trimester of pregnancy is no different from that of non-pregnant 
women, but it increases an additional 340 kcal per day in the second trimester, and 452 kcal 
per day in the third trimester (Kaiser & Allen, 2008). Total daily calorie intake for most 
pregnant women is between 2,200 to 2,900 kcal per day, but this recommendation should be 
individualized based on prepregnancy BMI, rate of weight gain, maternal age and appetite 
according to the American Dietetic Association positioning report (Kaiser & Allen, 2008). 
Pregnant women are also advised to consume a variety of foods to meet the higher need for 
specific vitamins and minerals. Currently, most health care providers would recommend 
pregnant women take a daily prenatal vitamin and mineral supplement; however, these 
supplements should not replace a healthy diet. In order to better facilitate the special needs 
of the pregnant population in the United States, ChooseMyPlate.gov has a special section of 
the website for pregnant women called “Daily Food Plan for Moms”, where pregnant 
women can make a food plan that covers individual energy needs and it also guides women 
to make good food choices during pregnancy (ChooseMyPlate.gov, 2013).   
Unfortunately, many women of childbearing age in the U.S. do not maintain good 
nutritional status before, during and after pregnancy (Kaiser & Allen, 2008). Studies have 
shown that maternal dietary factors can significantly influence the health outcomes of the 
mother and baby (Camargo et al., 2007; Hibbeln et al., 2007; King, 2000; Moon et al., 2013; 
Rifas-Shiman, Rich-Edwards, Kleinman, Oken, & Gillman, 2009; Scholl, Hediger, Schall, 
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Khoo, & Fischer, 1996). In more recent years, researchers also demonstrated that maternal 
high fat diets or “junk food” diets, which consisted of high-fat, sugar and salt, during 
pregnancy and lactation contributed to the development of offspring obesity (S. A. Bayol, 
Simbi, Bertrand, & Stickland, 2008; Stéphanie A. Bayol, Farrington, & Stickland, 2007; 
Franco et al., 2012). Project Viva examined the dietary quality of pregnant women (n = 
1,777) using the Alternate Healthy Eating Index- Pregnancy (AHEI-P) on a 90-point scale 
(10 points for each component), and the average score of the women was 61 ± 10 (minimum 
33, maximum 89) (Rifas-Shiman et al., 2009). The nine dietary components of AHEI-P 
include vegetables, fruit, ratio of white to red meat, fiber, trans-fat, ratio of polyunsaturated 
to saturated fatty acids, folate, calcium and iron. Food-frequency questionnaires were used 
to collect the dietary intake of the participants; however, in order to have a meaningful 
interpretation of the diet quality, results were simplified into this composite score. 
Participants in the study, who were younger (-1.3 points per 5 years, 95% CI: -1.8 – -0.7), 
less educated (-5.2 points for high school or less vs. college graduate, 95% CI: -7.0 – -3.5), 
had more children (-1.5 points per child, 95% CI: -2.2 – -0.8), and who had higher pre-
pregnancy BMI (-0.9 points per 5 k/m2, 95% CI: -1.3 – -0.4), had poorer-quality diets. They 
also observed that the lower the AHEI-P score, the higher the blood glucose levels of the 
women at the first trimester, and the higher the risk of developing pre-eclmpsia at the second 
trimester.  
Good maternal nutrition does not only benefit the mother, but it is also a key factor 
for the health of our next generation. Health-promoting strategies which support a healthful-
balanced diet and active lifestyle cannot be taken lightly during pregnancy. A substantial 
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body of evidence supports the notion that pregnancy could be an ideal time to make healthy 
lifestyle choices. 
C) Pregnancy-specific lifestyle interventions 
a) Overview of the effectiveness of current lifestyle interventions on GWG 
    Eleven systematic or meta-analysis reviews published in English between  2010- 
2012 addressed the effect of lifestyle interventions, either by modifying PA, and/or diet, on 
GWG and/or proportion of women exceeding the IOM guidelines were identified. Some of 
these reviews only included randomized-controlled trials (RCTs), but some included both 
RCTs and non-randomized interventions. Many of the earliest and highly cited interventions 
on reducing excessive GWG were non-randomized interventions (Oken & Gillman, 2012). 
i) Physical activity and/or dietary lifestyle interventions 
Among the 11 reviews, 7 included PA and/or dietary lifestyle interventions: four of 
these reviews concluded that PA and/or dietary lifestyle interventions successfully 
minimized GWG (Gardner, Wardle, Poston, & Croker, 2011; Oteng-Ntim, Varma, Croker, 
Poston, & Doyle, 2012; Ina Streuling, Beyerlein, & Kries, 2010; Thangaratinam et al., 
2012); two reviews did not provide conclusive results (Mudd et al., 2013; Ronnberg & 
Nilsson, 2010; Skouteris et al., 2010) and one review found no significant difference in 
GWG among participants in the intervention group compared to the control group 
(Campbell, Johnson, Messina, Guillaume, & Goyder, 2011).  
In the Streuling et al. meta-analysis, only articles in English and German were 
included. The review was comprised of four RCTs and five non-randomized trials with a 
total of 1549 women. When random-effects model analysis was performed to quantify the 
effect estimates, a significant (p = 0.01) reduction of the standardized mean difference 
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(SMD) of -0.22 units (95% CI: -0.33 – -0.03) in the intervention groups was observed. This 
corresponded to an average of 1.2 kg GWG reduction, indicating a clinically relevant result 
(Ina Streuling et al., 2010). The authors also observed that interventions supplemented with 
weight monitoring had an additional beneficial effect on weight reduction.  
The results of Streuling et al. were supported by another more comprehensive meta-
analysis performed by Thangaratinam et al. (Thangaratinam et al., 2012). This meta-analysis 
included all published randomized controlled trials (44 RCTs, n = 7278) with no language 
restrictions. The results showed that there was a 1.42 kg reduction (95% CI: 0.95 – 1.89) in 
GWG with any intervention (diet, PA, and a mixed approach) compared with control; 
however, the largest reduction was found in dietary interventions (3.84 kg; 95% CI: 2.45 – 
5.22, p < 0.001). Unfortunately, this meta-analysis showed that there was no significant 
difference between the groups in meeting the IOM weight gain recommendations (relative 
risk 0.85; 95% CI: 0.66 – 1.1).  
When evaluating lifestyle interventions aimed at overweight and obese pregnant 
women, Oteng-Ntime and colleagues included thirteen RCT and six non-RCTs in their 
meta-analysis and systematic review (Oteng-Ntim et al., 2012). All of these trials were 
performed in developed countries and 16 out of the 19 trials measured GWG. The findings 
of this study showed that weight reduction was only significant in RCTs (10 studies, n = 
1,228, -2.21 kg; 95% CI: -2.86 – -1.57), but not in non-RCTs (6 studies, n = 1,534; -0.42 kg; 
95% CI: -1.03 – 0.19) among the overweight and obese pregnant women.  
The last meta-analysis, which showed positive results in changing diet and PA to 
reduce GWG, is from Gardner et al. (Gardner et al., 2011). This is a novel meta-analysis, in 
that the authors deconstructed the different aspects of the intervention content by identifying 
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the use of theoretical basis, and behavioral change techniques in the studies. Among the 
twelve RCTs included in the analysis, Gardner et al. only identified two interventions 
reporting the use of behavioral theories to inform intervention design: one mentioned the use 
of social learning theory (Gray-donald et al., 2000), and the other used precede-proceed and 
transtheoretical model (Kinnunen et al., 2007). However, neither of the study authors 
included detail regarding how the theoretical constructs were used to develop the 
interventions. Gardner et al. also identified 16 of the 40 behavioral techniques described by 
Michie et al. (Michie et al., 2011) in 10 of the RCTs. The three most commonly used 
techniques were self-monitoring (8 trials), provision of feedback on performance (6 trials), 
and goal-setting (5 trials); however, none of these techniques were particularly effective. 
The overall findings of the paper showed that the 12 RCTs were effective in minimizing 
weight gain among the pregnant women in the intervention group compared to the control 
group with a weighted mean difference (WMD) of -1.19 kg (95% CI: -1.74 – -0.65, p < 
0.0001); however, two of the theoretical based interventions had no effect on weight gain 
(WMD = -0.41, 95% CI: -1.76 – 0.95, p < 0.56). The authors concluded that it could be that 
inappropriate theories were used in these studies that lead to the ineffectiveness, especially 
when no detail in regard to the theories was given.  
Two review articles showed that PA and/or diet interventions provided inconclusive 
and inconsistent results in minimizing excessive GWG. Skouteris et al. demonstrated that 
even though six out of the total ten studies (RCTs and non-RCTs) reported significantly 
lower weight gain among women in the intervention compared to control, the intervention 
program only affected one group of participants (e.g. normal-weight women, low-income 
women, obese women), but not uniformly across all participants in the same intervention. 
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Three out of these six studies showed that women in the intervention group were more likely 
to meet the IOM guidelines. Interventions that significantly improved diet or PA were not 
successful in reducing GWG. Therefore, the authors concluded that the most appropriate 
factors to be targeted in interventions to reduce GWG remain unknown. The findings of 
Skouteris were further supported by Ronnberg and Nilsson, who assessed all available RCTs 
and non-RCTs with total or rate of GWG as the primary outcomes using the Grading of 
Recommendations, Assessment, Development and Evaluation (GRADE) system, which is a 
system for rating quality of evidence in systematic reviews and guidelines using a structured 
process (Ronnberg & Nilsson, 2010). Among all eight studies included in the review, a 
majority of them showed no significant difference in rate of weight gain or proportion 
exceeding IOM weight gain guidelines. In summary, the assessment found that there were 
important limitations in study design, inconsistency, and lack of directness; therefore, the 
overall quality of published interventions was judged to be very poor.  
The objective of the systematic review performed by Campbell et al. in 2011 was to 
assess the effectiveness of behavioral interventions to prevent excessive GWG (using 
quantitative analysis) and to investigate the views of women on weight management during 
pregnancy (using qualitative analysis) (Campbell et al., 2011). The quantitative analysis 
showed that despite intense and often tailored intervention, there was no significant 
difference in GWG among participants in the intervention group compared to the control 
group (mean difference -0.28; 95% CI: -0.64 – 0.09). While the qualitative analysis showed 
that most women viewed pregnancy as a time of transition and change, the messages with 
regard to weight management in pregnancy were conflicting and contradictory and they 
perceived lack of control to maintain healthy weight gain during pregnancy. As a result, 
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when the authors aligned the quantitative and qualitative analyses, they concluded that some 
common barriers (i.e.: lack of information, contradictory information received and social 
support) pregnant women faced in gaining appropriate weight during pregnancy were not 
addressed by the interventions.  
ii) Physical activity interventions 
Thus far, only one meta-analysis has been performed to evaluate the impact of 
lifestyle intervention, with increasing PA as the only modification during pregnancy, on 
GWG (Streuling et al., 2011). Twelve RCTs were included in this analysis with trials 
varying by intensity, duration and mode of activity. Seven of the trials reported a trend for 
lowering GWG in the intervention group, one showed significant reduction in GWG, and 
five showed no significant effect. The overall meta-analysis finding demonstrated that PA 
modification indeed resulted in significant GWG reduction (mean difference of -0.61; 95% 
CI: -1.17 – -0.06, p = 0.03). When the mean difference was plotted against METs per 
intervention, the graph showed no dose-dependent effect of exercise on GWG. The author of 
this study concluded that prenatal PA might be an ideal strategy to minimize excessive 
GWG.  
iii) Dietary interventions 
Two systematic reviews (Dodd, Grivell, Crowther, & Robinson, 2010; Tanentsapf, 
Heitmann, & Adegboye, 2011) and one meta-analysis (Quinlivan, Julania, & Lam, 2011) 
were conducted to evaluate the effectiveness of  dietary interventions to prevent excessive 
GWG. In the Tanentsapf et al review, ten out of thirteen included trials reported total GWG; 
two reported weekly GWG and four reported percentage weight gain exceeding IOM weight 
recommendations. The results showed that dietary modification significantly reduced total 
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GWG in the intervention group (WMD = -1.92; 95% CI: -3.65 – -0.19, p = 0.03), and 
significantly reduced weekly GWG (WMD = -0.26 kg/wk, 95% CI: -0.42 – -0.09, p = 
0.003), but did not lower the risk of women who gained more than IOM recommended 
weight (reduction in risk (RR) 0.90; 95% CI: 0.77 – 1.05, p = 0.18). When Quinlivan and 
colleagues conducted a meta-analysis which focused on the overweight and obese 
population, they found that dietary interventions significantly restricted maternal weight 
gain during pregnancy, with a pooled mean difference of -6.5 kg (95% CI: --7.6 – -5.4) 
(Quinlivan et al., 2011). On the contrary, when Dodd and colleagues examined antenatal 
dietary interventions for overweight and obese women, they did not find a significant 
reduction in weight gain among the women who were in the intervention group (WMD = -
3.10 kg; 95% CI: -8.32 – 2.13) when a random-effects model was used (Dodd et al., 2010).  
To conclude, in the words of Ronnberg and Nisson “interventions designed to reduce 
excessive GWG still appear to be in their infancy” (Ronnberg & Nilsson, 2010). Many, if 
not all, of these systematic and meta-analysis reviews observed a trend of poor to low 
quality of the published interventions, heterogeneity of trials, and inconsistent results, 
especially across subgroups (e.g., income, weight category) (Oken & Gillman, 2012). It is 
seconded by a Cochrane Review that no one intervention thus far appears to be appropriate 
for preventing excessive GWG, which is due to the poor quality and small effect size of 
current published interventions (Muktabhant, Lumbiganon, Ngamjarus, & Dowswell, 2012). 
Fortunately, in recent years, numerous efforts have been invested to support research 
programs focused on this area. For example, in 2011, the US National Institutes of Health 
invited grant application proposals ‘to conduct studies testing behavioral/lifestyle 
interventions in overweight and obese pregnant women designed to improve weight and 
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metabolic outcomes in both the pregnant women and their offspring. Studies are expected to 
continue follow-up of mothers and their offspring for a minimum of 12 months post-partum. 
Weight and/or metabolic outcomes must be assessed in both mothers and offspring’ 
(Department of Health and Human Services, 2011). Optimistically, strategies to help women 
prevent excessive GWG that could lead to a better health for the mothers and children are 
within the reach in the next few years.  
Overall, randomized controlled trials with adequate power are needed to provide 
evidence-based recommendations for health care providers to combat the issue of maternal 
obesity and/or excessive GWG. Additionally, there is also a lack of well-conducted trials 
demonstrating the benefits of antenatal lifestyle interventions on down-stream child growth 
and development outcomes, especially considering the issue of childhood obesity. Lastly, 
despite the consensus that intervention studies should be theoretically driven (Dishman, 
2001), most prenatal PA intervention studies are not based on theoretical frameworks 
specifically targeting promotion of  PA behavior. This has limited the mechanistic insight to 
intervention effectiveness. As a result, there is a need for theoretically driven randomized 
controlled trials to better understand the complex interactions among the psychological, 
behavioral, and biological determinants of prenatal PA (Downs et al., 2012). These trials 
would then serve as a foundation to develop strategies or recommendations for the obstetric 
providers to help women achieve optimal weight gain during pregnancy.  
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CHAPTER 3: A RANDOMIZED-CONTROLLED WALKING INTERVENTION TO 
IMPROVE PREGNANCY AND BIRTH OUTCOMES BY PROMOTING 
MODERATE PHYSICAL ACTIVITY AMONG OVERWEIGHT AND OBESE 
PREGNANT WOMEN: MOMS TO MOVE (M2M) STUDY 
A paper to be submitted to the journal Medicine and Science in Sports and Exercise   
Kai Ling Kong, Christina G Campbell, Randal C Foster, Anna D Peterson, Lorraine M 
Lanningham-Foster         
Abstract 
Few studies have investigated the use of walking among overweight and obese pregnant 
women as a strategy for meeting the physical activity (PA) recommendation during 
pregnancy in order to limit excessive gestational weight gain (GWG). Purpose: To promote 
moderate PA participation among previously non-exercising, overweight and obese pregnant 
women, via walking, and to evaluate the impact of increased moderate PA on GWG and 
birth outcomes.  Methods: Thirty seven overweight or obese (BMI > 25.0 kg/m2) pregnant 
women were randomly assigned to a walking intervention versus no-intervention control 
group. Anthropometric, objective physical activity (StepWatch™ Activity Monitor), and self-
reported diet data were collected for one-week at a time at each of the following gestational 
time point: weeks 10-14 (V1), 17-19 (V2), 27-29 (V3) and 34-36 (V4) of gestation. 
Participants provided information of the infant’s delivery and birth outcomes. Cadence of 
≥80 steps/min was defined as moderately intense PA and “meaningful walking” was defined 
as moderately intense cadence in bouts of  at least 8 minutes of walk. ANOVA was used to 
determine the differences in walking amount and meaningful walks; Kolmogorov-Smirnov 
test was used for walking intensity analysis; Fisher’s exact test was used for total GWG and 
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infant outcomes analyses. Results: There were significantly more moderately intense 
cadence (cadence ≥80 steps/min) among the women in the intervention group compared to 
control group at V2 (overweight p < 0.0001; obese p < 0.025), V3 (overweight p < 0.0001; 
obese p = 0.0722), and V4 (overweight p < 0.0001; obese p < 0.025). Women in the 
intervention group also significantly increased their meaningful walks at V2 (diff = 32.6 
min, p = 0.054), V3 (diff = 37.1 min, p = 0.01) and V4 (diff = 35.4 min, p = 0.014). Even 
though it was not statistically significant, there was a trend for women in the intervention 
group to have overall more favorable pregnancy and birth outcomes compared to the control 
group. Conclusion: The walking intervention increased the walking intensity and time spent 
in meaningful walking of all women enrolled in the intervention group during pregnancy.  
Key words: walking intensity, moderately intense cadence, pregnancy, gestational weight 
gain 
Introduction 
In the United States, approximately two-thirds of childbearing age women are either 
overweight or obese (46). There is increased risk of adverse maternal and fetal health 
outcomes, such as gestational diabetes (9), gestational hypertension or pre-eclampsia (6), 
and labor/delivery  complications (58, 63) among overweight and obese pregnant women. 
Excessive gestational weight gain (GWG) is another concern in the field of maternal and 
child health. In 2009, the Institute of Medicine released updated GWG recommendations 
based on a woman’s pre-pregnancy BMI (46). The latest data showed that in the U.S., 63% 
of overweight and 65% of obese women exceeded the 2009 IOM GWG recommendations 
(59). Excessive GWG can be particularly concerning for overweight and obese women due 
to their already increased risk for adverse pregnancy outcomes. In addition, maternal obesity 
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and GWG are two of the main causes of giving birth to large-for-gestational-age (LGA) 
(birth weight ≥ 90th percentile) infants in most Western countries (2, 14, 34, 36). The 
influence of maternal obesity on offspring obesity may be  sustained from childhood through 
adulthood (27, 28, 49, 60).  
Healthy eating habits and regular physical activity (PA) are two modifiable targets in 
managing and preventing weight gain. These behaviors should be encouraged among 
pregnant women, too. In recent years, PA during pregnancy has been viewed as an important 
part of reproductive health. Pregnant women are encouraged to have an active lifestyle, 
which has replaced the traditional view that pregnant women should engage in limited 
exercise. The risks of moderate-intensity PA performed by healthy women during pregnancy 
are very low and do not increase the risk of low birth weight, preterm delivery, or early 
miscarriage (18). However, when examining the prevalence of PA participation for pregnant 
women, pregnancy appears to be a life event which leads to a drastic decrease in PA 
participation among many women (7, 22, 32).  
Studies have suggested positive benefits of PA during pregnancy to both the mother 
and fetus including decreased risk of developing pre-eclampsia (26) and gestational diabetes 
(16), fewer incidences of operative deliveries (12), and decreased low back pain (41). 
Additionally, some observational studies have supported the role of PA in helping pregnant 
women to minimize, if not prevent, excessive GWG (11, 23, 37, 52). According to the 
American College of Obstetrics and Gynecology (ACOG) 2002 guidelines, in the absence of 
either medical or obstetric complications, pregnant women are encouraged to accumulate 30 
minutes or more of moderate-intensity PA (MPA) on most, if not all days of the week (1). 
Later, when the U.S. Department of Health and Human Services issued the first-ever PA 
87 
 
 
guidelines for Americans (PAG) in 2008, they included recommendations for pregnant 
populations who are healthy and without medical complications (64). Different from the 
ACOG guidelines, the 2008 PA guidelines prescribe a total of 150 minutes of MPA per 
week (spread throughout the week) for pregnant women. Despite these recommendations, 
the evidence of US pregnant women meeting PA guidelines is low (20, 21). According to 
the NHANES 2003 – 2006 data, pregnant women only participated in an average of 12.0 ± 
0.86 minutes/day of moderate activity and 0.3 ± 0.08 minutes/day of vigorous activity when 
their PA participation was objectively measured by ActiGraph accelerometer (21). With the 
higher risk of adverse maternal and fetal health outcomes along with an increased possibility 
of gaining excessive weight during gestation, it is imperative that strategies to promote MPA 
in this population be identified. 
Interventions have been conducted to examine the effectiveness of healthy lifestyle 
with the incorporation of prenatal PA to limit GWG and/or proportion of women exceeding 
the 2009 IOM guidelines (5, 10, 24, 31, 40, 50). The findings of these intervention studies 
are generally inconsistent, possibly due to the differences in the type, intensity, duration and 
frequency of the activities included. Walking is a common and popular choice of PA during 
pregnancy because of its lower intensity and higher accessibility compared with some other 
leisure-time PA (LTPA) (30, 39). During pregnancy, all categories of activity decrease 
except walking (30). Few studies, if any, have investigated the use of walking among 
overweight and obese pregnant women as a strategy for meeting the recommendation of 150 
minutes per week of moderate intensity PA during pregnancy in order to limit excessive 
GWG. Therefore, we conducted a pilot randomized controlled trial (RCT) to evaluate the 
feasibility of increasing PA participation of previously non-exercising, overweight and 
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obese pregnant women by walking. The objectives of this study were 1) to promote 
moderate PA participation among previously non-exercising, overweight and obese pregnant 
women, via walking; 2) and to evaluate the impact of increased moderate PA on pregnancy 
and birth outcomes. The hypotheses of the current study were that previously non-
exercising, overweight and obese women could increase moderate PA participation during 
pregnancy via a walking intervention, and those who increased their moderate PA 
participation would have more favorable pregnancy and birth outcomes.     
Methods 
Participants 
Recruitment for participants occurred from January 2011 to March 2012 through 
emails, online advertisements, and fliers posted throughout the community and at local 
obstetric clinics. Potential participants who expressed interest were screened for 
qualification criteria. Each participant was provided with an informed consent document for 
review.  The study was approved by the Institutional Review Board of Iowa State 
University.  
All pregnant women were recruited before they began their fifteenth week of 
gestation. Gestational age was calculated based on the self-reported date of the patients’ last 
normal menstrual cycle or the due date determined by their medical providers using 
ultrasound. Forty-six pregnant women enrolled in the study, and the final number of women 
who completed the study was 37 (n = 18 in intervention group; n = 19 in control group). 
Five women withdrew from the study (Figure 1). Participants who were enrolled met the 
following inclusion criteria: maternal age between 18-45 years old, singleton pregnancy, 
non-smoker, self-reported overweight (BMI > 25.0 kg/m2) or obese (BMI > 30.0 kg/m2) 
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prior to pregnancy, no prior history of chronic diseases (including type 1 diabetes, 
cardiovascular disease, thyroid disorder or lung disorder), and no prior history of gestational 
diabetes. In addition, only women who engaged in less than three times per week of LTPA 
for 30 minutes or more per session, 6-months preceding their enrollment into the study were 
recruited. Pre-pregnancy PA participation was self-reported (questions in the screening 
process) and LTPA was defined as activities performed each week beyond normal daily 
routines.  
Study design  
Procedure 
 Participants who met inclusion criteria were invited for an enrollment appointment 
prior to week 15 of gestation. During the enrollment, participants signed the consent form, 
filled out a medical history questionnaire, and provided their medical providers’ contact 
information. Height and weight of the women were measured by a trained staff member 
after the consent form was signed. All participants were approved by their medical providers 
to join the study. After the initial enrollment, participants were randomly assigned to the 
intervention or control group. Randomization was conducted using a computer-based 
random number generator (Microsoft Excel 2010, WA). All participants reported to the 
clinical research center at each of the following time points: weeks 10 – 14 (V1), 17 – 19 
(V2), 27 – 29 (V3) and 34 – 36 (V4) of gestation. At each gestational data collection time 
point, anthropometric, objective PA, and self-reported diet data were collected for one-week 
at a time. Weeks 10 – 14 of gestation (V1) served as the baseline data collection period. 
Participants randomized to the intervention group had an additional intervention training 
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session after the baseline visit. Participants filled out a post-partum questionnaire that 
provided information regarding the infant’s delivery and birth outcomes.   
Intervention: walking program 
The intervention in this study was an unsupervised walking program. Immediately 
after the baseline data collection (V1), women in the intervention group attended a training 
session. At this session, the women were verbally given the 2008 U.S. Physical Activity 
Guidelines, which is to accumulate a minimum of 150 minutes per week of moderate PA 
during pregnancy. The women were advised to spread their walking throughout the week, 
such as 30 minutes of walking five days per week (1). The women were also given 
permission to walk in shorter bouts; however, they were advised to keep the bouts to at least 
10 minutes (61). Walking could occur indoors, such as walking at the mall, or outdoors, 
such as walking at the park. To help participants in the intervention group achieve their 
walking goal, treadmills were provided to use in their homes for the duration of the study 
and were returned following the completion of the walking program.  A treadmill was 
provided to eliminate some of the common prenatal PA barriers pregnant women face (13, 
19). These barriers include, but are not limited to, lack of access to available resources (i.e.: 
gyms, trails), lack of childcare support, and weather-related concerns. The instructions and 
safety of using a treadmill was discussed with individual participants. A treadmill was 
delivered to the participant’s home and assembled by study staff.  All treadmills were 
functioning when placed in the participant’s home and all treadmills were verified to be 
functioning when removed.  A study staff member picked up the treadmill from the 
participant’s home at the end of the walking intervention period. 
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The walking program began no earlier than week 12 and no later than week 15 of 
gestation and lasted until at least week 35. Depending on the length of each participant’s 
pregnancy, all the intervention participants were able to complete at least 20 weeks of the 
walking program. The first three weeks of the intervention program served as an acclimation 
period. At week one, participants were asked to walk for at least 10 minutes per day and at 
least 5 days per week,  followed by 20 minutes per day at week 2 and 30 minutes per day at 
week three.  By week 18, all participants were encouraged to be at their walking goal of 30 
minutes most days of the week for an overall total of at least 150 minutes of weekly 
moderate PA. During the acclimation period, participants received weekly contacts from the 
study coordinator to report their progression. Participants were also given a PA log to record 
the duration, method and location of their walks throughout the intervention period. They 
returned the PA logs to the study coordinator at each gestational data collection time point. 
Women in the control group were not provided recommendations with respect to PA 
participation, but they were not restricted from any form of PA participation during 
pregnancy. They were also given a PA log to record any leisure activities (including 
walking) that they participated in throughout the study period. The control group was not 
given treadmills for home use.   
Data Collection 
Anthropometric and demographic data 
 Height and weight were measured at each gestational time point visit. Height was 
measured to the nearest 0.1 cm (Ayrton 226 Hite-Rite Precision Mechanical Stadiometer, 
Quick Medical GS, Snoqualmie, WA) and weight was measured to the nearest 0.1 kg 
(Detecto Model 6855 Cardinal Scale, Manufacturing Co., Webb City, MO). Pre-pregnancy 
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BMI was determined by using height measured at enrollment and women’s self-reported 
weight prior to conception. Total GWG was calculated by subtracting weight measured at 
V4 from self-reported pre-pregnancy weight. This value was used to determine if 
participants met the 2009 IOM recommendation after adjusting for their weeks of gestation 
at V4. Total GWG during M2M was calculated by subtracting weight measured at V4 from 
V1. Rate of GWG during M2M was then calculated by dividing total GWG during M2M 
from gestational weeks between V1 and V4. During enrollment, participants reported their 
age, education level, employment, race, marital status, income level, and parity. Infant birth 
weights and sex were obtained from the post-partum questionnaire. To maintain consistency, 
account for sex differences, and enable comparison of effect sizes, birth weights were 
converted to z-scores. Birth weights were adjusted to gestational age and sex-specific z-
score (birth weight z-score) using US reference data (35).  
Objective physical activity data: StepWatch™ Activity Monitor 
Physical activity was monitored using the StepWatch™ Activity Monitor (SAM), an 
objective accelerometer-based measurement tool worn on the outer side of the right ankle 24 
hours per day for one week. The SAM contains a microprocessor that uses a combination of 
acceleration, position, and timing to detect steps; therefore, the outputs of the SAM are 
based on the amount, rate, and pattern of walking. It is calibrated to the individual’s height. 
PA participation was determined using step data (counts) from the SAM.  Instructions in 
regards to proper use (especially orientation) of the monitor were given to participants.  For 
example, if the monitor was worn upside down, no step data was recorded, despite being 
worn on the ankle.  
Data processing 
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SAM measured step data in one-minute epochs.  In other words, SAM was used to 
detect the number of steps taken by the participants for each minute.  The sample rate of the 
SAM is pre-set and there are no options to change the sampling settings. Individual primary 
SAM files were examined visually by graphing the data in order to detect non-wear time. 
Step count data was collected during 24-hour periods for 7 consecutive days. Data were 
excluded for a day if the participant did not wear the monitor (non-wear time or improper 
placement) for ≥ 300 consecutive minutes during typical waking hours (i.e. 7AM-10PM for 
most participants). In adults, it has been reported that at least 3 days of monitoring using 
accelerometry is required to provide reliable estimation of habitual PA (53); therefore, at 
each gestational time point data collection women who provided at least 3 valid days of step 
counts were included. The raw step data was smoothed using an exponential smoother (R: 
Moving averages, R Foundation for Statistical Computing, Vienna, Austria) to determine 
cadence (steps/minute) and bouts of walking among the participants. The weight used in the 
smoother formula was 1/10. Overall, the goal of this process was to help account for random 
stops (i.e.: waiting at a stop light) during any episode or bout of walking. 
Meaningful walk determination  
 In order to determine the intensity of the walks, the number of steps taken per minute 
(cadence) was used. For a non-pregnant population, approximately 100 steps/minute equals 
a cadence of 3 metabolic equivalents of task (METs) with a walking range between 2.4 to 3 
mph (56); however, this value was reported in laboratory conditions and was commonly 
measured using treadmills. It has been reported that the MET value of pregnant women (10 
– 14 weeks gestation) who walked at 2 mph at 0% incline was 3.12 ± 0.32 (8). Therefore, in 
this study, a cadence ≥80 steps/min was defined as moderate intensity walking for pregnant 
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women under free-living conditions with the assumption that some of the women might 
walk outdoors (i.e.: parks, walking trails). Additionally, evidence shows that accumulated 
short bouts of brisk walking can improve aerobic fitness and physiological outcomes and 
that these bouts should be continuous activities for ≥ 10 minutes in duration in the non-
pregnant population (61). In addition to the use of cadence ≥ 80 steps/min as the moderate 
activity cut point, slowing down from a walk and/or brief rest during a walk needed to be 
accounted for; therefore, the definition of meaningful walk in this study would be any steps 
taken at moderately intense cadence (≥80 steps/min), and must also be in bouts of at least 8 
minutes of walk.  In other words, meaningful walks are those walks that should be counted 
towards meeting the PA guidelines, which not only stress total time and bouts, but intensity. 
Dietary intake 
 Three-day weighed diet records were collected at each data collection time point. All 
participants in the intervention and control groups were provided with a food log and a 
Precision Electronic Cuisinart scale (model SA-110A; Cuisinart, Newark, NJ) for one week 
at a time. Participants were asked to weigh (in grams) and document all food and beverages 
consumed for three days throughout a one-week period. The recording days consisted of two 
weekdays and one weekend day. A trained staff member provided each participant with 
explicit verbal and written instructions on how to weigh and document all foods and 
beverages using food models, scale, and food log.  
Post-partum questionnaire 
 All participants completed a post-partum questionnaire. The questionnaire included 
pregnancy risks and labor procedures (i.e.: used of epidural, C-section delivery) as well as 
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infant’s birth outcomes (sex, anthropometric data and APGAR (appearance, pulse, grimace, 
activity, respiration) scores).   
Process Measures/Fidelity 
 Physical activity logs provided for the participants were used to measure the 
compliance of the women who were in the walking intervention. They were asked to return 
the logs at each gestational time point data collection. The logs were visually examined and 
a trained staff member would discuss any issues or concerns arisen during the intervention 
period with the participants at those visits. Additionally, the PA level of the participants 
were measured for 1 week at a time during the gestational data collection periods. This PA 
measurement would allow the investigators to discern if the participants in the intervention 
group were participating in the walking program (compliance).   
Statistical analysis 
Demographic data were analyzed by descriptive analysis. Multivariate analysis of 
variance was conducted to examine differences in demographic variables (age, height, pre-
pregnancy weight, pre-pregnancy BMI, education, employment, race, marital status, total 
household income, parity) between the groups. Two-way analysis of variance (ANOVA) 
was used to determine the differences in total steps per day (average steps/day), average 
minutes of meaningful walk (min/week), total GWG (kg), rate of GWG during M2M 
(kg/week), average dietary intake (kcal or g/day), birth weight (g), gestational length at 
delivery (week), birth weight z-score, and APGAR score (min) by treatment group and pre-
pregnancy BMI category. Absolute difference (diff) between groups was reported when 
there was significant difference. Pairwise comparison tests (all pairs Tukey-Kramer p = 
0.05) were then performed to further determine the differences among overweight women in 
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the intervention group (Int-OW), overweight women in the control group (Con-OW), obese 
women in the intervention group (Int-OB), and obese women in the control group (Con-OB) 
on the aforementioned  variables. Fisher’s exact tests were used to analyze differences in 
meeting 2009 IOM GWG recommendations, pregnancy complications, and infant outcomes 
among Int-OW, Con-OW, Int-OB and Con-OB women. All moderately intense cadences 
(≥80 steps/min) taken by participants for any bout length at each gestational data collection 
time point were visualized graphically (Matlab, Mathworks, Natick, MA).  The 
Kolmogorov-Smirnov test was used to compare the probability distribution of the bouts of 
moderately intense cadence between the intervention and control groups by pre-pregnancy 
BMI category. Significance was defined as P < 0.05. Results are presented as mean ± 
standard deviation (mean ± SD). Data analyses were conducted using JMP, Version 7 (SAS 
Institute Inc., Cary, NC).  
Results 
Participant characteristics 
 Participant characteristics in each group by treatment and BMI category are 
presented in Table 1. Multivariate analysis of variance showed there were no significant 
differences between groups for age, height, gestational length at V1, education, 
employment, race, marital status, total household income, and parity. Pre-pregnancy weight 
and pre-pregnancy BMI were significantly different between overweight and obese 
participants. Overall, participants in the study were predominantly married, educated, and 
Caucasian.  
Objectively measured step counts using StepWatch™ 
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 Number of participants who provided at least 3 valid days of data at each gestational 
time point was as followed: V1 (n = 31), V2 (n = 36), V3 (n = 35), and V4 (n = 35). 
Participant’s files that were not included in the final analysis were mainly due to missing 
data, and misplacement of the monitor by the participants. Overall, participants in this study 
were compliant in wearing the PA monitor. Participant’s files, which were included in the 
final PA analysis, had on average 6 days of data at each gestational data collection time 
point. Statistical analysis showed that there was no significant difference in participant’s 
compliance among the groups (Int-OW, Con-OW, Int-OB, Con-OB).  
Walking amount: total steps per day 
 At V1 (baseline) and V2, there was no significant difference between the treatment 
groups, pre-pregnancy BMI category, or interaction effect in total steps per day (F = 1.049, p 
= 0.387 for V1; F = 0.834, p = 0.485 for V2). At V3, there was a significant difference 
between the pre-pregnancy BMI category (OW = 10016 steps; OB = 7931 steps; diff = 2130 
steps; p = 0.011), but not the treatment groups or interaction effect in total steps per day (F = 
3.227, p = 0.036). It was the same for V4, there was a significant difference between the pre-
pregnancy BMI category (OW = 8703 steps; OB = 7036; diff = 1667; p = 0.025), but not the 
treatment groups or interaction effect in total steps per day (F = 2.519, p = 0.076). Pairwise 
comparison tests showed that only Int-OW vs. Int-OB at V3 was significant different, but 
not for the rest of the visits among the groups (Table 2).  
Walking intensity: moderately intense cadence 
 Walking intensity characteristics of the women were determined using cadence 
(steps/min). Cadence ≥80 steps/min was considered a moderately intense cadence; therefore, 
any wear times that had ≥80 steps/min were extracted. Figure 2 shows the length of time 
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spent walking at cadence ≥80 steps/min, shown by color intensity, separated into bouts of 
lengths (x-axis). This demonstrates the distribution pattern of lengths of bouts of moderately 
intense walking that woman achieved while under observation. At V1, the Kolmogorov-
Smirnov test showed no significant difference between the distributions of cadence ≥80 
steps/min among the intervention and control groups for obese women, but there was a trend 
of significance difference between intervention and control for the overweight women.  At 
V2, there was a significantly higher amount of cadence ≥80 steps/min in the intervention 
group for both overweight (p < 0.0001) and obese (p < 0.025) women. At V3, overweight 
women in the intervention group had significantly more cadence ≥80 steps/min than the 
control group (p < 0.0001); a trend of significance was observed among obese women (p = 
0.072). At V4, there was a significantly higher amount of cadence ≥80 steps/min in the 
intervention group for both overweight (p < 0.0001) and obese (p < 0.025) women. In 
addition, overweight women in the intervention group at V3 (p < 0.01) and V4 (p < 0.005) 
had a significantly higher amount of cadence ≥80 steps/min than obese women in the same 
treatment.  
Meaningful walks: moderately intense cadence for at least eight minutes 
Any moderately intense cadences taken for at least 8 min in length of bout were 
further extracted to identify the amount (minutes) of meaningful walks taken by the 
participants. In other words, any time spent walking at cadence ≥80 steps/min after the 8 
minutes mark shown in Figure 2 would be considered as meaningful walks. Generally, there 
were higher percentages of overweight and obese women in the control group who had no 
minutes of meaningful walk across pregnancy (Table 2). When the average minutes of 
meaningful walks was examined using two way ANOVA, there was no significant 
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difference between the treatment groups, pre-pregnancy BMI category, or interaction effect 
at V1 (F = 0.954, p = 0.428). At V2, there were strong trends of significance for both 
treatment group (Int = 52.8 min; Con = 20.2 min; diff = 32.6; p = 0.054) and interaction 
effect (p = 0.066), but not pre-pregnancy BMI category (F = 2.983, p = 0.046). At V3, 
significant differences were observed between the treatment group (Int = 44.9 min; Con = 
7.8 min; diff = 37.1 min; p = 0.01), pre-pregnancy BMI (OW = 45.8 min; OB = 6.9 min; diff 
= 38.9 min; p = 0.007) and interaction effect (p = 0.002) (F = 7.556, p < 0.001). At V4, 
treatment group (Int = 42.1 min; Con = 6.7 min; diff = 35.4 min; p = 0.014) and pre-
pregnancy BMI (OW = 41.7 min; OB = 7.1 min; diff = 34.6 min; p = 0.016) were 
significantly difference, but not interaction effect (F = 5.341, p = 0.004). Table 2 shows the 
pairwise comparison tests for all four groups of participants at each gestational time point.  
Gestational weight gain 
 There was no significant difference in total GWG (F = 0.253, p = 0.859) or rate of 
GWG during M2M (kg/week) (F = 0.428, p = 0.734) among the women in the intervention 
group compared to the women in the control group for both pre-pregnancy BMI categories 
(Table 2). However, it appeared that overweight women in the intervention group were more 
likely to gain within the 2009 IOM recommendations compared to the control group, 
according to the Fisher’s exact test (p = 0.163) (Table 3). 
Dietary intake 
 Number of participants who provided complete 3-days of data at each gestational 
time point was as followed: V1 (n = 37), V2 (n = 37), V3 (n = 36), and V4 (n = 36). 
Participants who had incomplete data were due to underreporting (n = 1) and preterm 
delivery (n = 1). When diet data were analyzed for each gestational data collection time 
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point, there was no significant difference between the groups for calories, carbohydrates, 
protein and total fat intake. Individual data was then combined across pregnancy to provide 
an overall average of dietary intake: calories (Int-OW = 2325.3 ± 509.6 kcal/day, Con-OW = 
1915.1 ± 308.6, Int-OB = 2094.3 ± 397.6, Con-OB = 2187.9 ± 757.3; p = 0.380), 
carbohydrates (Int-OW = 300.5 ± 63.2 g/day, Con-OW = 248.5 ± 50.8, Int-OB = 275.3 ± 
46.1, Con-OB = 288.3 ± 91.0; p = 0.558), protein (Int-OW = 89.0 ± 17.1g/day, Con-OW = 
78.3 ± 13.8, Int-OB = 81.3 ± 14.3, Con-OB = 88.8 ± 29.9; p = 0.351), and total fat (Int-OW 
= 90.6 ± 27.1 g/day, Con-OW = 70.9 ± 16.9, Int-OB = 78.7 ± 21.3, Con-OB = 78.7 ± 36.0; p 
= 0.446).  
Pregnancy complications and infant outcomes 
 There were no significant differences in pregnancy complications and infant 
outcomes among all four groups of women (Table 3). A lower birth weight z-score (p = 
0.239) and lower risk of macrosomia (p = 0.335) were observed among obese women who 
were in the intervention group compared to the control group; however, there was not a 
significant difference between the groups (Int-OB:  birth weight z-score= 0.46 ± 0.99; 
macrosomia: 22.2%; Con-OB: birth weight z-score = 1.09 ± 1.19, macrosomia: 55.6%).   
Discussion 
One of the objectives of the current intervention was to help previously non-
exercising, overweight and obese pregnant women to increase their moderate PA 
participation during pregnancy via walking. Our hypothesis was that previously non-
exercising, overweight and obese women could increase moderate PA participation during 
pregnancy via a walking intervention. The results of the study showed that women in the 
intervention group were able to significantly increase their moderately intense cadence as 
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defined in the study especially among the overweight women. In fact, there were overweight 
women in the intervention group who met the minimum recommendation of 150 minutes per 
week of moderate PA (n = 2 at V2, n = 3 at V3, n = 2 at V4); however, none of the 
overweight women in the control group met the recommendation. Additionally, when at 
least 8 minute bouts of moderately PA were examined, women in the intervention group had 
more minutes of meaningful walks than control group. This was especially true among the 
overweight women after the intervention was introduced. On the contrary, more than 50% of 
the overweight and obese women in the control group had zero minutes of meaningful walks 
across pregnancy. Perhaps, the current intervention was successful in helping pregnant 
women increase their moderate PA participation during pregnancy particularly the 
overweight women. 
Overall, the amount of moderately PA engaged by the overweight and obese women 
in the current intervention was substantially higher than other reported current PA trends 
among pregnant and non-pregnant populations. When prenatal PA participation was  
objectively measured using an ActiGraph accelerometer in the NHANES 2003 – 2006 cross-
sectional data (n = 359) (21), the data showed that pregnant women only participated in an 
average of 12.0 ± 0.86 minutes/day of moderate activity and 0.3 ± 0.08 minutes/day of 
vigorous activity. When cadence of non-pregnant populations were examined by Tudor 
Locke et al. using the 2005 – 2006 NHANES data (n = 1963 females), women only 
accumulated 12.78 minutes/day of cadence ≥ 80 steps/min (55). Furthermore, it has been 
well documented that PA participation decreases as pregnancy progresses (42). It was 
reported by Evenson and colleagues that U.S. pregnant women spent 11.5 minutes/day 
during the first trimester, 14.3 minutes/day during the second trimester, and 7.6 minutes/day 
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during the third trimester in moderate to vigorous PA (21). In the current study, overweight 
women in the intervention group successfully maintained their duration of moderately 
intense walking throughout pregnancy, even during the late third trimester when step counts 
were monitored by StepWatch™.  
Both the PA recommendations by ACOG 2002 and 2008 Physical Activity 
Guidelines for Americans prescribe moderate PA for the pregnant women. These guidelines 
are supported by evidence that shows moderately intense activities are identified with 
substantial health benefits among the non-pregnant population (43). Due to the growth of 
fetal tissue, the elevated basal metabolic rate and the increased energy cost of moving a 
heavier body, women may select less demanding activities and reduce the pace of those 
activities (44). Studies have demonstrated that pregnant women walk at a slower pace as 
pregnancy progresses and when walking pace among pregnant women is compared with a 
non-pregnant population (17, 29, 45). Therefore, even though the current intervention did 
not significantly increase the total steps per day taken (amount) by the women between the 
groups, it was successful in changing the intensity of the steps taken by the overweight and 
obese women in the intervention group. These women walked at a higher intensity and were, 
most importantly, able to sustain these habits until late pregnancy.  
 We further hypothesized that those participants who increased their moderate PA 
participation via the walking intervention would have more favorable GWG outcomes. 
Overall, the rate of GWG throughout the study between intervention and control groups for 
both overweight and obese women were not significantly different. When percentage of 
participants meeting 2009 IOM GWG guidelines was examined at V4, greater proportion of 
overweight women in the intervention group gaining within the recommendations, even 
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though it was not statistically significant (55.6 % among Int-OW vs. 20 % among Con-OW , 
p = 0.163). The findings of the present  study are supported by a meta-analysis conducted by 
Streuling and colleagues, which evaluated trials that only involved increased PA as the 
means to minimize GWG (51). Twelve RCTs were included in this analysis with 
interventions varying by intensity, duration, and mode of activity. Seven of the trials 
reported a trend for lowering GWG in the intervention group, one trial showed significant 
reductions in GWG, and five trials showed no significant effect on GWG. When all RCTs 
were combined on a scale, the overall meta-analysis finding demonstrated that PA 
modification resulted in significant GWG reduction (mean difference of -0.61; 95% CI: -
1.17 – -0.06, p = 0.03). The walking program of the current study significantly increased the 
moderately intense steps of women in the intervention group especially the overweight 
women during their pregnancy; therefore, the trend of a higher percentage of women in Int-
OW group meeting the GWG guidelines may be partly explained by the increased moderate 
PA during pregnancy.  
Our final hypothesis was that those participants who increased their moderate PA 
participation via the walking intervention would have more favorable birth outcomes. The 
walking program in this study did not cause any adverse effects on labor/delivery 
complications and birth outcomes. In fact, there was a trend for obese women who 
participated in the walking program to have lower infant birth weight z-scores and decreased 
odds of fetal macrosomia compared to obese women in the control group. In recent years, 
evidence shows that maternal PA participation increases the likelihood of giving birth to 
appropriate-for-gestational-age (AGA) infants. Most importantly, maternal PA helped 
reduce the risk of giving birth to LGA infants by not increasing the odds for a SGA infant 
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(25, 33, 38). In a large cohort observational study (n = 79,692), Juhl et al. found that the 
longer the amount of time (h/week) women spent in PA participation during pregnancy, the 
lower the risk of delivering LGA infants; however, the intensity of the workout regimen was 
not mentioned in this study. In two smaller cohorts of observational studies, women who 
participated in at least 120 min/week of at least moderate PA during pregnancy had a 
significantly lower risk of delivering a LGA infant without increasing the risk for a SGA 
infant (3, 33). Thus, since the obese women in the intervention group significantly increased 
their moderately intense cadence after joining the walking program, a trend of increased in 
favorable child outcomes observed in the study may be explained by this positive change.  
Walking is a common and popular choice of PA during pregnancy (30, 39). In 
observational studies, walking at a brisk pace has been shown to reduce the risk of 
gestational diabetes (62), pre-eclampsia (48), excessive GWG (52), and macrosomia (38). 
Mottola et al. conducted a case-controlled trial to assess the impact of combined energy 
restriction and a walking program on prevention of excessive weight gain in overweight 
Canadian pregnant women (NELIP) (31). The walking program was individualized to reach 
30% peak heart rate (HR) reserve of the participant, and it was performed three to four times 
a week (40 min per session). Mottola et al. observed a significant increase in average daily 
step counts from the baseline value of 5677.6 ± 1738.0 steps to more than 10,000 steps per 
day. This study also resulted in 80% of the participants meeting the 2009 IOM weight gain 
recommendations on NELIP. To our knowledge, the current intervention was the first pilot 
randomized-controlled trial to help previously non-exercising, overweight and obese women 
increase moderate PA participation via walking. Different from the NELIP study, the 
present intervention was a PA-only intervention. Diet counseling was not provided nor was 
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caloric restriction emphasized in the study. As a result, any positive maternal and child 
health outcomes observed in the study would be primarily attributed to the increased PA 
participation during pregnancy. Interestingly, diet data was collected at each visit in this 
study, and the results showed no significant difference between the treatment groups in total 
calories, carbohydrate, protein and total fat intake.  
Little information is available about the feasibility and benefits of previously non-
exercising overweight and obese pregnant women increasing their moderate physical 
activity, via walking. Therefore, this intervention added unique contributions in the field of 
maternal and child health. This is the first study to objectively measure walking 
cadence/intensity of pregnant women in order to evaluate PA participation and patterns 
during pregnancy in a randomized-controlled trial. The current trial was an unsupervised, 
free-living walking program. The women were provided with a treadmill for home use. Thus 
far, the majority of successful interventions that have targeted overweight and obese 
pregnant women consist of fully or partially supervised activities (4, 15, 31). The current 
intervention was the first to help pregnant women increase moderate PA participation by 
providing a tool for home use, without direct supervision. A treadmill could be a relatively 
cost-effective intervention tool compared to other interventions, which require trained staff 
members to supervise the workout sessions. In addition, since walking is the most common 
activity practiced among pregnant women, being able to objectively measure step counts and 
use the cadence to determine activity intensity could provide further insight into the 
relationship between PA participation during pregnancy and health outcomes of the mother 
and fetus. In recent years, the use of cadence in intervention and behavioral research has 
been promoted due to its easily interpretable results (57).  
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It is acknowledged that the present study has some limitations. A major limitation of 
the current study is its small sample size and high variability among the groups. These 
factors could potentially reduce the ability to detect statistically significant effects of the 
intervention. Secondly, there is no known study that has been conducted to measure the 
walking cadence/intensity of the pregnant population. As a result, the present study has 
utilized the evidence in the literature to define the moderately intense cadence for pregnant 
women, which was a cadence ≥ 80 steps/min of the participants. Further research in this area 
is needed. Thirdly, self-reported pre-pregnancy BMI was used in the study, which could lead 
to inaccurate data because evidence has shown that overweight women are more likely to 
underreport their weight compared to normal or underweight women (47). Fourth, research 
has shown that seasonal changes and weather can have an effect on PA participation (54). 
The current intervention was a longitudinal study and women were enrolled for a minimum 
of 20 weeks and were thus enrolled over 2 different seasons. In future studies, 
environmental variables that may support or hinder PA participation should be taken into 
consideration. Lastly, the StepWatch™ monitor may not have accounted for other activities 
the women participated in during the intervention period, such as running, biking or 
swimming.  Considering that the intervention was focused on walking, the StepWatch™ 
monitor was viewed as an acceptable measurement tool for quantifying the intervention 
effect.  
In conclusion, the current intervention changed the walking intensity of all women 
enrolled in the intervention group during pregnancy. Even though it was not statistically 
significant, there was a trend for women in the intervention group to have more favorable 
pregnancy and birth outcomes compared to the control group. The findings of the present 
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study provide preliminary results in understanding walking patterns during pregnancy and 
health outcomes of the mother and baby. Since the study of the relationship between 
cadence and one’s free-living patterns of ambulatory activity is a new and innovative area, 
future research is needed to examine the relationship between mother’s cadence intensity 
and pregnancy outcomes.  
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Table 1: Participant demographic characteristics 
Variable  Intervention  Control 
  Overweight   Obese   Overweight   Obese  
   (n = 9)  (n = 9)  (n = 10)  (n = 9) 
Age (years)   26.2 ± 2.6  28.6 ± 5.3  27.3 ± 3.6  25.7 ± 4.0 
Height (cm)   163.8 ± 7.4  165.2 ± 7.1  169.3 ± 6.8  165.1 ± 6.5 
Pre‐pregnancy weight* (kg)   71.5 ± 8.9  94.8 ± 14.4  78.8 ± 7.8  93.4 ± 11.2 
Pre‐pregnancy BMI* (kg/m²)   26.5 ± 1.2   34.7 ± 4.6   27.4 ± 1.4   34.2 ± 3.6  
Gestational length at V1 (weeks)   12.6 ± 1.3  12.3 ± 0.8  12.3 ± 1.4  12.4 ± 1.8 
Employment (n)         
     Full time ≥ 40 hours  2  5  4  3 
     Part time < 40 hours  4  2  4  2 
     Non‐employed = 0 hours  3  2  2  4 
Total household Income (n)         
     < $25 000  1  2  0  3 
     $25 000 to $50 000  6  2  3  3 
     $50 000 to $75 000  1  1  4  3 
     > $75 000  1  4  3  0 
Nulliparasa (n)  3  3  5  3 
Paras ≥ 1 b (n)  6  6  5  6 
 Values shown are mean ± SD, unless otherwise noted (n) 
*pre‐pregnancy weight and BMI significantly different between overweight and obese women 
 Nulliparas refers to first‐time pregnant women 
 Paras ≥ 1 refers to women with at least one pregnancy 
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Table 2: Physical activity outcome measures by treatment group and pre‐pregnancy BMI 
category 
Variables  Overweight  Obese 
  Intervention  Control  Intervention  Control 
   (n = 9)  (n = 10)  (n = 9)  (n = 9) 
Total steps (steps/day)         
   V1  8534 ± 2104  7964 ± 2300  7737 ± 1693  6758 ± 1635 
   V2   9346 ± 1826  8496 ± 2104  7751 ± 2065  8520 ± 2561 
   V3   10912 ± 1582 
9210 ± 
3040  7867 ± 1475  7996 ±2581 
   V4   9327 ± 1976  8078 ± 2378  7416 ± 1439  6655 ± 2341 
Participants with no min of 
meaningful walk (%)         
   V1   37.5  50.0  62.5  71.4 
   V2   11.1  60.0  44.4  75.0 
   V3   22.2  60.0  50.0  75.0 
   V4   33.3  60.0  62.5  100.0 
Average min of meaningful 
walks (min/week) *         
   V1   23.3 ± 26.7  11.9 ± 18.6  6.5 ± 10.5  13.9 ± 24.3 
   V2   76.7 ± 51.1  13.2 ± 25.6  28.9 ± 37.2  27.3 ± 73.5 
   V3   81.3 ± 75.4  10.2 ± 14.1  8.4 ± 11.1  5.4 ± 12.0 
   V4   70.1 ± 68.5  13.3 ± 22.6  14.1 ± 32.6  0.0 ± 0.0 
 Values shown are mean ± SD       
* meaningful walks = moderately intense walk (≥ 80 steps/min) in bout of at least 8 consecutive minutes 
 Different letters indicate significant differences (all pairs Tukey‐Kramer p = 0.05) 
V1 = weeks 10 ‐14 of gestation; V2 = weeks 17 ‐ 19 of gestation; V3 = weeks 27 ‐ 29 of gestation; V4 = weeks 
34 ‐ 36 of gestation; GWG = gestational weight gain; M2M = Moms to Move study 
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Table 3: Pregnancy and infant outcomes by treatment group and pre‐pregnancy BMI category 
Variables  Overweight  Obese 
  Intervention  Control  Intervention  Control 
   (n = 9)  (n = 9)  (n = 9)  (n = 10) 
Weekly GWG during M2M (kg/wk)  0.5 ± 0.18  0.39 ± 0.16  0.47 ± 0.33  0.48 ± 0.30 
Total GWG (kg)  10.53 ± 5.37  9.94 ± 6.14  12.07 ± 9.01  12.48 ± 8.51 
Meeting 2009 IOM guidelines         
   Exceeded IOM (%)  44.4  50.0  77.8  77.8 
   Within IOM (%)   55.6  20.0  0.0  11.1 
   Below IOM (%)   0.0  30.0  22.2  11.1 
Birth weight (g)  3.76 ± 0.44  3.59 ± 0.46  3.54 ± 0.51  3.94 ± 0.48 
Gestational length at delivery (week)  39.7 ± 0.7  39.2 ± 1.6  39.0 ± 1.2  39.7 ± 0.7 
Birth weight z‐score  0.68 ± 0.94  0.54 ± 0.67  0.46 ± 0.99  1.09 ± 1.19 
Low birth weight < 2500 g (n)  0  0  0  0 
Macrosomia > 4000 g (n)  3  1  2  5 
APGAR score         
   1 min  7.9 ± 0.6  8.1 ± 0.9  8.0 ± 0.9  7.3 ± 1.8 
   5 min  8.9 ± 0.6  8.6 ± 1.0  8.6 ± 0.7  8.4 ± 1.8 
Pregnancy complications         
   Preterm delivery, <37 week (n)  0  1  0  0 
   Cesarean delivery(n)  0  4  5  5 
   Pre‐eclampsia (n)  0  0  1  0 
   Maternal hypertension (n)  0  0  0  0 
   Gestational diabetes (n)  1  1  0  0 
 Values shown are mean ± SD, unless otherwise noted % or n 
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Figure 1: Participant flow chart 
Figure 2: Walking bouts distribution for each participant in the intervention and control 
groups. All bouts of walking at cadence ≥80 steps/min are shown for all participants at each 
gestational data collection time point. Each segment on the Y-axis across the panel 
represents a week’s worth of step count data for a single participant. All participants are 
represented in the same order on the 4 panels, across measurement periods. The length of 
time spent walking at cadence >=80 steps/min, shown by color intensity, separated into 
bouts of lengths given on the x-axis. Bouts after dotted lines (at 8 minute mark) represent 
meaningful walking.  (OW- overweight women; OB- obese women; V1 = weeks 10 – 14 of 
gestation; V2 = weeks 17 – 19 of gestation; V3 = weeks 27 – 29 of gestation; V4 = weeks 34 
– 36 of gestation). 
Figure 3: Overweight and obese pregnant women who met the 2009 IOM gestational 
weight gain recommendations at the last study vist (V4).   
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Figure 2: Walking bouts distribution for each participant in the intervention and control groups. 
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Figure 3: Overweight and obese pregnant women who met the 2009 IOM gestational 
weight gain recommendations at the last study vist (V4).   
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CHAPTER 4: OBJECTIVELY MEASURED STEP COUNT CAN BE PREDICTED 
BY SELF-EFFICACY AND PRE-PREGNANCY BMI AMONG OVERWEIGHT 
AND OBESE PREGNANT WOMEN IN A RANDOMIZED-CONTROLLED TRIAL   
A paper has been submitted to the International Journal of Behavioral Nutrition and Physical 
Activity 
Kai Ling Kong, Amy S Welch, Christina G Campbell, Anna D Peterson, Lorraine M 
Lanningham-Foster    
Abstract 
Background: Research in understanding the relationship between self-efficacy and physical 
activity (PA) participation during pregnancy is limited. The purposes of this study were 1) to 
evaluate exercise self-efficacy of pregnant women in a walking intervention; 2) to examine 
the relative contribution of pre-pregnancy body mass index, barrier self-efficacy and task 
self-efficacy in predicting PA participation during pregnancy. 
Methods: Thirty seven overweight or obese (BMI > 25.0 kg/m2) pregnant women were 
randomly assigned to a walking intervention versus no-intervention control group. Exercise 
self-efficacy was assessed using barrier and task self-efficacy questionnaires, and PA 
participation was quantified by step counts using a StepWatch™ Activity Monitor. These 
assessments were performed at the end of the second (V3) and late third trimester (V4); 
while, self-reported pre-pregnancy BMI was obtained during enrollment. ANOVA was used 
to determine the differences in barrier and task self-efficacy between the groups. Linear and 
all-subsets regression analyses were used to identify the relative contribution of pre-
pregnancy BMI, barrier and task self-efficacy to predict step count. 
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Results: Barrier self-efficacy was 13.3% and 15.2% higher in the intervention group 
compared to the control group at V3 and V4 respectively; while, task self-efficacy was 
30.9% (V3) and 29.5% (V4) higher in the intervention group compared to the control group 
at both visits. At V3, task self-efficacy (r2 = 0.254, p < 0.003) and barrier self-efficacy (r2 = 
0.123, p < 0.049) independently predicted step count; however task self-efficacy together 
with pre-pregnancy BMI explained 30.0% (p < 0.006) of the variance, which was selected as 
the best model to predict step count.  At V4, task self-efficacy (r2 = 0.234, p < 0.003) and 
pre-pregnancy BMI (r2 = 0.167, p < 0.015) independently predicted step count, and both 
variables combined explained 35.9% of the variance (p < 0.001), which was selected as the 
best model to predict step count. 
Conclusions: Interventions designed to increase self-efficacy might be effective to promote 
active lifestyles during pregnancy, especially later in gestation for women with higher pre-
pregnancy BMI.   
Keywords: Prenatal physical activity, Pregnancy, Step count, Barrier self-efficacy, Task 
self-efficacy 
Background 
Prenatal physical activity (PA) has become an important aspect within the field of 
maternal and child health due to the evidence of positive health outcomes of PA during 
pregnancy for the mother and fetus, such as the reduced risk of excessive gestational weight 
gain [1], preeclampsia [2], gestational diabetes [3], incidence of operative delivery [4], and 
low back pain [5]. According to Physical Activity Guidelines for Americans (PAG) in 2008, 
pregnant women who are healthy and without medical complications should engage in a 
minimum of 150 minutes of moderate-intensity activities spread throughout the week [6]. 
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Moderate-intensity exercise is defined as an activity that expends 3.5-7 kcal/min, an 
intensity of 50-70% max heart rate, or is within the range of 3 to 6 metabolic equivalents of 
task (METs). In spite of these recommendations and the benefits of engaging in maternal 
PA, many pregnant women still do not meet the PA recommendations [7, 8]. Additionally, 
women who were active before becoming pregnant significantly decreased their PA 
participation during pregnancy [9]. This decline in PA participation is particularly common 
when pregnant women reach their third trimester, regardless of pre-pregnancy Body Mass 
Index (BMI) [8, 10]. With the prevalence of sedentary and low active lifestyles among 
pregnant women, interventions are needed to help women increase their PA participation.  
Unfortunately, despite the consensus that intervention studies should be theoretically 
driven [11], there is an extremely limited number of interventions in this field that have been 
based on theoretical frameworks. In a recent meta-analysis, Gardner et al. only  identified 
two interventions reporting the use of behavioral theories to inform intervention design [12]: 
one mentioned the use of social learning theory [13], and the other used precede-proceed 
and transtheoretical models [14]. However, neither of these papers included detail regarding 
how the theoretical constructs were used to develop the interventions. Ideally, correlates or 
predictors associated with positive behavioral modification should be identified before any 
intervention is designed or implemented. These correlates or predictors can potentially help 
with program adherence if they are targeted in the interventions [15]. Dropout rate for 
exercise programs is generally high in the non-pregnant population [11], thus  the same if 
not, higher dropout rate among pregnant women due to the increased psychological and 
physical demands during pregnancy [16] might be expected. Numerous studies have 
examined the association of theory-based psychosocial factors in predicting PA participation 
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during pregnancy according to a review by Gaston and Cramp [17]. These theory-based 
psychosocial factors were mainly taken from the Theory of Planned Behavior [16, 18–21], 
the socioecologic framework [22, 23], and the social cognitive theory variables [24]. Among 
these psychosocial factors, self-efficacy from the social cognitive theory has yielded the 
most consistent positive relationship with PA participation during pregnancy. Therefore, 
self-efficacy is clearly an important factor that needs  to be targeted in behavioral 
interventions among the pregnant population [25].  
Self-efficacy is the belief in one’s capabilities to put forth the necessary effort to 
overcome various challenges [26]. It influences the adoption, initiation, and maintenance of 
health behaviors such as leisure time PA participation [27, 28]. Studies have shown that self-
efficacy is a strong correlate and determinant of PA among diverse populations including 
children, men, and non-pregnant women [29–33]. As a result, increasing pregnant women’s 
exercise self-efficacy could inevitably help to increase their maternal PA participation. In 
fact, when Hinton and Olson [34] examined the psychosocial predictors of pregnancy-
related changes in PA participation, they concluded that exercise self-efficacy was a key 
predictor of PA participation during the perinatal period after controlling for age, pre-
pregnancy BMI, and frequency of pre-pregnancy exercise. They also noted that pre-
pregnancy BMI was a predictor of PA participation during pregnancy.  Women who had 
higher pre-pregnancy BMI were predicted to be more active during pregnancy, which was 
contrary to other studies that showed a negative relationship between pre-pregnancy BMI 
and PA participation during pregnancy [35–37]. Further, Cramp and Bray [24] completed an 
observational study that supported the findings of Hinton and Olson. In this cross-sectional 
study, they demonstrated that exercise self-efficacy (barrier and task self-efficacy) 
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independently predicted leisure time PA participation across pregnancy (at week 18, 24, 30 
and 35 of gestation). One limitation to these studies was the use of self-reported PA which is 
subject to social desirability bias and misreporting [38]. As a result, there is a need for an 
objective measure of PA when self-efficacy is measured prospectively among pregnant 
women in order to better understand the relationship of self-efficacy and PA participation 
during pregnancy. 
Overall, it appears that both self-efficacy and pre-pregnancy BMI are important 
variables in understanding the PA behavior of pregnant women. Interventions have been 
designed to help women to increase their PA participation during pregnancy in order to 
improve maternal and fetal health outcomes [39–42], yet, to our knowledge, none of these 
studies has investigated the impact of their interventions on psychosocial outcomes, for 
example, exercise self-efficacy.  Walking has been documented to be an appropriate and 
easily tolerated  activity [43] and is one of the most frequent leisure activities performed by 
pregnant women [7, 36]. Therefore, the purpose of this study was 1) to compare exercise 
self-efficacy (barrier self-efficacy and task self-efficacy) of participants in a walking 
intervention versus non-intervention control group toward the end of a randomized 
controlled trial; 2) to examine the relative contribution of pre-pregnancy BMI, barrier self-
efficacy and task self-efficacy in predicting step count at the end of second and late third 
trimesters of pregnancy using an objective measurement tool. Our hypotheses were 1) 
women in the walking intervention group would have higher barrier and task self-efficacy 
toward the end of the intervention; 2) pre-pregnancy BMI together with barrier and task self-
efficacy would be a better predictor of step count at the end of second and late third 
trimester than any of the predictors independently. 
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Methods 
Study Design 
The Blossom Project team of Iowa State University conducted a pilot randomized 
controlled trial entitled ‘Moms to Move’ (M2M). The objectives of M2M study were 1) to 
increase PA participation among previously non-exercising, overweight and obese pregnant 
women to meet the PA recommendations of a minimum 150 minutes of moderate-intensity 
activities spread throughout the week, via walking; 2) and to evaluate the impacts of walking 
on gestational weight gain and birth weight of offspring when previously non-exercising, 
overweight and obese pregnant women meet the PA guidelines. The intervention in this 
study was a walking program. Women in the intervention group were advised to increase PA 
participation via walking to meet the minimum recommendation of 150 minutes per week of 
moderate intensity PA during pregnancy. They were also advised to spread their activities 
throughout the week, such as 30 minutes of walking five days per week [44]. They were 
allowed to walk in shorter bouts; however, they were advised to keep the bouts to at least 10 
minutes in order to gain exercise benefits from their walk [45]. Women in the control group 
were not provided advice with respect to PA participation, but they were not restricted with 
any form of PA participation during pregnancy.  Barrier self-efficacy, task self-efficacy and 
PA were measured at the end of the second trimester (weeks 27-28 of gestation) and the late 
third trimester (weeks 34-36 of gestation) of pregnancy. Self-reported pre-pregnancy BMI 
was obtained during enrollment.  
Participants 
Participant recruitment occurred from January 2011 to March 2012 through emails, 
online advertisements, and fliers posted in the community and at local obstetric clinics. 
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Participants met the following inclusion criteria: prior to week 15 of gestation, maternal age 
between 18-45 years old, singleton pregnancy, non-smoker, self-reported overweight (BMI 
> 25.0 kg/m2) or obese (BMI > 30.0 kg/m2) prior to pregnancy, no history of chronic 
diseases (including type 1 diabetes, cardiovascular disease, thyroid disorder or lung 
disorder), and no history of gestational diabetes. In addition, only non-exercising women 
(less than three times per week of leisure time PA participation at 30 minutes or more per 
session) for at least six months preceding their enrollment into the study were recruited. 
Gestational length was calculated based on the self-reported date of the participants’ last 
normal menstrual cycle or the due date determined by the medical provider using 
ultrasound.  
Potential participants who expressed interest were screened for qualification criteria.  
Each participant was provided with an informed consent document for review. The study 
was approved by the Institutional Review Board of a large, mid-western university. Forty-
six pregnant women enrolled in the study. The final number of women who completed the 
protocol was 37 (n = 18 participants in the intervention; n = 19 participants in the control).  
Five women withdrew from the study due to time conflicts and four women experienced 
pregnancy-related complications unrelated to study, such as miscarriage. Mean ages of 
participants in each group were 27.4 ± 1.0 years old (intervention group) and 26.5 ± 0.7 
years old (control group).  
Procedure 
Participants who qualified through email screening were invited for an enrollment 
appointment prior to week 15 of gestation. During the enrollment, participants signed the 
consent form, filled out a medical history questionnaire and provided contact details of their 
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medical providers. Approvals for participation in the study were obtained from medical 
providers of the women. Height and weight were measured during this first visit. 
Participants were then randomly assigned to either the intervention or control condition. 
Randomization was conducted using a computer-based random number generator (Microsoft 
Excel 2010, WA). All participants reported to the clinical research center at each of the 
following time points: weeks 10-14 (V1), 17-19 (V2), 27-29 (V3), and 34-36 (V4) of 
gestation. Following the completion of the questionnaires, women were provided an ankle-
worn pedometer, StepWatch™ Activity Monitor (OrthoCare Innovations, LLC, Oklahoma 
City, Oklahoma). This pedometer allowed monitoring of the average daily step count of 
women during the preceding week for a total of seven days. 
The walking intervention began no earlier than week 12 and no later than week 15 of 
gestation and lasted until at least week 35. Walking could occur indoors, such as walking at 
the mall or outdoors, such as walking at the park. To encourage the participants in the 
intervention group to achieve their walking goal, treadmills were provided to the participants 
to use in their homes for the duration of the study. Treadmills were returned following the 
completion of the walking intervention. Participants in the control group were not given 
treadmills for home use during the study. 
Data Collection 
 Anthropometric and demographic data. 
Height and weight were measured at each gestational time point visit. Height was 
measured to the nearest 0.1 cm (Ayrton 226 Hite-Rite Precision Mechanical Stadiometer, 
Quick Medical GS, Snoqualmie, WA) and weight was measured to the nearest 0.1 kg 
(Detecto Model 6855 Cardinal Scale, Manufacturing Co., Webb City, MO). Pre-pregnancy 
128 
 
 
 
BMI was determined by using height measured at enrollment and woman’s self-reported 
weight prior to conception.  
Self-efficacy data. 
Exercise self-efficacy was examined from two perspectives (barrier and task) using 
questionnaires.  
Barrier self-efficacy.  
An open-and close-ended questionnaire was used to assess barriers to PA over the 
subsequent 6 weeks by participants [24, 46] at V3 and V4. Barriers were defined as 
“anything that may stop you from doing physical activity”. Participants were asked to list up 
to four barriers to PA that were relevant to them and were anticipated to occur in the next 6 
weeks. Based on previous research [46] and to limit subject burden [24], the list of barriers 
was limited to four. For each barrier that was listed on the questionnaire, participants were 
asked to indicate their confidence to overcome that particular barrier should it occur in the 
next 6 weeks. Confidence was rated on a scale of 0% (absolutely not confident) to 100% 
(absolutely confident), using 10-point increments. The overall strength of the barrier self-
efficacy was calculated by averaging the sum of the rated confidence of each barrier. The 
internal consistencies for this scale were high at each visit (Cronbach’s alpha = 0.873 at V3; 
Cronbach’s alpha = 0.829 at V4). 
Task self-efficacy.  
A 7-item questionnaire was used to assess participants’ confidence in their ability to 
walk for at least 30 minutes at their preferred pace on one day up to seven days in the 
subsequent week. Participants’ responses could range from 10% (lowest confidence) to 
100% (highest confidence). Overall average task self-efficacy was calculated by summing 
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the scores for each item and dividing it by seven. This scale was developed in accordance 
with the guidelines for developing self-efficacy scales [47, 48]. The internal consistencies 
for this scale were high at each visit (Cronbach’s alpha = 0.941 at V3; Cronbach’s alpha = 
0.944 at V4). 
Physical activity data: StepWatch™ Activity Monitor. 
Physical activity was monitored using the StepWatch™ Activity Monitor (SAM), an 
objective measurement tool, worn on the outer side of the right ankle for one week, 24 hours 
per day for 7 days. The SAM contains a microprocessor that uses a combination of 
acceleration, position, and timing to detect steps therefore, the outputs of the SAM are based 
on the amount, rate, and pattern of walking. It is calibrated to the individual’s height. In our 
study, the PA data was obtained after the collection of self-efficacy data at V3 and V4. PA 
participation was determined using step data (step counts) from the SAM.  
Data processing. 
Individual preliminary data files were examined graphically. Step count data was 
collected for consecutive 24 hours period for seven days. The excluded data in this study 
provided less than 300 consecutive  minutes per day of wear time (step/min > 0) during her 
typical waking hours (i.e. 7 am to 10 pm). Only women recording at least three valid days of 
step count were included in the final PA analysis. 
Statistical Analysis 
Demographic data was analyzed by descriptive analysis. Multivariate analysis of 
variance was conducted to examine differences in demographic variables (age, height, pre-
pregnancy weight, pre-pregnancy BMI, education, employment, race, marital status, total 
household income, parity) between the two groups. Two-way analysis of variance 
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(ANOVA) was used to determine the differences in barrier and task self-efficacy by 
treatment group and BMI category. Where there was significant difference between the 
groups, absolute difference (diff) would be reported. A Pearson correlation coefficient 
analysis was also conducted to examine the association between pre-pregnancy BMI, barrier 
and task self-efficacy. Linear regression analyses were conducted to determine if pre-
pregnancy BMI, barrier, and task self-efficacy could independently predict step count at V3 
and V4. All-subsets regression analyses were conducted to determine the best fit models for 
step count prediction at these two visits using the same variables. The top three best models 
based on the AIC values are shown in Table 3. Significance was defined as P < 0.05. Results 
are presented as mean ± standard deviation (mean ± SD). Data analyses were conducted 
using IBM SPSS Statistics, Version 19.0 (SPSS Inc., Armonk, NY) and JMP, Version 7 
(SAS Institute Inc., Cary, NC).  
Results 
Participant Characteristics 
Participant characteristics in each group by treatment and BMI category can be 
found in Chapter 3, Table 1. The mean age of overweight women in the intervention group 
(Int-OW) (n = 9) was 26.2 ± 2.6 years old; overweight women in the control (Con-OW) (n = 
10) was 27.3 ± 3.6; obese women in the intervention group (Int-OB) (n = 9) was 28.6 ± 5.3; 
obese women in the control group (Con-OB) (n = 9) was 25.7 ± 4.0. Multivariate analysis of 
variance showed there were no significant differences between groups for age, height, 
gestational length at V1, education, employment, race, marital status, total household 
income, and parity. Pre-pregnancy weight and pre-pregnancy BMI were significantly 
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different between overweight and obese participants. Overall, participants in the study were 
predominantly married, educated, and Caucasian.  
Comparison of Barrier and Task Self-Efficacy across Treatment Groups 
Barrier self-efficacy. 
At V3, there was as strong trend of significant difference between the treatment 
group (Int = 70.3%; Con = 57.0%; diff = 13.3%; p = 0.077), significant difference between 
the pre-pregnancy BMI (OW = 72.4%; OB = 54.9%; diff = 17.5%; p = 0.023), but no 
interaction effect (F = 2.8911, p = 0.052). At V4, there was a significant difference between 
the treatment groups (Int = 64.6%; Con = 49.4%; diff = 15.2%; p = 0.045), but not pre-
pregnancy BMI or interaction effect (F = 1.6607; p = 0.194). In other words, barrier self-
efficacy was 13.3% and 15.2% higher in the intervention group compared to the control 
group at V3 and V4 respectively (Figure 1).  
Task self-efficacy. 
At V3, there was a significant difference between the treatment group (Int = 78.2%; 
Con = 47.3%; diff = 30.9%; p < 0.0001), pre-pregnancy BMI (OW = 70.6%; OB = 54.9%; 
diff = 15.7%; p < 0.006), and a strong trend of significance for the interaction effect (p = 
0.067) (F = 14.932; p < 0.0001). At V4, there was a significant difference between the 
treatment groups (Int = 73.7%; Con = 44.2%; diff = 29.5%; p < 0.0001), but not BMI 
category or interaction effect (F = 6.6934; p = 0.001). In short, task self-efficacy of women 
in the intervention group was 30.9% (V3) and 29.5% (V4) higher than the control group at 
both visits (Figure 2). 
Correlations and Step Count Prediction 
132 
 
 
 
Table 1 shows that barrier and task self-efficacy were positively correlated with each 
other (p < 0.0001) at both time points (r = 0.585 at V3 and r = 0.683 at V4). Linear 
regression analyses were conducted to determine if pre-pregnancy BMI, barrier, and task 
self-efficacy could independently predict the amount of steps taken by the women at V3 and 
V4 respectively. Table 2 shows that at V3, task self-efficacy (p = 0.003) and barrier self-
efficacy (p = 0.049) independently predicted the amount of steps taken by the women.  At 
V4, task self-efficacy (p = 0.003) and pre-pregnancy BMI (p = 0.015) independently 
predicted the amount of steps taken by the women. All-subsets regressions were then 
conducted to determine the best fit models to predict the PA participation of the women at 
each visit using three variables, pre-pregnancy BMI, barrier, and task self-efficacy. The top 
three best models based on the AIC values are listed in Table 2. At V3, the model that 
included task self-efficacy and pre-pregnancy BMI (r2 of 0.300, p = 0.006) was selected as 
the best model for step count prediction due to its small root mean square error (RMSE) and 
AIC value. At V4, task self-efficacy and pre-pregnancy BMI (r2 of 0.359, p = 0.001) 
provided the best model for the step count prediction (with the smallest corresponding 
RMSE and AIC).  
Discussion 
The findings of this study demonstrated that pregnant women in a walking 
intervention, which started at the beginning of the second trimester (weeks 12-15 of 
gestation) had a higher barrier and task self-efficacy at the end of second (V3) and late third 
trimester (V4).  In the past, many outcome measures of lifestyle interventions in pregnancy 
have focused on health outcomes of their participants, such as interventions designed to 
increase PA participation to limit excessive gestational weight gain [39–42]. However, no 
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such studies have assessed the impact of these interventions on psychosocial outcomes of 
the participants. Even though the present intervention was not designed to change the self-
efficacy of participants, women in the intervention group had a higher perceived capability 
to overcome barriers and a higher confidence in carrying out the task of walking for at least 
30 minutes at their preferred pace for the upcoming week at the end of second trimester and 
late third trimester compared with women in the control group. This observed higher self-
efficacy among women in the intervention group could be due to the treadmill available at 
home. In studies conducted by Leiferman et al. [23], and Evenson et al.[22], environmental 
factors such as the weather (too hot or too cold), ability to access recreational facilities, as 
well as care giving duties were some of the reported barriers to not being physically active 
during pregnancy. Therefore, having a treadmill at home could potentially help women to 
overcome some of these perceived barriers.  
Additionally, women in the intervention group were also given advice to perform 
shorter bouts of walking (at least 10 min) to meet the 30 minutes of walking on most days of 
the week for a minimum of 150 minutes per week of moderate physical activity 
recommendation. Prenatal PA participation decreases progressively with gestation [7, 8, 49]. 
This decrease in PA participation could be due to physical and physiological changes, such 
as heavier body weight due to the growing stomach and water retention especially toward 
the end of the pregnancy. Therefore, smaller bouts of exercise might be more feasible to the 
pregnant women, which explained the higher self-efficacy among women in the intervention 
group compared to control group. 
Using linear regression analyses, the present study was able to show that task self-
efficacy and barrier self-efficacy independently predicted the amount of steps taken by the 
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women at the end of the second trimester (V3). At late third trimester (V4), both task self-
efficacy and pre-pregnancy BMI independently predicted the step count. The result of the 
present study, which was the first to use an objective measure of PA, was supported by 
Cramp and Bray’s previous work using self-reported PA measure [24]. In their observational 
study, they found that across pregnancy (at week 18, 24, 30 and 35 of gestation), both 
barrier and task self-efficacy independently predicted self-report leisure time PA 
participation. The finding that pre-pregnancy BMI influenced step count prediction is in 
agreement with two other studies, which showed that the greater the pre-pregnancy BMI, the 
higher the likelihood of women dropping out from sports involvement or any form of 
structured exercise programs after becoming pregnant [36, 37]. However, Hinton and Olson 
conducted an observational study to examine changes in PA levels during pregnancy and 
found that higher pre-pregnancy BMI predicted higher PA level from pre-pregnancy to 
pregnancy [34]. They suggested that their findings were not a result of sedentary women 
with higher pre-pregnancy BMI becoming more physically active in pregnancy, but 
physically active women of lower pre-pregnancy BMI decreased their PA level significantly 
during pregnancy. 
Additionally, in the current study, both task self-efficacy and pre-pregnancy BMI 
were selected as the best model to predict step counts at the end of second trimester and late 
third trimester. The all-subsets analysis showed that at V3, task self-efficacy together with 
pre-pregnancy BMI explained 30% of the variance in step count prediction; while at V4, 
task self-efficacy together with pre-pregnancy BMI explained 36% of the variance. As a 
result, even though barrier self-efficacy showed moderate to significant predictive 
magnitude according to the linear regression analyses, task self-efficacy and pre-pregnancy 
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BMI emerged as the major contributors to the prediction at both time points. In other words, 
task self-efficacy and pre-pregnancy BMI were the most proximal determinants of PA 
participation for overweight and obese pregnant women during pregnancy.  
The findings of this study concur with other studies, which have shown the dominant 
effect of task self-efficacy in PA prediction both in pregnant [24], as well as non-pregnant 
[46] populations. Similar to the results of Cramp and Bray’s study [24], the present study 
also observed a considerably large variance shared by barrier self-efficacy and task self-
efficacy according to the correlation analysis. This shared variance could explain the 
minimum contribution of barrier self-efficacy to the step count prediction model when task 
self-efficacy was included in the model. Additionally, the findings of this study also 
suggested that pre-pregnancy BMI seemed to play a role in predicting maternal PA 
participation at late third trimester (V4), but not at the end of the second trimester (V3). 
When pre-pregnancy BMI was entered into the model, it explained an additional 12.5% of 
variance in predicting step count at V4.  
  Little information is available about the relationship between exercise (i.e. walking) 
self-efficacy and PA participation among pregnant women. Therefore, there are many 
strengths of the present study that are unique contributions to the existing body of research 
in this area. First, the PA assessment tool used in this study was an objective measurement. 
Since walking is the most common activity among pregnant women, the objective 
measurement tool used in this study was  the StepWatch™ Activity Monitor, an ankle-bound 
pedometer with previously reported high levels of accuracy and precision for measuring 
walking in various populations [50–52]. Self-reported PA of participants were not used in 
this study, which other researchers have suggested may be biased or result in under/over 
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reporting of actual PA [53–55].  Secondly, even though the present study has a small sample 
size of 37 women, it was a longitudinal study across pregnancy instead of a cross-sectional 
study at one time point during pregnancy. The same group of women was followed from the 
beginning of their second trimester until their late third trimester of gestation. Thirdly, the 
present study was the first to include pre-pregnancy BMI into a multiple regression model to 
predict maternal PA participation. Indeed, it showed that pre-pregnancy BMI added 
significant variance to the prediction model especially at the late third trimester. Lastly, this 
study also was the first to evaluate the exercise self-efficacy of overweight and obese 
pregnant women. In addition to dealing with excessive pre-pregnancy weight and potentially 
excessive gestational weight gain, overweight and obese women might also face many 
psychosocial factors which can prevent them from being physically active during pregnancy. 
For example, they may lack motivation and social support, not to mention self-efficacy. The 
psychosocial factors faced by overweight and obese women might be different from the 
normal weight women. The predictive strength of the statistical model might be different 
between the two groups as well; therefore, future studies might be needed to compare the 
walking self-efficacy between normal weight and overweight/obese women  
Despite the several strengths, it is acknowledged that the present study has some 
limitations. This intervention did not involve experimental manipulation of self-efficacy, 
therefore, the cause-effect relationship of exercise self-efficacy with PA participation that 
was observed in this study can only be assumed. Lastly, the population in this study was not 
diverse with respect to race, ethnicity or social economic status (SES); therefore, the 
findings of this study might not apply to a more diverse and lower SES population. The 
barriers faced by more diverse groups of pregnant women may be different.  
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Conclusion 
In conclusion, self-efficacy and pre-pregnancy BMI are important in predicting PA 
participation during pregnancy especially at late pregnancy. When considering the health of 
the mother and fetus, particularly among the overweight and obese population, interventions 
designed to help increase PA participation during pregnancy are crucial. Psychosocial 
factors like self-efficacy are modifiable in a way that most demographic factors are not. 
Interventions designed to promote PA could focus on behavioral strategies for increasing 
self-efficacy toward PA participation during pregnancy, which then could bring positive 
influence to the health of the women and their children. The findings of the present study 
provided preliminary results in understanding the relationship between self-efficacy and PA 
participation during pregnancy, yet larger intervention studies are needed before a causal 
relationship can be established.  
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Table 1: Correlations between pre‐pregnancy BMI, barrier self‐efficacy and task self‐
efficacy  
  Pre‐pregnancy BMI    Barrier self‐efficacy    Task self‐efficacy 
V3 (weeks 27‐29 of gestation) 
Pre‐pregnancy BMI  1    ‐    ‐ 
Barrier self‐efficacy  ‐0.21    1    ‐ 
Task self‐efficacy  ‐0.19     0.59*     1 
V4 (weeks 34‐36 of gestation) 
Pre‐pregnancy BMI  1    ‐    ‐ 
Barrier self‐efficacy  ‐0.16     1    ‐ 
Task self‐efficacy  ‐0.14      0.68*     1 
* indicates p < 0.0001         
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Table 2: Linear regression and all‐subsets analysis in predicting step count 
Predictor  Outcome    R2    RMSE   
Overall 
regression 
model (p‐ 
value)    AIC 
   Prediction for V3 (weeks 27‐29 of gestation) 
Linear Regression  Step count                 
TSE      0.254        0.003     
BSE      0.123        0.049     
Pre‐BMI      0.095        0.086     
                   
All‐subsets  Step count                 
TSE      0.254    2272.74    0.003    590.24
TSE, Pre‐BMI      0.300    2238.25    0.006    590.80
TSE, BSE      0.258    2305.39    0.013    592.70
   Prediction for V4 (weeks 34‐36 of gestation) 
Linear Regression  Step count                 
TSE      0.234        0.003     
Pre‐BMI      0.167        0.015     
BSE      0.098        0.067     
                   
All‐subsets  Step count                 
TSE, Pre‐BMI      0.359    1833.75    0.001    631.51
BSE, TSE, Pre‐BMI      0.362    1858.79    0.003    634.09
TSE       0.234    1974.24    0.003     635.20
  TSE = task self‐efficacy; BSE = barrier self‐efficacy; Pre‐BMI = pre‐pregnancy BMI  
  Top 3 best models based on AIC values listed             
RMSE = root‐mean‐square‐error     
Akaike information criterion     
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Figure 1: Barrier self-efficacy between treatment groups at end of second trimester (V3) 
and late third trimester (V4). 
Overweight and obese pregnant women were enrolled and randomized to either intervention 
(encouraged to increase moderate intensity physical activity each week by walking) or 
control (no PA recommendations provided, but not restricted to PA participation) groups 
between weeks 15 – 35 of gestation. Barrier self-efficacy was assessed at V3 = weeks 27 – 
29 of gestation, end of second trimester, and V4 = weeks 34 – 36 of gestation, late third 
trimester. At V3, there was as strong trend of significant difference between the treatment 
group (Int = 70.3%; Con = 57.0%; diff = 13.3%; p = 0.077); at V4, there was a significant 
difference between the treatment groups (Int = 64.6%; Con = 49.4%; diff = 15.2%; p = 
0.045).  
Figure 2: Task self-efficacy between treatment groups at end of second trimester (V3) and 
late third trimester (V4). 
Overweight and obese pregnant women were enrolled and randomized to either intervention 
(encouraged to increase moderate intensity physical activity each week by walking) or 
control (no PA recommendations provided, but not restricted to PA participation) groups 
between weeks 15 – 35 of gestation. Task self-efficacy was assessed at V3 = weeks 27 – 29 
of gestation, end of second trimester, and V4 = weeks 34 – 36 of gestation, late third 
trimester. At V3, there was a significant difference between the treatment group (Int = 
78.2%; Con = 47.3%; diff = 30.9%; p < 0.0001); at V4, there was a significant difference 
between the treatment groups (Int = 73.7%; Con = 44.2%; diff = 29.5%; p < 0.0001).  
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Figure 1: Barrier self-efficacy between treatment groups at end of second trimester (V3) 
and late third trimester (V4). 
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Figure 2: Task self-efficacy between treatment groups at end of second trimester (V3) and 
late third trimester (V4). 
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CHAPTER 5: IMPACT OF A WALKING INTERVENTION DURING 
PREGNANCY ON POST-PARTUM WEIGHT RETENTION AND INFANT 
OUTCOMES 
A paper to be submitted to journal Obesity 
Kai Ling Kong, Christina G Campbell, Kelly A Wagner, Anna D Peterson, Lorraine M 
Lanningham-Foster         
Abstract 
Few studies have investigated the impact of physical activity interventions during pregnancy 
on post-partum weight retention and post-natal growth. Objectives:  There were two 
objectives of the current study; 1) to compare maternal weight retention and child outcomes 
of overweight and obese participants enrolled in a walking intervention during pregnancy 
versus a non-intervention control group, and 2) to examine the relationship between pre-
pregnancy body mass index (BMI) and rates of gestational weight gain (GWG) at different 
time points during pregnancy with maternal weight retention and infants’ weight-for-length 
z-scores (WLZ-scores). Design and Methods: Thirty seven overweight or obese (BMI > 
25.0 kg/m2) pregnant women were randomly assigned to a walking intervention or no-
intervention control group. The length of the walking intervention was at least 20 weeks. 
Weight of the mother and weight, length and body composition of the infant were collected 
at one month post-partum (n = 37) and six months post-partum (n = 33). ANOVA was used 
to determine the differences in maternal post-partum weight and child outcomes. A Pearson 
correlation coefficient analysis was conducted to examine the association between pre-
pregnancy BMI, rates of GWG at different time points across pregnancy, % weight retention 
and infant WLZ-score. Results: At six months post-partum, obese women in the 
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intervention group retained less than 1% of their maternal weight compared to obese women 
in the control group who retained 7% of their maternal weight. Lower WLZ scores at one 
month (Int-OB = -0.037 ± 0.615; Con-OB = 0.311 ± 0.520) and six months (Int-OB = 0.167 
± 0.706; Con-OB = 1.102 ± 1.332) were observed among infants who were born to obese 
women in the intervention group. Percentage of weight retention and WLZ score were 
significantly correlated with rates of GWG especially at the early time points during 
pregnancy. Conclusion: Targeting PA interventions for women early during pregnancy, or 
even before conception, could be a promising starting point for obesity prevention. 
Introduction 
The incidence of obesity among children has rapidly increased worldwide. Within 
the United States, 9.7% of infants and toddlers have a high weight-for-recumbent length and 
16.9% of children and adolescents 2 – 19 years of age were obese (1). These values are 
concerning, as obese children and adolescents are more likely to become obese adults and 
possess obesity-associated morbidities later in life (2). The development of obesity has 
largely been attributed to unhealthy lifestyle choices or uncontrollable genetic 
predispositions; however, emerging evidence reveals that one’s exposure within the 
intrauterine environment may play a pivotal role in the development of obesity (3–5). The 
Developmental Origins of Health and Disease (DOHaD) hypothesis or better known as 
“Barker’s hypothesis” has been recently used to gain new insights into the obesity epidemic 
(4, 6, 7). The DOHaD hypothesis elucidates how an unfavorable intrauterine environment 
due to several conditions, including maternal obesity and excessive gestational weight gain 
(GWG), increases the risk of obesity in the offspring.  
Maternal obesity and excessive GWG are two of the main causes of giving birth to a 
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large-for-gestational-age (LGA) (birth weight ≥ 90th percentile) infant in most Western 
countries  (6–9). Further, evidence suggests that the association between maternal obesity 
and offspring obesity can be continued through childhood, adolescence, and into adulthood 
(10–13). When examining the relationship between excessive GWG and offspring obesity, 
epidemiological and observational studies have supported an association between the two (6, 
8, 14).This is especially true among overweight and obese women compared to normal 
weight women (15–17). The latest data showed that in the U.S., 63% of overweight and 65% 
of obese women exceeded the IOM (2009) GWG recommendations (18). Unfortunately, the 
majority of these women also fail to lose weight after pregnancy, and excessive GWG  is 
strongly associated with maternal weight retention at six and 12 months post-partum (8, 19, 
20). Overweight and obese women retain more weight compared with women who are of 
normal weight prior to pregnancy (21). Overweight and obese women then carry this excess 
weight from one pregnancy to the next, and each subsequent pregnancy may result in more 
weight gain (19). This is concerning for the health of these women, as retention of 
gestational weight can be a significant contributor to long-term obesity and its associated 
health risks (22).  
Besides the total amount of weight gained during pregnancy, the timing of GWG is 
also important (23). Weight gain at the beginning of pregnancy closely reflects maternal fat 
gain, while weight gain later in pregnancy reflects fetal components (23, 24). Thus, when a 
woman gains excessive weight early in pregnancy, her offspring may potentially be at risk 
for obesity (25, 26). Women increase their fat stores during early- and mid-pregnancy as a 
caloric reserve for feto-placental and increased maternal demands during late gestation and 
lactation (28); therefore, women entering into pregnancy who are overweight or obese are 
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not required to have an extra caloric reserve (27). In fact, women who are overweight or 
obese prior to conceiving should avoid excessive GWG at all costs. The current 2009 GWG 
recommendations by the Institute of Medicine (IOM) was developed based on a woman’s 
pre-pregnancy BMI (28). In general, obese women are advised to gain less weight than non-
obese women. 
Observational studies have supported the role of physical activity (PA) as a strategy 
for pregnant women to minimize, if not prevent, excessive GWG (29–32). Thus, many 
interventions have been designed to help women increase their PA participation during 
pregnancy to improve maternal and fetal health outcomes (33–38). Yet, few studies have 
investigated the impact of these interventions on maternal post-partum weight.  
Additionally, many of these interventions did not include follow-up studies to examine post-
natal growth in the offspring of women who engaged in maternal PA during pregnancy. 
Therefore, the purposes of this study were 1) to compare maternal weight retention of 
participants enrolled in a walking intervention during pregnancy versus a non-intervention 
control group, as well as their child outcomes (weight-for-length z-score, fat mass and % fat 
mass) at one and six months post-partum; 2) to examine the relationship between pre-
pregnancy BMI and rates of GWG at different time points during pregnancy with maternal 
weight retention and weight-for-length z-scores of infants at one and six months post-
partum. Our hypotheses were 1) women who participated in the walking intervention during 
pregnancy would have less maternal weight retention and more favorable child outcomes 
compared to women who did not participate in the walking intervention during pregnancy; 
2) pre-pregnancy BMI together with GWG in early pregnancy (< 20 weeks of gestation) 
would be significantly correlated to maternal weight retention and weight-for-length z-
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scores of the infants in this study. 
Methods and Procedures 
Study Design 
The Blossom Project team at Iowa State University conducted a pilot randomized 
controlled trial entitled ‘Moms to Move’ (M2M). The objectives of the M2M study were 1) 
to increase PA participation among previously non-exercising, overweight and obese 
pregnant women in order to meet the PA recommendations of 150 total minutes of 
moderate-intensity PA (MPA) spread throughout the week, via walking; 2) and to evaluate 
the impact of walking during pregnancy on GWG and birth outcomes when women meet the 
PA guidelines. The intervention in this study was a walking program. Women in the 
intervention group were advised to walk for at least 150 minutes per week. The women 
could spread the walk throughout the week, such as walking for 30 minutes, five days per 
week (39). Participants were allowed to walk in shorter bouts, however, women were 
advised to keep bouts at least 10 minutes in length (40). The walking program began no 
earlier than week 12 and no later than week 15 of gestation and lasted until at least week 35. 
Depending on the length of each participant’s pregnancy, all intervention participants were 
able to complete at least 20 weeks of the walking program. Walking could occur indoors, 
such as walking inside a mall, or outdoors, such as walking in the park. To help participants 
in the intervention group achieve the walking goal, treadmills were provided in women’s 
homes for the duration of the study and were returned following the completion of the 
program. Women in the control group were not provided recommendations with respect to 
PA participation, but they were not restricted from participating in any form of PA during 
pregnancy. The control group was not given treadmills for home use. Post-partum data 
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regarding the anthropometric information of mothers and infants were collected one and six 
months after delivery.  
Participants 
Recruitment for participants occurred from January 2011 to March 2012 through 
email, online advertisement, and flier postings throughout the community and in local 
obstetric clinics. Potential participants who expressed interest were screened for 
qualification criteria via email. Each participant was provided with an informed consent and 
assent document for review. The study was approved by the Institutional Review Board of 
Iowa State University.  
All pregnant women were recruited before they began their fifteenth week of 
gestation. Gestational age was calculated based on the self-reported date of the patients’ last 
normal menstrual cycle or based on the due date determined by their medical providers 
using the clinical ultrasound. Forty-six pregnant women enrolled in the study. The final 
number of women who completed the gestational data collection was 37 (n = 18 in 
intervention group; n = 19 in control group), one month post-partum data collection was 37 
(n = 18 in intervention group; n = 19 in control group), and six months post-partum 
collection was 33 (n = 15 in intervention group; n = 19 in control group). Details on 
dropouts were presented in Figure 1. Participants who were enrolled met the following 
inclusion criteria: maternal age between 18-45 years old, singleton pregnancy, non-smoker, 
self-reported overweight (BMI > 25.0 kg/m2) or obese (BMI > 30.0 kg/m2) prior to 
pregnancy, no prior history of chronic diseases (including type 1 diabetes, cardiovascular 
disease, thyroid disorder or lung disorder), and no prior history of gestational diabetes. 
Additionally, women were only recruited into the study if they engaged in leisure time 
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physical activity (LTPA) for 30 minutes or less fewer than three times per week during the 6 
months prior to enrollment. Pre-pregnancy PA participation was self-reported and LTPA 
was defined as activities performed each week beyond normal daily routines.  
Procedure 
 Participants who qualified through the email screening were invited for an 
enrollment appointment prior to week 15 of gestation. During the enrollment, participants 
signed the consent and assent forms, filled out the medical history questionnaire, and 
provided their medical providers’ contact information. Height and weight of the women 
were measured by a trained staff member after the consent form was signed. All participants 
were approved by their medical providers to join the study. After the initial enrollment, 
participants were randomly assigned to the intervention or control group. Randomization 
was conducted using Microsoft Excel randomization function (Microsoft Excel 2010, WA). 
All participants reported to the clinical research center at each of the following gestational 
data collection time points: weeks 10 – 14 (V1), 17 – 19 (V2), 27 – 29 (V3) and 34 – 36 
(V4) of gestation, and post-partum time points: one month post-partum and six months post-
partum. At each gestational data collection time point, anthropometric, objective physical 
activity, and self-reported diet data were collected for one-week at a time. Weeks 10 – 14 of 
gestation (V1) served as the baseline gestational data collection period. Participants in the 
intervention group had an additional intervention training session after the baseline visit. At 
each post-partum data collection time point, weight of the mother and weight, length and 
body composition of the infant were collected.  
Data Collection 
Maternal anthropometric and demographic data 
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 Height and weight were measured at each gestational and post-partum data collection 
time point visit. Heights were measured to the nearest 0.1 cm with shoes removed (Ayrton 
226 Hite-Rite Precision Mechanical Stadiometer, Quick Medical GS, Snoqualmie, WA) and 
weights were measured to the nearest 0.1 kg in light clothing (Detecto Model 6855 Cardinal 
Scale, Manufacturing Co., Webb City, MO). Pre-pregnancy BMIs were determined by using 
height measured at enrollment and women’s self-reported weights prior to conception. 
Weight retention was calculated by subtracting post-partum weight from self-reported pre-
pregnancy weight. Weight retention was then converted to a percentage of weight retention 
(% wt. ret) based on each woman’s self-reported pre-pregnancy BMI. Individual weight 
change from 1 month to 6 months post-partum was further calculated and analyzed. Rate of 
GWG was determined by dividing the weight difference between two time points with the 
total weeks between the time points. Four different rates of GWG were calculated for the 
study:  weight gain per week from 0 week to baseline data collection at V1 (considered as 
rate of weight gain before the start of the intervention, before M2M), weight gain per week 
between V1 and V2 (rate V1-V2), weight gain per week between V2 and V3 (rate V2-V3), 
and weight gain per week between V3 and V4 (rate V3-V4). During enrollment, participants 
reported their age, education level, employment, race, marital status, income level, and 
parity. 
Infant anthropometric data   
 At the clinical research facility, infant lengths at one and six months were measured 
to the nearest 0.1 cm using a measuring board (seca 416, Medical Scales and Measuring 
Systems seca corp., Chino, CA). Body weights and body compositions were measured to the 
nearest 0.001 kg (PEA POD® or BOD POD Pediatric Option™, COSMED USA, Concord, 
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CA). PEA POD® and BOD POD Pediatric Option™ are systems for body composition 
measurement based on air displacement plethysmography. Instruments were calibrated once 
daily during testing days. The weight limit of the PEA POD® is 12.000 kg; therefore two six 
months babies were measured using the BOD POD Pediatric Option™. Before the 
measurement of weights and body composition, infants were undressed and baby oil was 
used to smooth the infants’ hair down to eliminate air trapped in her/his hair. Body weights 
and body compositions needed to be performed on babies with clothing removed in the PEA 
POD®; however, light-weighted and form-fitting shorts were provided for infants measured 
using the BOD POD Pediatric Option™. Infants were weighed first and then body volume 
was assessed while infants were lying in the chamber of PEA POD or sitting on the inserted 
chair of BOD POD while he/she was awake.  
To maintain consistency, account for sex differences, and enable comparison of 
effect sizes, all infant anthropometric outcomes were converted to z-scores. Infant weights  
(WAZ), lengths (LAZ), and weight-for-lengths (WLZ) at one and six months were 
calculated to sex- and age-specific z-scores using the 2000 Centers for Disease 
Control/National Center for Health Statistics growth charts (41). 
Statistical analysis 
Demographic data were analyzed by descriptive analysis. Multivariate analysis of 
variance was conducted to examine differences in demographic variables (age, height, pre-
pregnancy weight, pre-pregnancy BMI, education, employment, race, marital status, total 
household income, parity) between the groups. Two-way analysis of variance (ANOVA) 
was used to determine the differences in weight retention (kg), % wt. ret, and child 
outcomes (weight, length, WAZ score, LAZ score, WLZ score, fat mass and % fat mass) by 
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treatment group and pre-pregnancy BMI (pre-BMI) category. Absolute difference (diff) was 
reported to show the magnitude and direction when there was significant difference. 
Pairwise comparison tests (all pairs Tukey-Kramer p = 0.05) were then performed to further 
determine the differences among overweight women in the intervention group (Int-OW), 
overweight women in the control group (Con-OW), obese women in the intervention group 
(Int-OB), and obese women in the control group (Con-OB) on the above mentioned 
variables. A Pearson correlation coefficient analysis was also conducted to examine the 
association between pre-pregnancy BMI, rates of GWG at different time points across 
pregnancy, % wt. ret and WLZ score at one and six months post-partum. Significance was 
defined as P < 0.05. Results are presented as mean ± standard deviation (mean ± SD). Data 
analyses were conducted using JMP, Version 7 (SAS Institute Inc., Cary, NC).  
Results 
Participant characteristics 
Participant characteristics in each group by treatment and BMI category can be 
found in Table 1 of Chapter 3. There was no significant difference between groups for age, 
height, gestational length at V1, education, employment, race, marital status, total household 
income, and parity. Pre-pregnancy weight and pre-pregnancy BMI were significantly 
different between overweight and obese participants. Majority of the participants in this 
study were married, educated, and Caucasian.  
Maternal post-partum weight 
 At 1 month post-partum, there was no significant difference between the treatment 
groups, pre-pregnancy BMI categories and interaction effect for both weight retention (F = 
0.420; p = 0.7400) and % wt. ret. (F = 0.468; p = 0.7069). For 6 months post-partum weight 
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retention, there was no significant difference between the treatment groups and pre-
pregnancy BMI categories, but there was a significance in the interaction effect (p = 0.0438) 
(F = 2.488; p = 0.0795); while, for 6 months post-partum % wt. ret., there was no significant 
difference between the treatment groups and pre-pregnancy BMI categories, but a strong 
trend of significance in the interaction effect (p = 0.0588) (F = 2.143; p = 0.1157). The 
pairwise comparison tests did not show significant differences between the four participant 
groups (Int-OW, Con-OW, Int-OB, and Con-OB) at each post-partum time point (Table 1). 
However, at one month post-partum, % wt. ret of Int-OB women was 2.0% and this value 
decreased to 0.8% at six months post-partum. In contrast, at one month post-partum, % wt. 
ret of Con-OB was 3.4% and this value increased to 7.0% at six months post-partum. 
Individual weight changes from 1 month to 6 months post-partum were further analyzed and 
were classified as gain or loss (Figure 2). The percentage of women who gained or lost 
weight from 1 to 6 months post-partum was relatively similar among the overweight women 
between the treatment groups; however, there were a higher percentage of obese women in 
the control group who gained weight from 1 to 6 months post-partum compared to the obese 
women in the intervention group.  
Child outcomes 
Overall, there were no significant differences in weight (F = 0.425, p = 0.736 at 1 
month; F = 0.364, p = 0.780 at 6 months), length (F = 0.148, p = 0.930 at 1 month; F = 
0.040, p = 0.989 at 6 months), WAZ score (F = 0.434, p = 0.730 at 1 month; F = 0.801, p = 
0.504 at 6 months), LAZ score (F = 0.087, p = 0.966 at 1 month; F = 0.024, p = 0.995 at 6 
months), WLZ score (F = 0.456, p = 0.715 at 1 month; F = 1.403, p = 0.262 at 6 months), fat 
mass (F = 0.274, p = 0.844 at 1 month; F = 0.867, p = 0.470 at 6 months), and % fat mass (F 
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= 0.395, p = 0.758 at 1 month; F = 0.911, p = 0.448 at 6 months) between the treatment 
groups, pre-pregnancy BMI category, or interaction effect at each post-partum visit. Lower 
WLZ scores at one month (Int-OB = -0.037; Con-OB = 0.311; diff = 0.348; p = 0.7904) and 
six months (Int-OB = 0.167; Con-OB = 1.04; diff = 0.873; p = 0.430) were observed among 
infants who were born to obese women in the intervention group compared to babies born to 
obese women in the control group. However, pairwise comparison tests showed no 
significant difference.   
Pre-pregnancy BMI and rates of gestational weight gain at different time points on 
maternal and child weight 
 Table 3 is a correlation matrix, which demonstrates the association between pre-
pregnancy BMI and rates of GWG at different time points during pregnancy, with % weight 
ret of the women and WLZ score of the child at one month and six months post-partum. 
Rate of GWG was calculated for weight gained before women joined the study (before 
M2M), rate of GWG between V1 and V2 (rate V1-V2), rate of GWG between V2 and V3 
(rate V2-V3), and rate of GWG between V3 and V4 (rate V3-V4). Table 3 shows that the 
rates of GWG at different time points were significantly correlated with the preceding rate 
of GWG. Rate of GWG between V1 and V2 (rate V1-V2) was significantly correlated with 
the rate of weight gain before the women joined the study (before M2M) (r = 0.493, p < 
0.01); rate V2-V3 was significantly correlated by V1-V2 (0.457, p < 0.01); rate V3-V4 was 
significantly correlated with V2-V3 (0.469, p < 0.01). Percentage of weight retention at one 
month and six months post-partum was significantly correlated with all rates of GWG at 
different time points throughout pregnancy, but not pre-pregnancy BMI. Weight-for-length 
z-score at one month post-partum was not significantly correlated with any rate of GWG or 
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pre-pregnancy BMI. However, WLZ score at six months post-partum was significantly 
correlated with rate of GWG before M2M, rate V1-V2, and rate V3-V4.  
Discussion 
 
The current study examines the impact of a walking intervention during pregnancy 
on women’s weight retention at one and six months post-partum and the impact on infant 
outcomes. At six months post-partum, obese women in the intervention group retained less 
than 1% of their maternal weight compared to 7% weight retention among obese women in 
the control group. Obese women in the control group experienced a 3.54% weight gain from 
one month to six months post-delivery. In contrast, obese women in the intervention group 
reduced their weight by 1.22% from one month to six months post-delivery. When 
individual weight change was further analyzed, a higher percentage of the obese women in 
the control group gained weight from one month to six months post-partum compared to 
obese women in the intervention group. In other words, a higher percentage of the obese 
women who participated in the walking intervention continued to lose the weight they had 
gained during pregnancy. Evidence shows that prenatal PA has the capability to help 
pregnant women minimize, if not prevent, excessive GWG (29–32); however, less is known 
about the effect of prenatal PA on gestational weight retention during the post-partum 
period. The walking intervention within this study was successful in changing the walking 
patterns (behavior) of the overweight and obese women in the intervention group (reported 
elsewhere). These women walked at a higher intensity and were, most importantly, able to 
sustain these walking habits until late pregnancy. As a result, the reduced weight retention 
among obese women in the intervention group may be explained in part by the lifestyle 
modification during pregnancy. During the post-partum period, obese women in the 
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intervention group may have continued their higher intensity walk, even after intervention 
termination 
Thus far, no known study has evaluated the impact of lifestyle intervention, using 
increased PA as the only modification during pregnancy, on post-partum weight retention. 
However, presently, two studies have examined the effects of PA together with dietary 
modification during pregnancy on post-partum weight retention (38, 42). Both studies 
showed that a significantly higher percentage of women in the physical activity/diet 
intervention group returned to their pre-conception weight when compared to the control 
group at 6 months post-partum.  
The current study did not observe differences in regards to the child’s body fat mass 
or % body fat between the groups (Int-OW, Con-OW, Int-OB and Con-OB). Although not 
statistically significant, there was a tendency for the offspring of obese women in the 
intervention group to have lower WLZ scores at one and six months old. In fact, this strong 
trend starts at birth; as obese women who participated in the walking intervention had lower 
infant birth weight z-scores and decreased odds of fetal macrosomia (data reported 
elsewhere). Overall, this is an encouraging finding within the present study. Evidence shows 
that maternal PA participation helps reduce the risk of giving birth to LGA infants (43–45). 
Unfortunately, to date, there is limited research that examines long-term longitudinal data on 
post-natal growth in the offspring of women who engaged in maternal PA during pregnancy. 
There are currently three such studies in the literature, yet these findings are based on 
observational studies rather than intervention follow-up studies (46–48). Different from our 
study population, two studies by Clapp and colleagues recruited women who were 
recreational athletes (i.e.: runners, cross-country skiers) and found conflicting results. In one 
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study, offspring of the women who continued their exercise regimens during pregnancy 
weighed less and were leaner at age 5 when compared to the control group’s offspring 
(previously recreational athletes who stopped all sustained exercise) (47). Interestingly, in 
the second study, Clapp and colleagues did not observe the same effect when measurements 
were taken at age 1 (46). In a more recent women/toddler pairs study (n = 23), Mattran and 
colleagues found that recall of LTPA at 3rd trimester (MET-min/wk) was marginally 
associated with lower toddler weight (rs = -0.39, p = 0.06) and weight-for-height z-score (rs 
= -0.40; p = 0.06) between 18 to 24 months of age in the offspring (48). 
The present study also suggests a “cascade effect” of weight gain throughout 
pregnancy. Rate of GWG at any point during pregnancy was significantly associated with 
the preceding rate of weight gain. In this study, weight gain after enrollment into the 
walking intervention was affected strongly by the weight already gained before the start of 
the intervention. This observed effect could be especially discouraging to investigators who 
hope to introduce lifestyle modifications during pregnancy to prevent excessive GWG. One 
such example is the NELIP study conducted by Mottola and colleagues, a personalized 
walking program that began between 16 and 20 weeks of gestation (37). The results of this 
intervention showed that 80% of the participants did not exceed 2009 IOM 
recommendations on NELIP and their average total weight gain on NELIP was only 6.8 ± 
4.1 kg. Unfortunately, many women had gained excessive weight before they joined the 
program; therefore, their average total weight gain was 12.0 ± 5.7 kg, which exceeded the 
total GWG range recommended by IOM for both overweight and obese women. 
Consequently, the suggestion by Weisman et al. to target the pre-conception period in order 
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to help women reduce overall weight and increase PA participation before entering 
pregnancy might be an effective strategy worth future investigation (18).  
In addition to the observed “cascade effect” of GWG, all rates of GWG across the 
gestational period were significantly associated with the percentage of weight retention at 
one and six months post-partum. It is well documented that total GWG is positively 
associated with post-partum weight retention (8, 19, 20) and is a strong predictor of long-
term overweight and obesity beyond pregnancy (49, 50). However, little information is 
available about the patterns of weight gain across the gestational period in relation with 
post-partum weight retention. Muscati and colleagues argued that timing of GWG was as 
important as the total amount of weight gain during pregnancy (23). They provided evidence 
that early GWG (≤ 20 weeks) was a strong predictor of six weeks post-partum weight 
retention. They further concluded that rate of weight gain during the first half of pregnancy 
should be carefully monitored among overweight women in order to avoid excessive fat 
deposition. The results of the present study did not concur with the findings of Muscati and 
colleagues. The present study shows that GWG during the second half of pregnancy (≥ 20 
weeks) could also play a significant role in predicting weight retention at one and six months 
post-partum. Nevertheless, more studies are needed to better understand the relationship 
between the timing of GWG and post-partum weight retention.  
When evaluating the relationship between GWG and child WLZ score, the current 
study did not demonstrate a relationship between pre-pregnancy BMI and rates of GWG at 
any point during pregnancy with one month infant WLZ score. However, a relationship was 
identified at six months WLZ score, especially in early pregnancy weight gain (≤ 20 weeks 
of gestation). Similarly with post-partum weight retention, the relationship between GWG 
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and offspring obesity is well established (6, 8, 14), yet very few studies  have investigated 
the pattern of weight gain across the gestational period in relation to offspring obesity. The 
finding of the present study is supported by one other study, which evaluated GWG during 
two specific periods: 0 to 14 weeks and 14 to 36 weeks. Using the Avon Longitudinal Study 
of Parents and Children (ALSPAC), a UK-based prospective pregnancy cohort (n =  
12,500), Fraser and colleagues reported a positive relationship between GWG in early 
pregnancy (0 to 14 weeks) and offspring adiposity at age 9 years in all data, while GWG 
was only related with offspring adiposity in women who gained > 500 g/wk between 14 and 
36 weeks (25). Through these findings, the authors concluded that women should avoid 
excessive weight gain in early pregnancy, as this early weight gain may cause the 
relationship between GWG and offspring adiposity.  
Evidence of the impact of maternal PA participation on post-partum weight retention 
and child obesity among overweight and obese women is limited. Therefore, there are many 
strengths of the present study, which provided unique contributions to the existing body of 
research in this area. The PA assessment tool used during the pregnancy portion of the study 
was an objective measurement. As a result, the study did not rely on women to self-report or 
recall their PA participation during pregnancy, eliminating any potential bias or under/over 
reporting of actual PA participation (51–53).  Even though the present study has a small 
sample size of 37 women, it longitudinally studied women across pregnancy rather than 
taking a cross-sectional sample at one time point. Among the 37 participants, all women 
were followed until one months post-partum, and 33 women were followed until six months 
post-partum. This study is the first to evaluate the impact of an independent PA intervention 
on the postnatal growth in offspring of overweight and obese pregnant women using a 
164 
 
 
 
randomized controlled trial. The positive findings of the present study could serve as 
preliminary data for future investigations in a larger randomized controlled trial. Lastly, this 
study was able to track the rate of weight gain at different time points during pregnancy by 
trained staff members. This is advantageous as the information collected could provide a 
better understanding of how the timing and the pattern of GWG affect post-partum weight 
retention and postnatal child growth.   
It is acknowledged that the present study has several limitations that should be noted.  
One major limitation of the current study is its small sample size and high variability among 
the groups. The small sample size could have reduced the ability to detect statistically 
significant effects of the intervention on post-partum maternal and child outcomes. 
Secondly, self-reported pre-pregnancy BMI was used in the study, which could lead to an 
inaccurate percentage of weight retention calculation because evidence has shown that 
overweight women are more likely to underreport their weight compared to normal or 
underweight women (54). Thirdly, the present study did not collect any PA or dietary data 
during the post-partum period. Therefore, the effects observed between PA participation 
during pregnancy and post-partum maternal and child outcomes can only be assumed. 
Lastly, this study did not account for other confounding factors, such as feeding practices 
and sociodemographic variables when association of rates of GWG with maternal and child 
outcomes during post-partum period were reported. Evidence has shown that breastfeeding, 
maternal age, race, and employment status are associated with weight retention (55, 56).  
In conclusion, it was surprising and unexpected that there was not a similar 
relationship between changes in PA pattern/intensity and post-partum weight retention and 
child health outcomes for both overweight and obese participants. It would appear that 
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lifestyle modification during pregnancy provided greater benefit for the obese women and 
possibly their offspring. In this study, even though the walking intervention during 
pregnancy did not significantly increase the minutes of meaningful walks taken by the obese 
women, it was successful in changing the intensity/pattern of their walks, and they were able 
to sustain those habits until late pregnancy. It is stated in the 2008 Physical Activity 
Guidelines for Americans that some activity is better than none (57); therefore, small change 
for previously non-exercising, obese pregnant appeared to bring health-related benefits. 
Maternal obesity and excessive GWG cause a perpetuating “vicious cycle” of obesity, where 
obese women or women who gain excess gestational weight have a higher risk of giving 
birth to large for gestational age  infants, who then, years later, can become obese adults 
entering into their own pregnancies (58) These women are also more likely to retain 
gestational weight, which then leads to higher weight status for future pregnancies (19). 
Therefore, targeting PA interventions for women during early pregnancy, or even before 
conception, could be a promising starting point for obesity prevention.  
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Table 1: Post‐partum maternal weight by treatment and pre‐pregnancy BMI 
Variables  Overweight    Obese 
  Intervention  Control    Intervention  Control 
   (n = 8)  (n = 10)    (n = 7)  (n = 9) 
  1‐month post‐partum 
Maternal weight           
   Weight retention (kg)  5.34 ± 6.05  1.62 ± 5.58    1.43 ± 5.36  3.05 ± 8.24 
   % weight retention (%)  7.73 ± 8.73  2.46 ± 7.31    2.02 ± 5.90  3.43 ± 9.25 
   6‐month post‐partum 
Maternal weight           
   Weight retention (kg)  1.64 ± 2.09  ‐0.94 ± 5.60    ‐0.10 ± 8.11  6.35 ± 7.47 
   % weight retention (%)  2.44 ± 2.97  ‐0.79 ± 6.98    0.80 ± 7.85  6.97 ± 8.34 
 Values shown are mean ± SD 
 % weight retention was calculated using self‐reported pre‐pregnancy weight 
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Table 2: Child outcomes by treatment group and pre‐pregnancy BMI category 
  1‐month post‐partum 
Variables  Overweight    Obese 
  Intervention  Control    Intervention  Control 
   (n = 9)  (n = 9)    (n = 9)  (n = 9) 
Child outcomes           
   Weight (kg)  4.49 ± 0.48  4.63 ± 0.59    4.37 ± 0.70  4.63 ± 0.42 
   Length (cm)  54.7 ± 3.1  54.9 ± 1.6    54.2 ± 2.9  54.5 ± 1.7 
   WAZ score  ‐0.37 ± 0.76  ‐0.16 ± 0.86    ‐0.49 ± 0.98  ‐0.10 ± 0.60 
   LAZ score  ‐0.60 ± 1.26  ‐0.46 ± 0.63    ‐0.70 ± 1.12  ‐0.59 ± 0.72 
   WLZ score  ‐0.07 ± 1.08  0.00 ± 0.75    ‐0.04 ± 0.62  0.31 ± 0.52 
   Fat mass (kg)  0.77 ± 0.23  0.86 ± 0.24    0.81 ± 0.24  0.81 ± 0.16 
   Fat mass (%)  17.0 ± 4.1  18.5 ± 3.0    18.2 ± 3.1  17.4 ± 2.7 
   6‐month post‐partum 
Variables  Overweight    Obese 
  Intervention  Control    Intervention  Control 
   (n = 8)  (n = 9)    (n = 7)  (n = 9) 
Child outcomes           
   Weight (kg)  7.94 ± 0.98  7.94 ± 1.21    7.85 ± 0.79  8.35 ± 1.24 
   Length (cm)  67.5 ± 3.2  67.7 ± 3.9    67.3 ± 3.4  67.1 ± 3.4 
   WAZ score  0.00 ± 0.91  0.03 ± 1.17    ‐0.04± 0.75  0.59 ± 0.98 
   LAZ score  0.07 ± 0.95  0.16 ± 1.2    0.02 ± 1.03  0.07 ± 1.1 
   WLZ score  0.26 ± 0.76  0.04 ± 1.47    0.17 ± 0.71  1.04 ± 1.26 
   Fat mass (kg)  2.05 ± 0.50  2.02 ± 0.55    2.10 ± 0.40  2.43 ± 0.83 
   Fat mass (%)  25.5 ± 4.1  24.4 ± 5.3    26.6 ± 3.0  28.6 ± 4.9 
 Values shown are mean ± SD 
WAZ score = weight‐for‐age z‐score; LAZ score = length‐for‐age z‐score; WLZ = weight‐for‐length z‐
score 
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Table 3: Correlations between pre‐pregnancy BMI and rates of gestational weight gain with % weight retention and child WLZ 
scores 
  
Pre‐
BMI 
Before 
M2M 
Rate V1‐
V2  
Rate V2‐
V3 
Rate V3‐
V4 
1‐m % wt. 
ret 
6‐m % wt. 
ret  1‐m WLZ  6‐m WLZ 
Pre‐BMI  1                 
Before M2M  0.07  1               
Rate V1‐V2   0.09  0.49**  1             
Rate V2‐V3  ‐0.25  0.24  0.46**  1           
Rate V3‐V4  ‐0.01  0.21  0.36*  0.47**  1         
1‐m % wt. ret  ‐0.19  0.52**  0.75***  0.72***  0.64***  1       
6‐m % wt. ret  ‐0.003  0.58***  0.60***  0.51**  0.49**  0.73***  1     
1‐m WLZ  ‐0.03  0.24  0.29  0.11  0.09  0.25  0.35  1   
6‐m WLZ  0.22  0.36*  0.49**  0.03  0.44**  0.27  0.33  0.3  1 
* indicates p < 0.05; ** indicates p < 0.01; *** indicates p < 0.001 
V1 = weeks 10 ‐14 of gestation; V2 = weeks 17 ‐ 19 of gestation; V3 = weeks 27 ‐ 29 of gestation; V4 = weeks 34 ‐ 36 of gestation; % wt. ret = % 
weight retention; M2M = Moms to Move study; WLZ = weight‐for‐length z‐score 
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Figure 1: Participant flow chart 
Figure 2: Percentages of women who gained or lost weight from 1 month to 6 months post-
partum 
Overweight and obese pregnant women were enrolled and randomized to either a walking 
intervention or control group during pregnancy. Maternal weight was collected at 1 month 
and 6 months post-partum. Individual weight change was classified as gain or loss from 1 
month post-partum to 6 months post-partum. (Int-OW = overweight women in the 
intervention group; Con-OW = overweight women in the control group; Int-OB = obese 
women in the intervention group; Con-OB = obese women in the control group) 
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Figure 1: Participant flow chart 
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Figure 2: Percentages of women who gained or lost weight from 1 month to 6 months post-
partum 
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CHAPTER 6: GENERAL CONCLUSIONS 
 
The intrauterine environment of obese women and of those with excessive 
gestational weight gain could potentially program long-term offspring obesity (Oken, 2009). 
In the words of Barker, ‘The womb may be more important than the home’ (Barker, 1990). 
In these past few decades, physical activity during pregnancy has been viewed as an 
important part of reproductive health. Pregnant women are encouraged to have an active 
lifestyle, which has replaced the traditional view that pregnant women should engage in 
limited exercise (Downs, Chasan-Taber, Evenson, Leiferman, & Yeo, 2012). According to 
the 2008 PA guidelines for Americans, in the absence of either medical or obstetric 
complications, pregnant women are encouraged to accumulate a total of 150 minutes of 
moderate PA per week, preferably spread throughout the week (“Physical activity guidelines 
advisory committee report, 2008. To the Secretary of Health and Human Services. Part A: 
executive summary,” 2009). 
To our knowledge, the current intervention was the first pilot randomized controlled 
trial to help previously non-exercising, overweight and obese women to increase moderate 
PA during pregnancy via walking. It was a PA-only intervention. Diet counseling was not 
provided nor was caloric restriction emphasized in the study. Additionally, the present study 
also was the first to objectively measure walking cadence/intensity of pregnant women in 
order to evaluate moderate PA participation during pregnancy in a randomized-controlled 
trial. The results of the study (Chapter 3) showed that the walking intervention helped 
change the walking intensity of all women enrolled in the intervention group during 
pregnancy especially among the overweight women. Even though it was not statistically 
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significant, there was a trend for women in the intervention group to have more favorable 
pregnancy and birth outcomes compared to the control group.  
Little information is available about the relationship between exercise (i.e. walking) 
self-efficacy and PA participation among pregnant women. The present study (Chapter 4) 
showed that self-efficacy and pre-pregnancy BMI are important in predicting PA 
participation during pregnancy especially at late pregnancy. Psychosocial factors like self-
efficacy are modifiable in a way that most demographic factors are not (Hinton & Olson, 
2001). Interventions designed to promote PA could focus on behavioral strategies for 
increasing self-efficacy toward PA participation during pregnancy, which then could bring 
positive influence to the health of the women and their children.  
Furthermore, evidence shows that prenatal PA has the potential to help pregnant 
women minimize, if not prevent, excessive GWG (Haakstad, Voldner, Henriksen, & Bø, 
2007; Olson & Strawderman, 2003; Stuebe, Oken, & Gillman, 2009); however, less is 
known about the effect of prenatal PA on gestational weight retention during the post-
partum period. The follow-up study (Chapter 5) of the current walking intervention showed 
that at six months post-partum, obese women in the intervention group retained less weight 
than the obese women in the control group. The obese women in the intervention group 
continued to lose the weight they had gained during pregnancy from one-month to six-
month post-partum. In contrast, obese women in the control group experienced weight gain 
from one month to six months post-delivery. In addition, thus far, there is limited research 
that examines long-term longitudinal data on post-natal growth in the offspring of women 
who engaged in maternal PA during pregnancy. Although not statistically significant, in the 
present study there was a trend for the offspring of obese women in the intervention group to 
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have lower WLZ scores at one and six months old. In fact, this trend started at birth; as 
obese women who participated in the walking intervention had lower infant birth weight z-
scores and decreased odds of fetal macrosomia. Overall, it was surprising and unexpected 
that there was not a similar relationship between changes in PA pattern/intensity and post-
partum weight retention and child health outcomes for both overweight and obese 
participants. It would appear that lifestyle modification during pregnancy benefited the 
obese women themselves and perhaps their children. In this study, the walking intervention 
during pregnancy was successful in changing the intensity/pattern of walking, and obese 
participants were able to sustain the walking until later in pregnancy. The 2008 Physical 
Activity Guidelines for Americans states that some physical activity is better than none (57).  
Perhaps for some populations like obese pregnant women, we may need to consider that the 
amount of walking is not as important as how the walking is performed.    
In conclusion, maternal obesity and excessive GWG cause a perpetuating “vicious 
cycle” of obesity, where obese women or women who gain excess gestational weight have a 
higher risk of giving birth to large for gestational age infants, who then, years later, can 
become obese adults entering into their own pregnancies. These women are also more likely 
to retain gestational weight, which then leads to higher weight status for future pregnancies. 
Therefore, targeting PA interventions for overweight and obese women during pregnancy 
could be a promising starting point for obesity prevention. Figure 2 serves as a summary of 
the overall impact of the Moms To Move Study on the “vicious cycle” of obesity. The 
findings of the present study will serve as preliminary data for future investigations in a 
larger randomized-controlled trial. 
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Figure 2: Overall impact of the Moms To Move Study on the “vicious cycle” of obesity. 
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APPENDIX A. RECRUITMENT MATERIALS 
 
Copy of email to send to ISU faculty, staff and students: 
Are you or is someone you know pregnant? 
We are conducting a study to better understand how walking can benefit women during 
pregnancy.  
QUALIFICATION CRITERIA INCLUDES: 
 
 Less than 14 weeks pregnant   
 At least 18 years of age 
 Exercise less than 3 days a week 
 Pregnant with only one baby 
 Non-smoker 
 No physical restrictions to walking 30 min at a time 
 No history of gestational diabetes, chronic disease, lung or thyroid disorder 
 No use of pacemaker or portable oxygen 
 
A maximum of 6 study sessions are required. Eligible participants will be 
compensated. Participation is voluntary. 
For further information: 
Call the Recruitment Team at 515-294-8673 or email: blossomproject@iastate.edu 
The Blossom Project is affiliated with Iowa State University.   
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APPENDIX B. APPROVED CONSENT FORM 
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APPENDIX C. M2M STUDY TIMELINE 
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APPENDIX D. MEDICAL HISTORY FORM 
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APPENDIX E. MEDICAL PROVIDER RELEASE FORM 
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APPENDIX F. THREE-DAY DIET RECORD INSTRUCTIONS 
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APPENDIX G. SELF-EFFICACY QUESTIONNAIRES 
 
 
 
 
Task Self-efficacy Questionnaire: 
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APPENDIX H. POST-PARTUM QUESTIONNAIRES 
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APPENDIX I. BLOOD PROFILES OF PARTICIPANTS 
 
 
Blood profiles of participants at all gestational time point and one month post‐
partum 
Variables  Overweight  Obese 
   Intervention  Control  Intervention  Control 
  V1 (10 ‐ 14 weeks of gestation) 
  n = 9  n = 10  n = 9  n = 9 
Glucose (mg/dL)  87.1 ± 3.8  86.9 ± 6.1  86.1 ± 5.7  86.6 ± 4.8 
Triacylglycerides (mg/dL)  121.7 ± 57.8  91.0 ± 30.9  150.0 ± 62.0  121.8 ± 36.6 
HDL (mg/dL)  62.4 ± 10.6  64.9 ± 10.1  61.3 ± 10.1  61.7 ± 10.2 
LDL (mg/dL)  92.8 ± 12.2  94.8 ± 33.4  103.2 ± 19.8  112.0 ± 32.3 
Total cholesterol (mg/dL)  179.7 ± 10.9  177.9 ± 40.1  194.6 ± 25.8  197.8 ± 36.0 
Iron (mcg/dL)  110.9 ± 28.2  99.4 ± 35.8  86.6 ± 38.2  98.1 ± 25.8 
  V2 (17 ‐ 19 weeks of gestation) 
  n = 9  n = 10  n = 9  n = 8 
Glucose (mg/dL)  84.7 ± 6.5  84.1 ± 3.8  83.7 ± 9.6  83.5 ± 5.6 
Triacylglycerides (mg/dL)  162.3 ± 59.8  131.4 ± 47.7  201.9 ± 76.7  156.9 ± 43.9  
HDL (mg/dL)  66.9 ± 10.6  64.5 ± 12.8  61.0 ± 8.3  64.9 ± 15.6  
LDL (mg/dL)  106.9 ± 14.9  108.4 ± 32.2  106.3 ± 17.3  111.8 ± 37.0 
Total cholesterol (mg/dL)  206.3 ± 23.5  199.1 ± 39.2  207.7 ± 23.9  208.0 ± 39.5 
Iron (mcg/dL)  113.7 ± 41.9  93.4 ± 30.3  85.4 ± 28.5  102.9 ± 62.6 
  V3 (27 ‐ 29 weeks of gestation) 
  n = 9  n = 7  n = 8  n = 6 
Glucose (mg/dL)  86.0 ± 7.1  83.0 ± 5.3  81.3 ± 8.6  86.3 ± 6.5 
Triacylglycerides (mg/dL)  185.8 ± 53.7  168.1 ± 33.6  245.4 ± 84.4  216.5 ± 79.5 
HDL (mg/dL)  75.9 ± 12.7  75.3 ± 13.6  68.1 ± 7.5  64.0 ± 17.4 
LDL (mg/dL)  133.8 ± 31.0  143.4 ± 42.9  129.7 ± 27.8  132.2 ± 34.5 
Total cholesterol (mg/dL)  246.8 ± 39.1  252.4 ± 40.2  247.9 ± 25.7  239.3 ± 35.5 
Iron (mcg/dL)  76.3 ± 22.2  94.0 ± 31.0   91.4 ± 34.3  70.5 ± 29.4 
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   V4 (34 ‐ 36 weeks of gestation) 
  n = 9  n = 7  n = 8  n = 6 
Glucose (mg/dL)  82.7 ± 9.5  83.4 ± 2.9  85.6 ± 8.4  89.3 ± 6.2 
Triacylglycerides (mg/dL)  221.6 ± 61.0  207.1 ± 80.6  275.1 ± 79.2  242.2 ± 79.2 
HDL (mg/dL)  67.1 ± 11.3  68.0 ± 17.5  65.5 ± 8.7  64.0 ± 12.2 
LDL (mg/dL)  137.0 ± 42.6  140.9 ± 33.9  133.0 ± 35.4  127.7 ± 42.9 
Total cholesterol (mg/dL)  248.4 ± 50.1  250.4 ± 43.2  252.8 ± 30.6  240.2 ± 41.4 
Iron (mcg/dL)  57.9 ± 14.3   98.0 ± 29.2  71.6 ± 35.9  72.8 ± 32.8 
  V5 (1‐month post‐partum) 
  n = 6  n = 6  n = 6  n = 5 
Glucose (mg/dL)  88.7 ± 6.3  88.0 ± 6.6  85.2 ± 7.3  89.0 ± 4.5 
Triacylglycerides (mg/dL)  130.8 ± 77.5  96.5 ± 58.5  163.8 ± 52.4  116.0 ± 52.6 
HDL (mg/dL)  48.2 ± 8.1  59.5 ± 9.4  53.7 ± 2.9  52.8 ± 5.1 
LDL (mg/dL)  110.3 ± 15.2  129.2 ± 37.3  150.8 ± 23.7  124.0 ± 38.2 
Total cholesterol (mg/dL)  184.5 ± 16.7  208.0 ± 44.8  237.3 ± 27.4  200.0 ± 47.3 
Iron (mcg/dL)  61.2 ± 10.5  95.2 ± 21.8  71.3 ± 34.1  121.6 ± 66.9 
 Values shown are mean ± SD        
HDL = high‐density lipoprotein; LDL = low‐density lipoprotein     
 
 
 
 
 
 
 
 
 
 
  
